{
  "metadata": {
    "config": {
      "backend": {
        "_target_": "cotlab.backends.VLLMBackend",
        "tensor_parallel_size": 1,
        "dtype": "bfloat16",
        "trust_remote_code": true,
        "max_model_len": 4096
      },
      "model": {
        "name": "google/medgemma-4b-it",
        "variant": "4b",
        "max_new_tokens": 512,
        "temperature": 0.7,
        "top_p": 0.9,
        "safe_name": "medgemma_4b"
      },
      "prompt": {
        "_target_": "cotlab.prompts.OncologyPromptStrategy",
        "name": "oncology",
        "contrarian": true,
        "few_shot": true,
        "answer_first": false,
        "output_format": "json"
      },
      "dataset": {
        "_target_": "cotlab.datasets.OncologyDataset",
        "name": "oncology",
        "path": "data/oncology.json"
      },
      "experiment": {
        "_target_": "cotlab.experiments.RadiologyExperiment",
        "name": "radiology",
        "description": "Pathological fracture detection from radiology reports",
        "num_samples": -1
      },
      "seed": 42,
      "verbose": true,
      "dry_run": false
    },
    "start_time": "2026-01-10T19:19:53.021976"
  },
  "experiment": "radiology",
  "model": "google/medgemma-4b-it",
  "prompt_strategy": "oncology",
  "metrics": {
    "correct": 100,
    "incorrect": 0,
    "true_positives": 50,
    "true_negatives": 50,
    "false_positives": 0,
    "false_negatives": 0,
    "parse_errors": 0,
    "accuracy": 1.0,
    "parse_error_rate": 0.0,
    "precision": 1.0,
    "recall": 1.0,
    "f1": 1.0
  },
  "raw_outputs": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"clinical improvement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a past infection or inflammatory process be masked by a currently normal presentation? Could a very early, subtle malignancy be missed? The report clearly states that the patient had a resolved febrile illness, blood counts have normalized, there is no organomegaly, and there is clinical improvement. Furthermore, the report explicitly states that no malignancy is identified. Although a very early or subtle malignancy is not impossible, the provided information is highly reassuring and does not indicate malignancy. Therefore, I am confident in stating that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"clinical improvement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a past infection or inflammatory process be masked by a currently normal presentation? Could a very early, subtle malignancy be missed? The report clearly states that the patient had a resolved febrile illness, blood counts have normalized, there is no organomegaly, and there is clinical improvement. Furthermore, the report explicitly states that no malignancy is identified. Although a very early or subtle malignancy is not impossible, the provided information is highly reassuring and does not indicate malignancy. Therefore, I am confident in stating that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"clinical improvement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a past infection or inflammatory process be masked by a currently normal presentation? Could a very early, subtle malignancy be missed? The report clearly states that the patient had a resolved febrile illness, blood counts have normalized, there is no organomegaly, and there is clinical improvement. Furthermore, the report explicitly states that no malignancy is identified. Although",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a past infection or inflammatory process be masked by a currently normal presentation? Could a very early, subtle malignancy be missed? The report clearly states that the patient had a resolved febrile illness, blood counts have normalized, there is no organomegaly, and there is clinical improvement. Furthermore, the report explicitly states that no malignancy is identified. Although a very early or subtle malignancy is not impossible, the provided information is highly reassuring and does not indicate malignancy. Therefore, I am confident in stating that no malignancy is present.",
      "findings": [
        "resolved febrile illness",
        "normalized blood counts",
        "no organomegaly",
        "clinical improvement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T19:20:55.840311"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a benign mass with secondary enhancement and hydrocephalus? However, the report explicitly mentions high-grade medulloblastoma on histology, which is a specific type of brain tumor. The presence of restricted diffusion further supports a malignant process. Alternative benign explanations are less likely given the specific diagnosis of medulloblastoma. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a benign mass with secondary enhancement and hydrocephalus? However, the report explicitly mentions high-grade medulloblastoma on histology, which is a specific type of brain tumor. The presence of restricted diffusion further supports a malignant process. Alternative benign explanations are less likely given the specific diagnosis of medulloblastoma. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a benign mass with secondary enhancement and hydrocephalus? However, the report explicitly mentions high-grade medulloblastoma on histology, which is a specific type of brain tumor. The presence of restricted diffusion further supports a malignant process. Alternative benign explanations are less likely given the specific diagnosis of medulloblastoma. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be a benign mass with secondary enhancement and hydrocephalus? However, the report explicitly mentions high-grade medulloblastoma on histology, which is a specific type of brain tumor. The presence of restricted diffusion further supports a malignant process. Alternative benign explanations are less likely given the specific diagnosis of medulloblastoma. Conclusion: malignancy confirmed, despite initial skepticism.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T19:20:55.840341"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could the reactive lymphadenopathy be subtle? While the report states 'no atypical features' and 'no malignancy identified', the presence of reactive lymphadenopathy itself warrants a degree of caution. The decreasing node size supports the benign nature of the finding. While the report explicitly states 'no malignancy identified', the possibility of a very early, subtle malignancy cannot be completely excluded without further investigation. Alternative benign explanations (viral infection) are supported by the report's findings. Conclusion: While the report provides reassurance, the presence of reactive lymphadenopathy necessitates follow-up to ensure its resolution and rule out any potential for early malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the reactive lymphadenopathy be subtle? While the report states 'no atypical features' and 'no malignancy identified', the presence of reactive lymphadenopathy itself warrants a degree of caution. The decreasing node size supports the benign nature of the finding. While the report explicitly states 'no malignancy identified', the possibility of a very early, subtle malignancy cannot be completely excluded without further investigation. Alternative benign explanations (viral infection) are supported by the report's findings. Conclusion: While the report provides reassurance, the presence of reactive lymphadenopathy necessitates follow-up to ensure its resolution and rule out any potential for early malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the reactive lymphadenopathy be subtle? While the report states 'no atypical features' and 'no malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could the reactive lymphadenopathy be subtle? While the report states 'no atypical features' and 'no malignancy identified', the presence of reactive lymphadenopathy itself warrants a degree of caution. The decreasing node size supports the benign nature of the finding. While the report explicitly states 'no malignancy identified', the possibility of a very early, subtle malignancy cannot be completely excluded without further investigation. Alternative benign explanations (viral infection) are supported by the report's findings. Conclusion: While the report provides reassurance, the presence of reactive lymphadenopathy necessitates follow-up to ensure its resolution and rule out any potential for early malignancy.",
      "findings": [
        "reactive lymphadenopathy secondary to viral infection",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T19:20:55.840365"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the lymphadenopathy be reactive? However, the biopsy confirming Burkitt lymphoma and elevated LDH levels provide strong evidence of malignancy. Alternative benign explanations (e.g., infection, inflammation) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the lymphadenopathy be reactive? However, the biopsy confirming Burkitt lymphoma and elevated LDH levels provide strong evidence of malignancy. Alternative benign explanations (e.g., infection, inflammation) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the lymphadenopathy be reactive? However, the biopsy confirming Burkitt lymphoma and elevated LDH levels provide strong evidence of malignancy. Alternative benign explanations (e.g., infection, inflammation) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the lymphadenopathy be reactive? However, the biopsy confirming Burkitt lymphoma and elevated LDH levels provide strong evidence of malignancy.",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the lymphadenopathy be reactive? However, the biopsy confirming Burkitt lymphoma and elevated LDH levels provide strong evidence of malignancy. Alternative benign explanations (e.g., infection, inflammation) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed despite initial skepticism.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "high LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T19:20:55.840382"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and the absence of CNS involvement provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Applying skeptical reasoning: Could high lymphocyte count be reactive? Playing devil's advocate against a benign conclusion: the report shows bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. However, the clinical context of suspected ALL and the presence of lymphoblasts makes malignancy the most likely explanation. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Applying skeptical reasoning: Could high lymphocyte count be reactive? Playing devil's advocate against a benign conclusion: the report shows bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. However, the clinical context of suspected ALL and the presence of lymphoblasts makes malignancy the most likely explanation. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and the absence of CNS involvement provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T19:20:55.840400"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be a manifestation of a low-grade malignancy? However, the report explicitly states that the lymphadenopathy is reactive and decreasing in size. No atypical features are noted. The final statement confirms that no malignancy was identified. The reassurance provided further supports the benign nature of the findings. Alternative benign explanations (viral infection, post-infectious lymphadenopathy) are supported by the report. Conclusion: Reactive lymphadenopathy is the most likely explanation, ruling out malignancy. No need for further investigation.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could reactive lymphadenopathy be a manifestation of a low-grade malignancy? However, the report explicitly states that the lymphadenopathy is reactive and decreasing in size. No atypical features are noted. The final statement confirms that no malignancy was identified. The reassurance provided further supports the benign nature of the findings. Alternative benign explanations (viral infection, post-infectious lymphadenopathy) are supported by the report. Conclusion: Reactive lymphadenopathy is the most likely explanation, ruling out malignancy. No need for further investigation.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could reactive lymphadenopathy be a manifestation of a low-grade malignancy? However, the report explicitly states that the lymphadenopathy is reactive and decreasing in size. No atypical features are noted. The final statement confirms that no malignancy was identified. The reassurance provided further supports the benign nature of the findings.",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could reactive lymphadenopathy be a manifestation of a low-grade malignancy? However, the report explicitly states that the lymphadenopathy is reactive and decreasing in size. No atypical features are noted. The final statement confirms that no malignancy was identified. The reassurance provided further supports the benign nature of the findings. Alternative benign explanations (viral infection, post-infectious lymphadenopathy) are supported by the report. Conclusion: Reactive lymphadenopathy is the most likely explanation, ruling out malignancy. No need for further investigation.",
      "findings": [
        "reactive lymphadenopathy",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T19:20:55.840421"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign lesion? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggest neuroblastoma. Stage III disease further supports this diagnosis. Alternative benign explanations (e.g., other types of tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign lesion? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggest neuroblastoma. Stage III disease further supports this diagnosis. Alternative benign explanations (e.g., other types of tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign lesion? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggest neuroblastoma. Stage III disease further supports this diagnosis. Alternative benign explanations (e.g., other types of tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be a benign lesion? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggest neuroblastoma. Stage III disease further supports this diagnosis. Alternative benign explanations (e.g., other types of tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed based on the report's findings.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T19:20:55.840438"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. The patient has no prior oncology history. The reassurance provided by the consultant reinforces the absence of malignancy. Therefore, the likelihood of malignancy is extremely low. No abnormalities were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. The patient has no prior oncology history. The reassurance provided by the consultant reinforces the absence of malignancy. Therefore, the likelihood of malignancy is extremely low. No abnormalities were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. The patient has no prior oncology history. The reassurance provided by the consultant reinforces the absence of malignancy. Therefore, the likelihood of malignancy is extremely low. No abnormalities were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. The patient has no prior oncology history. The reassurance provided",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. The patient has no prior oncology history. The reassurance provided by the consultant reinforces the absence of malignancy. Therefore, the likelihood of malignancy is extremely low. No abnormalities were found.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T19:20:55.840463"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: The report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: The report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: The report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: The report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"ab",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: The report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.",
      "findings": [
        "Normal CBC",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T19:20:55.840480"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\", \"Wilms Tumor\"],\n        \"rationale\": \"Initial skepticism: Could a benign renal cyst be misinterpreted as a mass? However, the report explicitly mentions a 'large heterogeneous left renal mass with pseudocapsule', which is highly suggestive of a neoplasm. The absence of vascular invasion and the presence of 'favorable histology' on biopsy further support the diagnosis of Wilms Tumor. The report also confirms the diagnosis of Wilms Tumor and provides staging information. Alternative benign explanations (renal cyst, angiomyolipoma) are ruled out by the presence of a mass, heterogeneous appearance, and the report of a Wilms Tumor. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\", \"Wilms Tumor\"],\n        \"rationale\": \"Initial skepticism: Could a benign renal cyst be misinterpreted as a mass? However, the report explicitly mentions a 'large heterogeneous left renal mass with pseudocapsule', which is highly suggestive of a neoplasm. The absence of vascular invasion and the presence of 'favorable histology' on biopsy further support the diagnosis of Wilms Tumor. The report also confirms the diagnosis of Wilms Tumor and provides staging information. Alternative benign explanations (renal cyst, angiomyolipoma) are ruled out by the presence of a mass, heterogeneous appearance, and the report of a Wilms Tumor. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\", \"Wilms Tumor\"],\n        \"rationale\": \"Initial skepticism: Could a benign renal cyst be misinterpreted as a mass? However, the report explicitly mentions a 'large heterogeneous left renal",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a benign renal cyst be misinterpreted as a mass? However, the report explicitly mentions a 'large heterogeneous left renal mass with pseudocapsule', which is highly suggestive of a neoplasm. The absence of vascular invasion and the presence of 'favorable histology' on biopsy further support the diagnosis of Wilms Tumor. The report also confirms the diagnosis of Wilms Tumor and provides staging information. Alternative benign explanations (renal cyst, angiomyolipoma) are ruled out by the presence of a mass, heterogeneous appearance, and the report of a Wilms Tumor. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II",
        "Wilms Tumor"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T19:20:55.840503"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mediastinal mass be reactive? However, the presence of bulky anterior mediastinal mass, FDG-avid nodes, and the description of Classical Hodgkin, nodular sclerosing type strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory response) are less likely given the FDG-avid nature and the specific Hodgkin subtype. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mediastinal mass be reactive? However, the presence of bulky anterior mediastinal mass, FDG-avid nodes, and the description of Classical Hodgkin, nodular sclerosing type strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory response) are less likely given the FDG-avid nature and the specific Hodgkin subtype. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mediastinal mass be reactive? However, the presence of bulky anterior mediastinal mass, FDG-avid nodes, and the description of Classical Hodgkin, nodular sclerosing type strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory response) are less likely given the FDG-avid nature and the specific Hodgkin subtype. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mediastinal mass be reactive? However, the presence of bulky anterior mediastinal mass, FDG-avid nodes, and the description of Classical Hodgkin, nodular sclerosing type strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory response) are less likely given the FDG-avid nature and the specific Hodgkin subtype. Conclusion: Malignancy confirmed.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T19:20:55.840519"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Skepticism: Could the mass be benign? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines are highly suggestive of neuroblastoma, a known childhood cancer. Stage III disease further strengthens this suspicion. Alternative benign explanations (e.g., benign adrenal tumor with reactive calcifications) are less likely given the combination of findings. Conclusion: Malignancy is highly probable, although a definitive diagnosis requires biopsy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report indicates a large heterogeneous suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and Stage III disease. These findings are highly suggestive of neuroblastoma, a known childhood cancer. The presence of calcifications, MIBG avidity, and elevated urinary catecholamines makes it less likely that the mass is benign. Stage III disease further strengthens this suspicion. Alternative benign explanations (e.g., benign adrenal tumor with reactive calcifications) are less likely given the combination of findings. Conclusion: Malignancy is highly probable, although a definitive diagnosis requires biopsy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report indicates a large heterogeneous suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and Stage III disease. These findings are highly suggestive of neuroblastoma, a known childhood cancer. The presence of calcifications, MIBG avidity, and elevated urinary catecholamines makes it less likely that the mass is benign. Stage",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skepticism: Could the mass be benign? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines are highly suggestive of neuroblastoma, a known childhood cancer. Stage III disease further strengthens this suspicion. Alternative benign explanations (e.g., benign adrenal tumor with reactive calcifications) are less likely given the combination of findings. Conclusion: Malignancy is highly probable, although a definitive diagnosis requires biopsy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T19:20:55.840537"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign liver lesion or metastatic disease? However, the report explicitly mentions a 'large heterogeneous hepatic mass' with elevated AFP, 'Fetal histology subtype' and 'PRETEXT stage II' which are all highly suggestive of Hepatoblastoma. Alternative benign explanations (e.g., metastatic disease from another primary, benign liver tumor) are less likely given the specific findings. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign liver lesion or metastatic disease? However, the report explicitly mentions a 'large heterogeneous hepatic mass' with elevated AFP, 'Fetal histology subtype' and 'PRETEXT stage II' which are all highly suggestive of Hepatoblastoma. Alternative benign explanations (e.g., metastatic disease from another primary, benign liver tumor) are less likely given the specific findings. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be a benign liver lesion or metastatic disease? However, the report explicitly mentions a 'large heterogeneous hepatic mass' with elevated AFP, 'Fetal histology subtype' and 'PRETEXT stage II' which are all highly suggestive of Hepatoblastoma. Alternative benign explanations (e.g., metastatic disease from another primary, benign liver tumor) are less likely given the specific findings. Conclusion: malignancy confirmed.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T19:20:55.840554"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"Initial skepticism: Could this be Langerhans Cell Histiocytosis (LCH) with reactive changes? However, the report explicitly states that the lesions are CD1a and Langerin positive, which are characteristic markers of LCH. Lytic lesions are also a key feature of LCH. Alternative benign explanations (e.g., metastasis from another primary) are less likely given the presence of characteristic LCH markers. Conclusion: Given the presence of Lytic lesions with positive CD1a and Langerin, it is likely LCH with a malignant component. Further investigation with biopsy is required for confirmation and classification of the disease. However, based on the current information, it is likely a malignant LCH. \"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"Initial skepticism: Could this be Langerhans Cell Histiocytosis (LCH) with reactive changes? However, the report explicitly states that the lesions are CD1a and Langerin positive, which are characteristic markers of LCH. Lytic lesions are also a key feature of LCH. Alternative benign explanations (e.g., metastasis from another primary) are less likely given the presence of characteristic LCH markers. Conclusion: Given the presence of Lytic lesions with positive CD1a and Langerin, it is likely LCH with a malignant component. Further investigation with biopsy is required for confirmation and classification of the disease. However, based on the current information, it is likely a malignant LCH. \"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"Initial skepticism: Could this be Langerhans Cell Histiocytosis (LCH) with reactive changes? However, the report",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could this be Langerhans Cell Histiocytosis (LCH) with reactive changes? However, the report explicitly states that the lesions are CD1a and Langerin positive, which are characteristic markers of LCH. Lytic lesions are also a key feature of LCH. Alternative benign explanations (e.g., metastasis from another primary) are less likely given the presence of characteristic LCH markers. Conclusion: Given the presence of Lytic lesions with positive CD1a and Langerin, it is likely LCH with a malignant component. Further investigation with biopsy is required for confirmation and classification of the disease. However, based on the current information, it is likely a malignant LCH. ",
      "findings": [
        "multiple lytic skull lesions with soft tissue component",
        "CD1a and Langerin positive"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T19:20:55.840574"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could post-viral lymphocytosis be malignant? Playing devil's advocate against a benign conclusion: the report explicitly states that there is no malignancy identified and that the atypical lymphocytes are resolving. The EBV serology confirms the diagnosis of mononucleosis. The finding of post-viral lymphocytosis is a common and benign response to infection. It is unlikely that the atypical lymphocytes are malignant, given the resolution of the findings and the absence of any other concerning features. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could post-viral lymphocytosis be malignant? Playing devil's advocate against a benign conclusion: the report explicitly states that there is no malignancy identified and that the atypical lymphocytes are resolving. The EBV serology confirms the diagnosis of mononucleosis. The finding of post-viral lymphocytosis is a common and benign response to infection. It is unlikely that the atypical lymphocytes are malignant, given the resolution of the findings and the absence of any other concerning features. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could post-viral lymphocytosis be malignant? Playing devil's advocate against a benign conclusion: the report explicitly states that there is no malignancy identified and that the atypical lymphocytes are resolving. The EBV serology confirms the diagnosis of mononucleosis",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could post-viral lymphocytosis be malignant? Playing devil's advocate against a benign conclusion: the report explicitly states that there is no malignancy identified and that the atypical lymphocytes are resolving. The EBV serology confirms the diagnosis of mononucleosis. The finding of post-viral lymphocytosis is a common and benign response to infection. It is unlikely that the atypical lymphocytes are malignant, given the resolution of the findings and the absence of any other concerning features. Conclusion: No malignancy present.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T19:20:55.840594"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the presence of a specific translocation, t(8;21), is a well-established marker for Acute Myeloid Leukemia (AML). While a reactive process is possible, the t(8;21) translocation strongly suggests AML. Alternative benign explanations (e.g., certain types of reactive marrow changes) are less likely to present with this specific cytogenetic abnormality. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the presence of a specific translocation, t(8;21), is a well-established marker for Acute Myeloid Leukemia (AML). While a reactive process is possible, the t(8;21) translocation strongly suggests AML. Alternative benign explanations (e.g., certain types of reactive marrow changes) are less likely to present with this specific cytogenetic abnormality. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the presence of a specific translocation, t(8;21), is a well-established marker for Acute Myeloid Leukemia (AML). While a reactive process is possible, the t(8;21) translocation strongly suggests AML. Alternative benign explanations (e.g., certain types of reactive marrow changes) are less likely to present with this specific cytogenetic abnormality. Conclusion: Malignancy confirmed",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the presence of a specific translocation, t(8;21), is a well-established marker for Acute Myeloid Leukemia (AML). While a reactive process is possible, the t(8;21) translocation strongly suggests AML. Alternative benign explanations (e.g., certain types of reactive marrow changes) are less likely to present with this specific cytogenetic abnormality. Conclusion: Malignancy confirmed.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T19:20:55.840610"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"Initial skepticism: Could the diagnosis be a misinterpretation or a reactive process? However, the report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension'. These findings are highly suggestive of malignancy, specifically embryonal rhabdomyosarcoma. The presence of a parameningeal mass and intracranial extension further supports the diagnosis. Alternative benign explanations (inflammatory process, reactive lesion) are less likely given the specific diagnosis and the clinical context. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension'. These findings are highly suggestive of malignancy, specifically embryonal rhabdomyosarcoma. The presence of a parameningeal mass and intracranial extension further supports the diagnosis. Alternative benign explanations (inflammatory process, reactive lesion) are less likely given the specific diagnosis and the clinical context. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension'. These findings are highly suggestive of malignancy, specifically embryonal rhabdomyosarcoma. The presence of a parameningeal mass and intracranial extension further supports the diagnosis. Alternative benign explanations (inflammatory process, reactive lesion) are less likely given the specific diagnosis and the clinical context. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the diagnosis be a misinterpretation or a reactive process? However, the report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension'. These findings are highly suggestive of malignancy, specifically embryonal rhabdomyosarcoma. The presence of a parameningeal mass and intracranial extension further supports the diagnosis. Alternative benign explanations (inflammatory process, reactive lesion) are less likely given the specific diagnosis and the clinical context. Conclusion: Malignancy confirmed despite initial skepticism.",
      "findings": [
        "embryonal rhabdomyosarcoma",
        "parameningeal mass with intracranial extension"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T19:20:55.840629"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. The chest radiograph is normal, with no mediastinal mass or other concerning findings. The heart size is normal. Therefore, there is no evidence of malignancy. Skepticism is unnecessary.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no previous oncology history\", \"no previous malignancy identified\"],\n        \"rationale\": \"The patient has no history of malignancy, and the report explicitly states that no malignancy was identified. This makes the screening unnecessary, and therefore, the report is valid. Skepticism is unwarranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. The chest radiograph is normal, with no mediastinal mass or other concerning findings. The heart size is normal. Therefore, there is no evidence of malignancy. Skepticism is unnecessary.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no previous oncology history\", \"no previous malignancy identified\"],\n        \"rationale\": \"The patient has no history of malignancy, and the report explicitly states that no malignancy was identified. This makes the screening unnecessary, and therefore, the report is valid. Skepticism is unwarranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there is no malignancy identified. The chest radiograph is normal, with no mediastinal mass or other concerning findings. The heart size is normal. Therefore, there is no evidence of malignancy. Skepticism is unnecessary.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T19:20:55.840642"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a reactive process? However, the presence of a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirmation of high-grade medulloblastoma on histology strongly suggests malignancy. Alternative benign explanations are ruled out by the histological confirmation. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a reactive process? However, the presence of a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirmation of high-grade medulloblastoma on histology strongly suggests malignancy. Alternative benign explanations are ruled out by the histological confirmation. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a reactive process? However, the presence of a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirmation of high-grade medulloblastoma on histology strongly suggests malignancy. Alternative benign explanations are ruled out by the histological confirmation. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a reactive process? However, the presence of a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be a reactive process? However, the presence of a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirmation of high-grade medulloblastoma on histology strongly suggests malignancy. Alternative benign explanations are ruled out by the histological confirmation. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T19:20:55.840658"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the imaging findings be due to benign processes? However, the presence of a large heterogeneous suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggests Neuroblastoma, a known childhood malignancy. The Stage III disease designation further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcifications, benign catecholamine-secreting tumor) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely based on the imaging findings and clinical context.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines. This presentation is highly suggestive of Neuroblastoma, a pediatric malignancy. The Stage III designation further supports this diagnosis. While a benign explanation is possible, it is less likely given the combination of findings. Conclusion: Malignancy is a strong possibility.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines. This presentation is highly suggestive of Neuroblastoma, a pediatric malignancy. The Stage III designation further supports this diagnosis. While a benign explanation is possible, it is less likely given the combination of findings. Conclusion: Malignancy is a strong possibility.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the imaging findings be due to benign processes? However, the presence of a large heterogeneous suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggests Neuroblastoma, a known childhood malignancy. The Stage III disease designation further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcifications, benign catecholamine-secreting tumor) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely based on the imaging findings and clinical context.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T19:20:55.840677"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be benign, or a reactive process? However, the report explicitly states a 'large heterogeneous left renal mass with pseudocapsule', 'no vascular invasion', 'favorable histology on biopsy', and 'stage II'. These findings are consistent with Wilms Tumor. Alternative benign explanations (e.g., cysts, renal vein thrombosis) are less likely given the report's findings. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be benign, or a reactive process? However, the report explicitly states a 'large heterogeneous left renal mass with pseudocapsule', 'no vascular invasion', 'favorable histology on biopsy', and 'stage II'. These findings are consistent with Wilms Tumor. Alternative benign explanations (e.g., cysts, renal vein thrombosis) are less likely given the report's findings. Conclusion: malignancy confirmed.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T19:20:55.840693"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that the surveillance is missing something? Playing devil's advocate against a benign conclusion: the report states that the brain MRI is normal, with no mass lesions, abnormal enhancement, or malignancy identified. The surveillance is routine, and there is no indication of a problem. Conclusion: No malignancy detected. A normal brain MRI with no evidence of malignancy does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that the surveillance is missing something? Playing devil's advocate against a benign conclusion: the report states that the brain MRI is normal, with no mass lesions, abnormal enhancement, or malignancy identified. The surveillance is routine, and there is no indication of a problem. Conclusion: No malignancy detected. A normal brain MRI with no evidence of malignancy does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that the surveillance is missing something? Playing devil's advocate against a benign conclusion: the report states that the brain MRI is normal, with no mass lesions, abnormal enhancement, or malignancy identified. The surveillance is routine, and there is no indication of a problem. Conclusion: No malignancy detected. A normal brain MRI with no evidence of malignancy does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Is it possible that the surveillance is missing something? Playing devil's advocate against a benign conclusion: the report states that the brain MRI is normal, with no mass lesions, abnormal enhancement, or malignancy identified. The surveillance is routine, and there is no indication of a problem. Conclusion: No malignancy detected. A normal brain MRI with no evidence of malignancy does not indicate malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T19:20:55.840709"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive? However, the report explicitly mentions a large heterogeneous mass, a pseudocapsule, and a diagnosis of Wilms Tumor, all strongly suggesting malignancy. The favorable histology and stage II are consistent with a diagnosis of Wilms Tumor. Alternative benign explanations (e.g., a benign renal cyst with reactive components) are unlikely given the overall picture. Conclusion: malignancy confirmed based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be benign, even with a mass? Playing devil's advocate against a benign conclusion: The report mentions no vascular invasion and favorable histology, which could potentially point to a benign process. Stage II could be a misdiagnosis, or the tumor could be non-aggressive. Without further information, it is impossible to rule out a benign process. Conclusion: No malignancy detected based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive? However, the report explicitly mentions a large heterogeneous mass, a pseudocapsule, and a diagnosis of Wilms Tumor, all strongly suggesting malignancy. The favorable histology and stage II are consistent with a diagnosis of Wilms Tumor. Alternative benign explanations (e.g., a benign renal cyst with reactive components) are unlikely given the overall picture. Conclusion: malignancy confirmed based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be reactive? However, the report explicitly mentions a large heterogeneous mass, a pseudocapsule, and a diagnosis of Wilms Tumor, all strongly suggesting malignancy. The favorable histology and stage II are consistent with a diagnosis of Wilms Tumor. Alternative benign explanations (e.g., a benign renal cyst with reactive components) are unlikely given the overall picture. Conclusion: malignancy confirmed based on the report's findings.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T19:20:55.840726"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there are no signs of malignancy. The patient's headache is attributed to migraine. There are no abnormal findings. Conclusion: No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there are no signs of malignancy. The patient's headache is attributed to migraine. There are no abnormal findings. Conclusion: No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there are no signs of malignancy. The patient's headache is attributed to migraine. There are no abnormal findings. Conclusion: No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there are no signs of malignancy. The patient's headache is attributed to migraine. There are no abnormal findings. Conclusion: No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal, and there are no signs of malignancy. The patient's headache is attributed to migraine. There are no abnormal findings. Conclusion: No evidence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T19:20:55.840740"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that there is a very early malignancy which is not yet visible on the PET-CT scan? The report explicitly states that no malignancy was identified. This is reassuring. There is no evidence of any abnormality. Conclusion: No malignancy identified. No evidence of malignancy. The report is reassuring and provides a definitive answer. Skeptical approach does not change the conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\", \"no abnormal features\", \"no evidence of disease\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a very subtle, early-stage malignancy that the scan missed? While the report states there are no findings of malignancy, the wording is broad. It's possible that a very small, early-stage tumor could be missed. However, the report also states that there are no abnormal features and no evidence of disease, which is reassuring. Overall, the report is reassuring. Conclusion: No evidence of malignancy. The report is definitive and reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\", \"no suspicious lesions\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that there is a very subtle, early-stage malignancy that the scan missed? While the report states there are no findings of malignancy, the wording is broad. It's possible that a very small, early-stage tumor could be missed. However, the report also states that there are no abnormal features and no suspicious lesions, which is reassuring. Overall, the report is reassuring. Conclusion: No evidence of malignancy. The report is definitive and reassuring. Skeptical approach does not change the conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Is it possible that there is a very early malignancy which is not yet visible on the PET-CT scan? The report explicitly states that no malignancy was identified. This is reassuring. There is no evidence of any abnormality. Conclusion: No malignancy identified. No evidence of malignancy. The report is reassuring and provides a definitive answer. Skeptical approach does not change the conclusion.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T19:20:55.840756"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could this be a very aggressive infection or inflammatory process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction, and, most importantly, the EWSR1 fusion positivity strongly suggest Ewing Sarcoma. While infection could cause some of these findings, the EWSR1 fusion is highly specific for this type of cancer. Alternative benign explanations are highly unlikely given the clinical context and the presence of a fusion. Conclusion: malignancy confirmed, despite initial skepticism based on the specific findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could this be a very aggressive infection or inflammatory process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction, and, most importantly, the EWSR1 fusion positivity strongly suggest Ewing Sarcoma. While infection could cause some of these findings, the EWSR1 fusion is highly specific for this type of cancer. Alternative benign explanations are highly unlikely given the clinical context and the presence of a fusion. Conclusion: malignancy confirmed, despite initial skepticism based on the specific findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could this be a very aggressive infection or inflammatory process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction, and",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could this be a very aggressive infection or inflammatory process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction, and, most importantly, the EWSR1 fusion positivity strongly suggest Ewing Sarcoma. While infection could cause some of these findings, the EWSR1 fusion is highly specific for this type of cancer. Alternative benign explanations are highly unlikely given the clinical context and the presence of a fusion. Conclusion: malignancy confirmed, despite initial skepticism based on the specific findings.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T19:20:55.840776"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the findings be reactive? However, the report explicitly mentions Burkitt lymphoma confirmed on biopsy, along with abdominal lymphadenopathy and high LDH levels. This points to a malignancy, specifically Burkitt lymphoma. The patient's history of Non-Hodgkin Lymphoma further supports the diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be reactive? The report explicitly mentions Burkitt lymphoma confirmed on biopsy, along with abdominal lymphadenopathy and high LDH levels. This points to a malignancy, specifically Burkitt lymphoma. The patient's history of Non-Hodgkin Lymphoma further supports the diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the findings be reactive? However, the report explicitly mentions Burkitt lymphoma confirmed on biopsy, along with abdominal lymphadenopathy and high LDH levels. This points to a malignancy, specifically Burkitt lymphoma. The patient's history of Non-Hodgkin Lymphoma further supports the diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be reactive? However, the report explicitly mentions Burkitt lymphoma confirmed on biopsy, along with abdominal lymphadenopathy and high LDH levels. This points to a malignancy, specifically Burkitt lymphoma. The patient's history of Non-Hodgkin Lymphoma further supports the diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T19:20:55.840792"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified, and that the fracture is healing normally. The bone density is normal, which is reassuring. No pathological features are present. Therefore, the likelihood of malignancy is extremely low. The patient is being reassured, which further supports the conclusion that there is no malignancy present. Conclusion: No malignancy identified. The report provides sufficient evidence to rule out malignancy. Skeptical reasoning has been applied and no alternative explanations for the findings have been identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"normal bone density\"],\n        \"rationale\": \"The report explicitly mentions 'no pathological features' and 'normal bone density'. This strongly suggests that there is no underlying malignancy. The healing fracture is a normal process. Therefore, the findings are consistent with a benign condition. Skeptical reasoning has been applied, and no alternative explanations for the findings have been identified. Conclusion: No malignancy identified. The report provides sufficient evidence to rule out malignancy. Skeptical reasoning has been applied and no alternative explanations for the findings have been identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"normal bone density\", \"healing fracture\"],\n        \"rationale\": \"The report clearly states that there are no pathological features, and that the bone density is normal. This is reassuring. The healing fracture is a normal process. The report also explicitly states that there is no malignancy identified. Skeptical reasoning has been applied, and no alternative explanations for the findings have been identified. Conclusion: No malignancy identified. The report provides sufficient evidence to rule out malignancy. Skeptical reasoning has been applied and no alternative explanations for the findings have been identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there is no malignancy identified, and that the fracture is healing normally. The bone density is normal, which is reassuring. No pathological features are present. Therefore, the likelihood of malignancy is extremely low. The patient is being reassured, which further supports the conclusion that there is no malignancy present. Conclusion: No malignancy identified. The report provides sufficient evidence to rule out malignancy. Skeptical reasoning has been applied and no alternative explanations for the findings have been identified.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T19:20:55.840811"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a subtle, early malignant process that has resolved? While the report explicitly states 'No malignancy identified', it's important to consider if a very early, indolent malignancy might have been present and subsequently resolved. However, the description of a benign bone cyst, lack of aggressive features, and normal bone density make this highly unlikely. The reassurance provided further strengthens the conclusion that malignancy is not present. Alternative benign explanations (e.g., transient inflammatory process) are considered, but the overall picture points towards a benign resolution of a bone cyst.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a subtle, early malignant process that has resolved? While the report explicitly states 'No malignancy identified', it's important to consider if a very early, indolent malignancy might have been present and subsequently resolved. However, the description of a benign bone cyst, lack of aggressive features, and normal bone density make this highly unlikely. The reassurance provided further strengthens the conclusion that malignancy is not present. Alternative benign explanations (e.g., transient inflammatory process) are considered, but the overall picture points towards a benign resolution of a bone cyst.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a subtle, early malignant process that has resolved? While the report explicitly states 'No malignancy identified', it's important to consider if a very early, indolent malignancy might have been present and subsequently resolved. However, the description",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could there be a subtle, early malignant process that has resolved? While the report explicitly states 'No malignancy identified', it's important to consider if a very early, indolent malignancy might have been present and subsequently resolved. However, the description of a benign bone cyst, lack of aggressive features, and normal bone density make this highly unlikely. The reassurance provided further strengthens the conclusion that malignancy is not present. Alternative benign explanations (e.g., transient inflammatory process) are considered, but the overall picture points towards a benign resolution of a bone cyst.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T19:20:55.840831"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Skeptical analysis: The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated catecholamines. These findings are highly suggestive of neuroblastoma, a childhood cancer. The stage III designation further supports this suspicion. While the report does not explicitly state malignancy, the constellation of findings strongly indicates it. Alternative benign explanations (e.g., benign adrenal tumor, reactive process) are less likely given the MIBG avidity and elevated catecholamines. Conclusion: Malignancy is highly probable based on the report findings. Further investigation and MDT discussion are warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be explained by a benign process? While the report describes a suprarenal mass with calcifications, MIBG avidity, and elevated catecholamines, it is important to consider if these findings could be explained by a benign process. The presence of calcifications and MIBG avidity could be due to a benign adrenal tumor. However, the elevated urinary catecholamines and Stage III disease suggest a more serious pathology. Therefore, it is important to consider the possibility of malignancy. Alternative benign explanations (e.g., reactive process) are less likely given the MIBG avidity and elevated catecholamines. Conclusion: Malignancy is likely given the report findings. Further investigation and MDT discussion are warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the findings be explained by a benign process?",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated catecholamines. These findings are highly suggestive of neuroblastoma, a childhood cancer. The stage III designation further supports this suspicion. While the report does not explicitly state malignancy, the constellation of findings strongly indicates it. Alternative benign explanations (e.g., benign adrenal tumor, reactive process) are less likely given the MIBG avidity and elevated catecholamines. Conclusion: Malignancy is highly probable based on the report findings. Further investigation and MDT discussion are warranted.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T19:20:55.840851"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the enhancement be from a benign cause? However, the report explicitly states 'high-grade medulloblastoma on histology' and 'restricted diffusion', both of which strongly suggest malignancy. The presence of hydrocephalus further supports a mass effect. Alternative benign explanations (e.g., vascular malformation) are less likely given the histological confirmation. Conclusion: Malignancy confirmed based on the presence of a high-grade medulloblastoma and associated findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the enhancement be from a benign cause? However, the report explicitly states 'high-grade medulloblastoma on histology' and 'restricted diffusion', both of which strongly suggest malignancy. The presence of hydrocephalus further supports a mass effect. Alternative benign explanations (e.g., vascular malformation) are less likely given the histological confirmation. Conclusion: Malignancy confirmed based on the presence of a high-grade medulloblastoma and associated findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the enhancement be from a benign cause? However, the report explicitly states 'high-grade medulloblastoma on histology' and 'restricted diffusion', both of which strongly suggest malignancy. The presence of hydrocephalus further supports a mass effect. Alternative benign explanations (e.g., vascular malformation) are less likely given the histological confirmation. Conclusion: Malignancy confirmed based on the presence of a high-grade medulloblastoma and associated findings.\"\n    }\n}\n```\n```json\n{\n    ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the enhancement be from a benign cause? However, the report explicitly states 'high-grade medulloblastoma on histology' and 'restricted diffusion', both of which strongly suggest malignancy. The presence of hydrocephalus further supports a mass effect. Alternative benign explanations (e.g., vascular malformation) are less likely given the histological confirmation. Conclusion: Malignancy confirmed based on the presence of a high-grade medulloblastoma and associated findings.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T19:20:55.840885"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Normal heart size\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is the report truly benign, or is there a subtle abnormality missed? Playing devil's advocate against a benign conclusion: The report explicitly states a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and no malignancy identified. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Normal heart size\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is the report truly benign, or is there a subtle abnormality missed? Playing devil's advocate against a benign conclusion: The report explicitly states a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and no malignancy identified. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Normal heart size\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is the report truly benign, or is there a subtle abnormality missed? Playing devil's advocate against a benign conclusion: The report explicitly states a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and no malignancy identified. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Is the report truly benign, or is there a subtle abnormality missed? Playing devil's advocate against a benign conclusion: The report explicitly states a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and no malignancy identified. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. Conclusion: No malignancy identified.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Normal heart size",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T19:20:55.840902"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign condition? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor, specifically a yolk sac tumor. Alternative benign explanations (e.g., non-cancerous tumors) are unlikely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign condition? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor, specifically a yolk sac tumor. Alternative benign explanations (e.g., non-cancerous tumors) are unlikely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign condition? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor, specifically a yolk sac tumor. Alternative benign explanations (e.g., non-cancerous tumors) are unlikely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be due to a benign condition? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor, specifically a yolk sac tumor. Alternative benign explanations (e.g., non-cancerous tumors) are unlikely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "sacrococcygeal mass",
        "mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T19:20:55.840917"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skepticism: Could the findings be due to a benign inflammatory process? However, the description of bulky mass, FDG-avid nodes, and the confirmed diagnosis of classical Hodgkin lymphoma strongly suggests malignancy. Alternative benign explanations (e.g., reactive lymphadenopathy) are unlikely given the specific characteristics of the mass and the confirmed Hodgkin lymphoma diagnosis. Conclusion: Malignancy is highly probable, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skepticism: Could the findings be due to a benign inflammatory process? However, the description of bulky mass, FDG-avid nodes, and the confirmed diagnosis of classical Hodgkin lymphoma strongly suggests malignancy. Alternative benign explanations (e.g., reactive lymphadenopathy) are unlikely given the specific characteristics of the mass and the confirmed Hodgkin lymphoma diagnosis. Conclusion: Malignancy is highly probable, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skepticism: Could the findings be due to a benign inflammatory process? However, the description of bulky mass, FDG-avid nodes, and the confirmed diagnosis of classical Hodgkin lymphoma strongly suggests malignancy. Alternative benign explanations (e.g., reactive lymphadenopathy) are unlikely given the specific characteristics of the mass and the confirmed Hodgkin lymphoma diagnosis. Conclusion: Malignancy is highly probable, despite initial skepticism.\"\n    }\n}\n```\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skepticism: Could the findings be due to a benign inflammatory process? However, the description of bulky mass, FDG-avid nodes, and the confirmed diagnosis of classical Hodgkin lymphoma strongly suggests malignancy. Alternative benign explanations (e.g., reactive lymphadenopathy) are unlikely given the specific characteristics of the mass and the confirmed Hodgkin lymphoma diagnosis. Conclusion: Malignancy is highly probable, despite initial skepticism.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T19:20:55.840934"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. The report explicitly states 'no malignancy identified'. Reassurance provided. Conclusion: No malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. The report explicitly states 'no malignancy identified'. Reassurance provided. Conclusion: No malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. The report explicitly states 'no malignancy identified'. Reassurance provided. Conclusion: No malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. The report explicitly states 'no malignancy identified'. Reassurance provided. Conclusion: No malignancy.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T19:20:55.840951"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"well-circumscribed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Is the lipoma truly benign, or could it be a subtle, early manifestation of a malignancy? Playing devil's advocate: The report explicitly states the lipoma is benign, well-circumscribed, shows no enhancement, requires no intervention, and contains no malignancy. The reassurance provided further strengthens the benign conclusion. Although the report is reassuring, the presence of a soft tissue mass warrants further investigation to confirm its benign nature. No evidence of malignancy is present. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. Therefore, there is no evidence of malignancy. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. Therefore, there is no evidence of malignancy. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. Therefore, there is no evidence of malignancy. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. Therefore, there is no evidence of malignancy. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Is the lipoma truly benign, or could it be a subtle, early manifestation of a malignancy? Playing devil's advocate: The report explicitly states the lipoma is benign, well-circumscribed, shows no enhancement, requires no intervention, and contains no malignancy. The reassurance provided further strengthens the benign conclusion. Although the report is reassuring, the presence of a soft tissue mass warrants further investigation to confirm its benign nature. No evidence of malignancy is present. Conclusion: No malignancy identified.",
      "findings": [
        "benign soft tissue mass - lipoma confirmed",
        "well-circumscribed",
        "no enhancement",
        "no intervention required",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T19:20:55.840970"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are normal, there is no mediastinal mass, heart size is normal, and no malignancy is identified. The patient was given reassurance. Therefore, there is no evidence of malignancy. Skeptical reasoning: Could a subtle malignancy be missed on a standard radiograph? The report's description is too reassuring to suggest malignancy, even if it is a screening test. Alternative benign explanations are overwhelming. Conclusion: No malignancy detected.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are normal, there is no mediastinal mass, heart size is normal, and no malignancy is identified. The patient was given reassurance. Therefore, there is no evidence of malignancy. Skeptical reasoning: Could a subtle malignancy be missed on a standard radiograph? The report's description is too reassuring to suggest malignancy, even if it is a screening test. Alternative benign explanations are overwhelming. Conclusion: No malignancy detected.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are normal, there is no mediastinal mass, heart size is normal, and no malignancy is identified. The patient was given reassurance. Therefore, there is no evidence of malignancy. Skeptical reasoning: Could a subtle malignancy be missed on a standard radiograph? The report's description is too reassuring to suggest malignancy, even if it",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph and lung fields are normal, there is no mediastinal mass, heart size is normal, and no malignancy is identified. The patient was given reassurance. Therefore, there is no evidence of malignancy. Skeptical reasoning: Could a subtle malignancy be missed on a standard radiograph? The report's description is too reassuring to suggest malignancy, even if it is a screening test. Alternative benign explanations are overwhelming. Conclusion: No malignancy detected.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T19:20:55.840987"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the findings be benign? However, the presence of a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. While other conditions could cause similar findings, the combination of these features is highly indicative of this malignancy. Alternative benign explanations (e.g., infection, trauma) are less likely given the context of a suspected osteosarcoma. Conclusion: Malignancy is likely present based on the ultrasound findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skepticism: Could the findings be due to other causes like infection or trauma? However, the combination of a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase is highly suggestive of osteosarcoma, especially in a patient with a suspected diagnosis. Alternative benign explanations are less likely given the clinical context. Conclusion: Malignancy is highly likely.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be due to other causes? However, the combination of a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggests osteosarcoma, especially given the clinical suspicion. Alternative benign explanations are less likely. Conclusion: Malignancy is likely.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elev",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be benign? However, the presence of a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. While other conditions could cause similar findings, the combination of these features is highly indicative of this malignancy. Alternative benign explanations (e.g., infection, trauma) are less likely given the context of a suspected osteosarcoma. Conclusion: Malignancy is likely present based on the ultrasound findings.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T19:20:55.841005"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the destructive lesion be benign? However, the presence of a destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest a bone tumor. Osteosarcoma is a highly likely diagnosis given the clinical context (osteosarcoma) and the report findings. Alternative benign explanations (trauma, infection) are less likely given the combination of findings and the patient's history. Conclusion: Malignancy confirmed based on the destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase, supported by the clinical history of osteosarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the destructive lesion be benign? However, the presence of a destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest a bone tumor. Osteosarcoma is a highly likely diagnosis given the clinical context (osteosarcoma) and the report findings. Alternative benign explanations (trauma, infection) are less likely given the combination of findings and the patient's history. Conclusion: Malignancy confirmed based on the destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase, supported by the clinical history of osteosarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the destructive lesion be benign? However, the presence of a destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest a bone tumor. Osteosar",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the destructive lesion be benign? However, the presence of a destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest a bone tumor. Osteosarcoma is a highly likely diagnosis given the clinical context (osteosarcoma) and the report findings. Alternative benign explanations (trauma, infection) are less likely given the combination of findings and the patient's history. Conclusion: Malignancy confirmed based on the destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase, supported by the clinical history of osteosarcoma.",
      "findings": [
        "destructive lesion in distal femur",
        "soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T19:20:55.841025"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"Skepticism: While the report mentions 'post-viral lymphocytosis' and 'atypical lymphocytes resolving', it also states 'no malignancy identified' and provides reassurance. The presence of a viral infection (EBV) is a common cause of transient lymphocytosis. The resolving atypical lymphocytes further support a benign process. The absence of malignancy is explicitly stated. Alternative benign explanations (viral infection, post-infectious lymphocytosis) are highly likely. Conclusion: No malignancy present, even with some abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"increased lymphocytes\", \"no evidence of malignancy\"],\n        \"rationale\": \"Skepticism: The report mentions lymphadenopathy and increased lymphocytes, which can be seen in both benign and malignant conditions. However, it explicitly states 'no evidence of malignancy'. The report also describes the lymphadenopathy as 'mild' and the increased lymphocytes as 'reactive'. The absence of other concerning features, such as enlarged spleen or liver, further supports a benign explanation. Alternative benign explanations (reactive lymphadenopathy, post-infectious lymphocytosis) are highly likely. Conclusion: No malignancy present, even with some abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"mild lymphadenopathy\", \"increased lymphocytes\", \"no evidence of malignancy\"],\n        \"rationale\": \"Skepticism: The report mentions mild lymphadenopathy and increased lymphocytes, which can be seen in both benign and malignant conditions. However, it explicitly states 'no evidence of malignancy'. The report also describes the lymphadenopathy as 'mild' and the increased lymphocytes as 'reactive'. The absence of other concerning features, such as enlarged spleen or liver, further supports a benign explanation. Alternative benign explanations (reactive lymphadenopathy, post-infectious lymphocytosis) are",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skepticism: While the report mentions 'post-viral lymphocytosis' and 'atypical lymphocytes resolving', it also states 'no malignancy identified' and provides reassurance. The presence of a viral infection (EBV) is a common cause of transient lymphocytosis. The resolving atypical lymphocytes further support a benign process. The absence of malignancy is explicitly stated. Alternative benign explanations (viral infection, post-infectious lymphocytosis) are highly likely. Conclusion: No malignancy present, even with some abnormal findings.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T19:20:55.841042"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the report be a benign finding? The report describes a large renal mass with features suggestive of Wilms Tumor, confirmed by biopsy. While a pseudocapsule and favorable histology are reassuring, they do not eliminate the possibility of malignancy. The stage II diagnosis indicates the presence of cancer. Alternative benign explanations (e.g., a benign tumor) are less likely given the description of the mass. Conclusion: Malignancy is likely, despite the features suggesting a favorable prognosis. Further investigation is warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the report be a benign finding? The report describes a large renal mass with features suggestive of Wilms Tumor, confirmed by biopsy. While a pseudocapsule and favorable histology are reassuring, they do not eliminate the possibility of malignancy. The stage II diagnosis indicates the presence of cancer. Alternative benign explanations (e.g., a benign tumor) are less likely given the description of the mass. Conclusion: Malignancy is likely, despite the features suggesting a favorable prognosis. Further investigation is warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the report be a benign finding? The report describes a large renal mass with features suggestive of Wilms Tumor, confirmed by biopsy. While a pseudocapsule and favorable histology are reassuring, they do not eliminate the possibility of malignancy. The stage II diagnosis indicates the presence of cancer. Alternative benign explanations (e.g., a benign tumor) are less likely given the description of the mass. Conclusion: Malignancy is likely, despite the features suggesting a favorable prognosis. Further investigation is warranted.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T19:20:55.841060"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"PET-CT showing FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the report explicitly states 'Classical Hodgkin, nodular sclerosing type' and 'FDG-avid nodes', which are characteristic of Hodgkin Lymphoma. The presence of a bulky mediastinal mass and FDG-avid nodes strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory process, infection) are considered less likely given the specific findings. Conclusion: Malignancy confirmed, specifically Hodgkin Lymphoma, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"PET-CT showing FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the report explicitly states 'Classical Hodgkin, nodular sclerosing type' and 'FDG-avid nodes', which are characteristic of Hodgkin Lymphoma. The presence of a bulky mediastinal mass and FDG-avid nodes strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory process, infection) are considered less likely given the specific findings. Conclusion: Malignancy confirmed, specifically Hodgkin Lymphoma, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"PET-CT showing FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the report explicitly states 'Classical Hodgkin, nodular sclerosing type' and 'FDG-avid nodes', which are characteristic of Hodgkin Lymphoma. The presence of a bulky",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be reactive or inflammatory? However, the report explicitly states 'Classical Hodgkin, nodular sclerosing type' and 'FDG-avid nodes', which are characteristic of Hodgkin Lymphoma. The presence of a bulky mediastinal mass and FDG-avid nodes strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory process, infection) are considered less likely given the specific findings. Conclusion: Malignancy confirmed, specifically Hodgkin Lymphoma, despite initial skepticism.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "PET-CT showing FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T19:20:55.841078"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could the 'post-viral lymphocytosis' be a sign of a more sinister condition, despite the reassurance provided? Playing devil's advocate: The report clearly states 'no malignancy identified' and provides supporting evidence (post-viral, resolving atypical lymphocytes, positive monospot, and EBV confirmation). The reassuring nature of the report strongly suggests a benign cause. While a post-viral lymphocytosis could theoretically be a precursor, the provided evidence strongly supports a benign explanation. Conclusion: No malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no previous oncology history\", \"no abnormalities identified\", \"no suspicious features\"],\n        \"rationale\": \"The report explicitly states that there are no abnormalities identified and no suspicious features. Given the patient's age and lack of prior oncology history, this is highly unlikely to be a malignancy. The report is reassuring, and there is no indication of any underlying malignancy. Conclusion: No malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphocytes 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and marrow infiltration pattern provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning:",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could the 'post-viral lymphocytosis' be a sign of a more sinister condition, despite the reassurance provided? Playing devil's advocate: The report clearly states 'no malignancy identified' and provides supporting evidence (post-viral, resolving atypical lymphocytes, positive monospot, and EBV confirmation). The reassuring nature of the report strongly suggests a benign cause. While a post-viral lymphocytosis could theoretically be a precursor, the provided evidence strongly supports a benign explanation. Conclusion: No malignancy is present.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T19:20:55.841096"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates a normal brain MRI, no mass lesion, no abnormal enhancement, and no malignancy identified. The patient is being reassured. This indicates that there is no evidence of malignancy. No abnormal findings are present, so no malignancy is present. Applying skeptical reasoning, I would need to find evidence of a mass, abnormal enhancement, or malignant cells to suggest malignancy. The report does not contain such evidence. Therefore, I conclude that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates a normal brain MRI, no mass lesion, no abnormal enhancement, and no malignancy identified. The patient is being reassured. This indicates that there is no evidence of malignancy. No abnormal findings are present, so no malignancy is present. Applying skeptical reasoning, I would need to find evidence of a mass, abnormal enhancement, or malignant cells to suggest malignancy. The report does not contain such evidence. Therefore, I conclude that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates a normal brain MRI, no mass lesion, no abnormal enhancement, and no malignancy identified. The patient is being reassured. This indicates that there is no evidence of malignancy. No abnormal findings are present, so no malignancy is present. Applying skeptical reasoning, I would need to find evidence of a mass, abnormal enhancement, or malignant cells to suggest malignancy. The report does not contain such evidence. Therefore, I conclude that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a normal brain MRI, no mass lesion, no abnormal enhancement, and no malignancy identified. The patient is being reassured. This indicates that there is no evidence of malignancy. No abnormal findings are present, so no malignancy is present. Applying skeptical reasoning, I would need to find evidence of a mass, abnormal enhancement, or malignant cells to suggest malignancy. The report does not contain such evidence. Therefore, I conclude that there is no malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T19:20:55.841112"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, onion-skin periosteal reaction, and, critically, the EWSR1 fusion positivity strongly suggests Ewing Sarcoma. This is a specific genetic marker. Alternative benign explanations (e.g., aggressive osteomyelitis, certain benign bone tumors) are less likely given the complete clinical picture. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism based on the possibility of a benign mimic.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, onion-skin periosteal reaction, and, critically, the EWSR1 fusion positivity strongly suggests Ewing Sarcoma. This is a specific genetic marker. Alternative benign explanations (e.g., aggressive osteomyelitis, certain benign bone tumors) are less likely given the complete clinical picture. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism based on the possibility of a benign mimic.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, onion-skin periosteal reaction, and, critically, the EWSR1 fusion positivity strongly suggests Ewing Sarcoma. This is",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be due to a benign process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, onion-skin periosteal reaction, and, critically, the EWSR1 fusion positivity strongly suggests Ewing Sarcoma. This is a specific genetic marker. Alternative benign explanations (e.g., aggressive osteomyelitis, certain benign bone tumors) are less likely given the complete clinical picture. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism based on the possibility of a benign mimic.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis with large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T19:20:55.841131"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This aligns with the patient's history of migraines and the absence of any prior oncology history. Skeptical reasoning is not required as the report provides reassurance and explicitly rules out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This aligns with the patient's history of migraines and the absence of any prior oncology history. Skeptical reasoning is not required as the report provides reassurance and explicitly rules out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This aligns with the patient's history of migraines and the absence of any prior oncology history. Skeptical reasoning is not required as the report provides reassurance and explicitly rules out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This aligns with the patient's history of migraines and the absence of any prior oncology history. Skeptical reasoning is not required as the report provides reassurance and explicitly rules out malignancy.\"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This aligns with the patient's history of migraines and the absence of any prior oncology history. Skeptical reasoning is not required as the report provides reassurance and explicitly rules out malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T19:20:55.841144"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"Initial skepticism: The report states 'Benign finding. No malignancy identified.' Could there be a subtle, early-stage malignancy not readily apparent on this single X-ray? Playing devil's advocate against a benign conclusion: the report explicitly states 'No malignancy identified.' It is highly unlikely that there is a malignancy in the spleen given the benign findings. Reassurance provided. Conclusion: No malignancy identified. Physiological splenomegaly is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"Initial skepticism: The report states 'Benign finding. No malignancy identified.' Could there be a subtle, early-stage malignancy not readily apparent on this single X-ray? Playing devil's advocate against a benign conclusion: the report explicitly states 'No malignancy identified.' It is highly unlikely that there is a malignancy in the spleen given the benign findings. Reassurance provided. Conclusion: No malignancy identified. Physiological splenomegaly is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"Initial skepticism: The report states 'Benign finding. No malignancy identified.' Could there be a subtle, early-stage malignancy not readily apparent on this single X-ray? Playing devil's advocate against a benign conclusion: the report explicitly states 'No malignancy identified.' It is highly unlikely that there is a malignancy in the spleen given the benign findings. Reassurance provided. Conclusion: No malignancy identified. Physiological splenomegaly is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: The report states 'Benign finding. No malignancy identified.' Could there be a subtle, early-stage malignancy not readily apparent on this single X-ray? Playing devil's advocate against a benign conclusion: the report explicitly states 'No malignancy identified.' It is highly unlikely that there is a malignancy in the spleen given the benign findings. Reassurance provided. Conclusion: No malignancy identified. Physiological splenomegaly is a benign finding.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T19:20:55.841160"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is the report accurate? The report clearly states that the lymphadenopathy is reactive and decreasing, and no atypical features or malignancy are present. Although the report provides reassurance, this does not preclude the possibility of an occult malignancy. Further investigation is not indicated given the absence of any concerning features. The report is consistent with a benign cause for the lymphadenopathy. Conclusion: No malignancy identified based on the findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, decreasing size, and absence of atypical features or malignancy. While the report provides reassurance, it does not definitively rule out occult malignancy. The findings are consistent with a benign cause. Conclusion: No malignancy identified based on the findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, decreasing size, and absence of atypical features or malignancy. While the report provides reassurance, it does not definitively rule out occult malignancy. The findings are consistent with a benign cause. Conclusion: No malignancy identified based on the findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, decreasing size, and",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Is the report accurate? The report clearly states that the lymphadenopathy is reactive and decreasing, and no atypical features or malignancy are present. Although the report provides reassurance, this does not preclude the possibility of an occult malignancy. Further investigation is not indicated given the absence of any concerning features. The report is consistent with a benign cause for the lymphadenopathy. Conclusion: No malignancy identified based on the findings.",
      "findings": [
        "reactive lymphadenopathy secondary to viral infection",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T19:20:55.841177"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the findings be related to benign conditions such as infection or trauma? However, the presence of a destructive lesion with a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. Alternative benign explanations (infection, trauma) are less likely given the clinical context and imaging characteristics. Conclusion: malignancy confirmed based on suggestive findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be related to benign conditions such as infection or trauma? However, the presence of a destructive lesion with a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. Alternative benign explanations (infection, trauma) are less likely given the clinical context and imaging characteristics. Conclusion: malignancy confirmed based on suggestive findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the findings be related to benign conditions such as infection or trauma? However, the presence of a destructive lesion with a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. Alternative benign explanations (infection, trauma) are less likely given the clinical context and imaging characteristics. Conclusion: malignancy confirmed based on suggestive findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be related to benign conditions such as infection or trauma? However, the presence of a destructive lesion with a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. Alternative benign explanations (infection, trauma) are less likely given the clinical context and imaging characteristics. Conclusion: malignancy confirmed based on suggestive findings.",
      "findings": [
        "destructive lesion in distal femur",
        "soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T19:20:55.841193"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be a sign of early malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states that the lymphadenopathy is reactive due to a viral infection and that there are no atypical features or malignancy identified. The node size is decreasing, suggesting resolution of the infection. The reassurance provided by the consultant further supports the benign interpretation. Alternative benign explanations (viral infection, post-infectious reactive lymphadenopathy) are strongly supported by the findings. Conclusion: No malignancy identified, consistent with the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be a sign of early malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states that the lymphadenopathy is reactive due to a viral infection and that there are no atypical features or malignancy identified. The node size is decreasing, suggesting resolution of the infection. The reassurance provided by the consultant further supports the benign interpretation. Alternative benign explanations (viral infection, post-infectious reactive lymphadenopathy) are strongly supported by the findings. Conclusion: No malignancy identified, consistent with the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be a sign of early malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states that the lymphadenopathy is reactive due to a viral infection and that there are no atypical features",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could reactive lymphadenopathy be a sign of early malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states that the lymphadenopathy is reactive due to a viral infection and that there are no atypical features or malignancy identified. The node size is decreasing, suggesting resolution of the infection. The reassurance provided by the consultant further supports the benign interpretation. Alternative benign explanations (viral infection, post-infectious reactive lymphadenopathy) are strongly supported by the findings. Conclusion: No malignancy identified, consistent with the report.",
      "findings": [
        "reactive lymphadenopathy secondary to viral infection",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T19:20:55.841214"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: the report explicitly states no malignancy is identified on the chest radiograph and MRI. Further, the patient has no history of malignancy. The findings are reassuring, but definitive exclusion requires a high level of certainty. It is possible the patient has a very early, subtle malignancy that was not detected, but without additional information, it is not possible to conclude malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: the report explicitly states no malignancy is identified on the chest radiograph and MRI. Further, the patient has no history of malignancy. The findings are reassuring, but definitive exclusion requires a high level of certainty. It is possible the patient has a very early, subtle malignancy that was not detected, but without additional information, it is not possible to conclude malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: the report explicitly states no malignancy is identified on the chest radiograph and MRI. Further, the patient has no history of malignancy. The findings are reassuring, but definitive exclusion requires a high level of certainty. It is possible the patient has a very early, subtle malignancy that was not detected, but without additional information, it is not possible to conclude malignancy.\"\n    }\n}\n```\n```json",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: the report explicitly states no malignancy is identified on the chest radiograph and MRI. Further, the patient has no history of malignancy. The findings are reassuring, but definitive exclusion requires a high level of certainty. It is possible the patient has a very early, subtle malignancy that was not detected, but without additional information, it is not possible to conclude malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T19:20:55.841231"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a previously overlooked, but now well-defined lipoma be misdiagnosed? Playing devil's advocate against a benign conclusion: The report explicitly states a benign lipoma with no enhancement or intervention. No evidence of malignancy. The purpose of the biopsy was follow-up post-treatment, which is reassuring. The initial concern about a soft tissue mass was confirmed to be a benign lipoma. Conclusion: No malignancy identified. The original concern was addressed and resolved.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. The report specifically states that no malignancy was identified. Conclusion: No malignancy identified. The initial concern about a soft tissue mass was confirmed to be a benign lipoma. The purpose of the biopsy was follow-up post-treatment, which is reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a previously overlooked, but now well-defined lipoma be misdiagnosed? Playing devil's advocate against a benign conclusion: The report explicitly states a benign lipoma with no enhancement or intervention. No evidence of malignancy. The initial concern about a soft tissue mass was confirmed to be a benign lipoma. Conclusion: No malignancy identified. The original concern was addressed and resolved.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a previously overlooked, but now well-defined lipoma be misdiagnosed? Playing devil's advocate against a benign conclusion: The report explicitly states a benign lipoma with no enhancement or intervention. No evidence of malignancy. The purpose of the biopsy was follow-up post-treatment, which is reassuring. The initial concern about a soft tissue mass was confirmed to be a benign lipoma. Conclusion: No malignancy identified. The original concern was addressed and resolved.",
      "findings": [
        "benign soft tissue mass - lipoma confirmed",
        "no enhancement",
        "no intervention required",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T19:20:55.841248"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the renal mass be a benign lesion, such as a simple cyst or angiomyolipoma? However, the report explicitly states 'large heterogeneous left renal mass with pseudocapsule', which is suggestive of a more complex or malignant process. No vascular invasion is a positive finding, but it does not rule out malignancy. Favorable histology on biopsy is reassuring but not definitive, as it only applies to the specific biopsy site. Stage II is also a positive finding. The presence of a large, heterogeneous mass with a pseudocapsule raises suspicion for malignancy. Alternative benign explanations (simple cyst, angiomyolipoma) are less likely given the description. Conclusion: malignancy is likely, though further investigation and staging are required to confirm the diagnosis and assess the extent of disease. Skeptical reasoning is tempered by the presence of a significant mass and the stage.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the renal mass be a benign lesion, such as a simple cyst or angiomyolipoma? However, the report explicitly states 'large heterogeneous left renal mass with pseudocapsule', which is suggestive of a more complex or malignant process. No vascular invasion is a positive finding, but it does not rule out malignancy. Favorable histology on biopsy is reassuring but not definitive, as it only applies to the specific biopsy site. Stage II is also a positive finding. The presence of a large, heterogeneous mass with a pseudocapsule raises suspicion for malignancy. Alternative benign explanations (simple cyst, angiomyolipoma) are less likely given the description. Conclusion: malignancy is likely, though further investigation and staging are required to confirm the diagnosis and assess the extent of disease. Skeptical reasoning is tempered by the presence of a significant mass and the stage.\"\n    }\n}\n```\n```json\n{\n    \"ab",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the renal mass be a benign lesion, such as a simple cyst or angiomyolipoma? However, the report explicitly states 'large heterogeneous left renal mass with pseudocapsule', which is suggestive of a more complex or malignant process. No vascular invasion is a positive finding, but it does not rule out malignancy. Favorable histology on biopsy is reassuring but not definitive, as it only applies to the specific biopsy site. Stage II is also a positive finding. The presence of a large, heterogeneous mass with a pseudocapsule raises suspicion for malignancy. Alternative benign explanations (simple cyst, angiomyolipoma) are less likely given the description. Conclusion: malignancy is likely, though further investigation and staging are required to confirm the diagnosis and assess the extent of disease. Skeptical reasoning is tempered by the presence of a significant mass and the stage.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T19:20:55.841272"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be a subtle presentation of malignancy? However, the report explicitly states 'reactive lymphadenopathy' and that the node size is decreasing. The absence of atypical features and the definitive statement that no malignancy was identified, with reassurance provided, strongly suggest a benign cause. The patient has no previous oncology history. Therefore, the most likely explanation is a benign process. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the lymphadenopathy is reactive and that no atypical features or malignancy were identified. The decreasing node size further supports the benign nature of the finding. The absence of a prior oncology history reduces the likelihood of an occult malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report clearly indicates reactive lymphadenopathy, a decreasing node size, and the absence of any atypical features or malignancy. The patient's history of no prior oncology makes a malignancy less likely. The reassurance provided by the consultant further supports a benign conclusion. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report's description of reactive lymphadenopathy, coupled with the decreasing node size and the absence of atypical features or malignancy, strongly suggests a benign cause. The patient's lack of prior",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could reactive lymphadenopathy be a subtle presentation of malignancy? However, the report explicitly states 'reactive lymphadenopathy' and that the node size is decreasing. The absence of atypical features and the definitive statement that no malignancy was identified, with reassurance provided, strongly suggest a benign cause. The patient has no previous oncology history. Therefore, the most likely explanation is a benign process. Conclusion: No malignancy identified.",
      "findings": [
        "reactive lymphadenopathy",
        "node size decreasing",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T19:20:55.841289"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of a large heterogeneous hepatic mass, elevated AFP, and the identification of a fetal histology subtype strongly suggest hepatoblastoma. The PRETEXT stage II indicates an advanced stage of the disease. Alternative benign explanations (infection, inflammatory process) are considered less likely given the combination of findings. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of a large heterogeneous hepatic mass, elevated AFP, and the identification of a fetal histology subtype strongly suggest hepatoblastoma. The PRETEXT stage II indicates an advanced stage of the disease. Alternative benign explanations (infection, inflammatory process) are considered less likely given the combination of findings. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of a large heterogeneous hepatic mass, elevated AFP, and the identification of a fetal histology subtype strongly suggest hepatoblastoma. The PRETEXT stage II indicates an advanced stage of the disease. Alternative benign explanations (infection, inflammatory process) are considered less likely given the combination of findings. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of a large heterogeneous hepatic mass, elevated AFP, and the identification of a fetal histology subtype strongly suggest hepatoblastoma. The PRETEXT stage II indicates an advanced stage of the disease. Alternative benign explanations (infection, inflammatory process) are considered less likely given the combination of findings. Conclusion: Malignancy confirmed.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T19:20:55.841305"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"normal heart size\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The findings are reassuring and consistent with a benign presentation. No evidence of abnormal findings suggestive of malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"normal heart size\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The findings are reassuring and consistent with a benign presentation. No evidence of abnormal findings suggestive of malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"normal heart size\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The findings are reassuring and consistent with a benign presentation. No evidence of abnormal findings suggestive of malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"normal heart size\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The findings are reassuring and consistent with a benign presentation. No evidence of abnormal findings suggestive of malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The findings are reassuring and consistent with a benign presentation. No evidence of abnormal findings suggestive of malignancy. Conclusion: No malignancy identified.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "normal heart size",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T19:20:55.841318"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be masking a subtle malignancy? However, the report explicitly states 'no atypical features' and 'no malignancy identified'. The finding is described as reactive, meaning it is a normal response to infection. Alternative benign explanations (viral infection, autoimmune process) are supported by the report's description. Conclusion: No malignancy identified, even with initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'reactive lymphadenopathy' and 'no atypical features'. These findings, along with the absence of malignancy, strongly suggest a benign cause for the lymph node enlargement. The report provides reassurance, further supporting a benign diagnosis. Alternative explanations include viral infection or autoimmune processes, which are consistent with reactive lymphadenopathy. Conclusion: No malignancy identified, even with initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report clearly states 'reactive lymphadenopathy' and 'no atypical features'. This, coupled with the absence of malignancy, strongly indicates a benign process. The report provides reassurance, supporting the benign diagnosis. Alternative benign explanations, such as a viral infection or autoimmune response, are consistent with reactive lymphadenopathy. Conclusion: No malignancy identified, even with initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report's clear statement of 'reactive lymphadenopathy' and 'no atypical features' and 'no malignancy identified' provides strong evidence for",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could reactive lymphadenopathy be masking a subtle malignancy? However, the report explicitly states 'no atypical features' and 'no malignancy identified'. The finding is described as reactive, meaning it is a normal response to infection. Alternative benign explanations (viral infection, autoimmune process) are supported by the report's description. Conclusion: No malignancy identified, even with initial skepticism.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T19:20:55.841333"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign condition with similar presentation? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest malignancy. The clinical context (paediatric oncology assessment for Germ Cell Tumor) further supports the likelihood of malignancy. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable based on the report findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign condition with similar presentation? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest malignancy. The clinical context (paediatric oncology assessment for Germ Cell Tumor) further supports the likelihood of malignancy. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable based on the report findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign condition with similar presentation? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest malignancy. The clinical context (paediatric oncology assessment for Germ Cell Tumor) further supports the likelihood of malignancy. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable based on the report findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could this be a benign condition with similar presentation? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest malignancy. The clinical context (paediatric oncology assessment for Germ Cell Tumor) further supports the likelihood of malignancy. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable based on the report findings.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T19:20:55.841349"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the elevated AFP and beta-hCG be reactive? Could the mixed solid and cystic components be benign? However, the presence of a sacrococcygeal mass, mixed solid and cystic components, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the elevated AFP and beta-hCG be reactive? Could the mixed solid and cystic components be benign? However, the presence of a sacrococcygeal mass, mixed solid and cystic components, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the elevated AFP and beta-hCG be reactive? Could the mixed solid and cystic components be benign? However, the presence of a sacrococcygeal mass, mixed solid and cystic components, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable, despite initial skepticism",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the elevated AFP and beta-hCG be reactive? Could the mixed solid and cystic components be benign? However, the presence of a sacrococcygeal mass, mixed solid and cystic components, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable, despite initial skepticism.",
      "findings": [
        "sacrococcygeal mass",
        "mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T19:20:55.841365"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the diagnosis be incorrect? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy'. While PAX-FOXO1 fusion negativity doesn't rule out all subtypes, it is a common finding in this type. The overall evidence strongly suggests malignancy. Alternative benign explanations (misinterpretation of normal tissue, reactive process) are unlikely given the explicit diagnosis. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the findings be misinterpretations? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy' and 'parameningeal mass with intracranial extension', indicating a tumor. While PAX-FOXO1 fusion negativity doesn't rule out all subtypes, it is a common finding in this type. The overall evidence strongly suggests malignancy. Alternative benign explanations (misinterpretation of normal tissue, reactive process) are unlikely given the explicit diagnosis. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the diagnosis be incorrect? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy'. While PAX-FOXO1 fusion negativity doesn't rule out all subtypes, it is a common finding in this type. The overall evidence strongly suggests malignancy. Alternative benign explanations (misinterpretation of normal tissue, reactive process) are unlikely given the explicit diagnosis. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the diagnosis be incorrect? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy'. While PAX-FOXO1 fusion negativity doesn't rule out all subtypes, it is a common finding in this type. The overall evidence strongly suggests malignancy. Alternative benign explanations (misinterpretation of normal tissue, reactive process) are unlikely given the explicit diagnosis. Conclusion: malignancy confirmed.",
      "findings": [
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T19:20:55.841379"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: The report explicitly states that no malignancy was identified. Further, the brain MRI is normal with no mass lesions or abnormal enhancement. Reassurance was provided. Therefore, there is no evidence to suggest malignancy. No abnormal findings are present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report clearly states that no malignancy was found. The MRI is normal with no lesions or enhancement. No other concerning findings are mentioned. Therefore, there is no evidence to suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The MRI is normal with no lesions or enhancement. No other concerning findings are mentioned. Therefore, there is no evidence to suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was found. The MRI is normal with no lesions or enhancement. No other concerning findings are mentioned. Therefore, there is no evidence to suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was found",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: The report explicitly states that no malignancy was identified. Further, the brain MRI is normal with no mass lesions or abnormal enhancement. Reassurance was provided. Therefore, there is no evidence to suggest malignancy. No abnormal findings are present.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T19:20:55.841393"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Could atypical lymphocytes be a precursor to malignancy? While the report mentions post-viral lymphocytosis and resolving atypical lymphocytes, the positive monospot test and confirmation of EBV infection suggest a benign viral etiology. The absence of any mention of malignant cells or concerning features further supports the benign conclusion. While a follow-up is warranted, no definitive evidence of malignancy is present. Conclusion: No malignancy identified. Skeptical analysis confirms a benign process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could atypical lymphocytes be a precursor to malignancy? While the report mentions post-viral lymphocytosis and resolving atypical lymphocytes, the positive monospot test and confirmation of EBV infection suggest a benign viral etiology. The absence of any mention of malignant cells or concerning features further supports the benign conclusion. While a follow-up is warranted, no definitive evidence of malignancy is present. Conclusion: No malignancy identified. Skeptical analysis confirms a benign process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could atypical lymphocytes be a precursor to malignancy? While the report mentions post-viral lymphocytosis and resolving atypical lymphocytes, the positive monospot test and confirmation of EBV infection suggest a benign viral etiology. The absence of any mention of malignant cells or concerning features further supports the benign conclusion. While a follow-up is warranted, no definitive evidence of",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could atypical lymphocytes be a precursor to malignancy? While the report mentions post-viral lymphocytosis and resolving atypical lymphocytes, the positive monospot test and confirmation of EBV infection suggest a benign viral etiology. The absence of any mention of malignant cells or concerning features further supports the benign conclusion. While a follow-up is warranted, no definitive evidence of malignancy is present. Conclusion: No malignancy identified. Skeptical analysis confirms a benign process.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T19:20:55.841410"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could the lymphadenopathy be a sign of early malignancy? The report explicitly states that the lymphadenopathy is reactive, secondary to a viral infection, and that no atypical features or malignancy were identified. The node size is decreasing on follow-up. Therefore, the findings are consistent with a benign process. The report provides reassurance. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the lymphadenopathy be a sign of early malignancy? The report explicitly states that the lymphadenopathy is reactive, secondary to a viral infection, and that no atypical features or malignancy were identified. The node size is decreasing on follow-up. Therefore, the findings are consistent with a benign process. The report provides reassurance. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the lymphadenopathy be a sign of early malignancy? The report explicitly states that the lymphadenopathy is reactive, secondary to a viral infection, and that no atypical features or malignancy were identified. The node size is decreasing on follow-up. Therefore, the findings are consistent with a benign process. The report provides reassurance. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could the lymphadenopathy be a sign of early malignancy? The report explicitly states that the lymphadenopathy is reactive, secondary to a viral infection, and that no atypical features or malignancy were identified. The node size is decreasing on follow-up. Therefore, the findings are consistent with a benign process. The report provides reassurance. Conclusion: No malignancy identified.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T19:20:55.841426"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could the resolved febrile illness be related to a malignancy? However, the report explicitly states that the blood counts normalized and there is no organomegaly. The absence of malignancy is the primary finding. Alternative benign explanations (viral infection, stress response) are supported by the resolution of the illness and the absence of concerning findings. Conclusion: No malignancy identified, reassuring the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no organomegaly\", \"no malignancy identified\", \"clinical improvement noted\"],\n        \"rationale\": \"The report indicates that the patient had a febrile illness which resolved and that there is no organomegaly and no malignancy identified. The report also states that the patient has clinical improvement. This information suggests that the patient's condition is improving. Therefore, the patient does not have a malignancy. There is no indication of malignancy. Conclusion: No malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no organomegaly\", \"no malignancy identified\", \"clinical improvement noted\", \"normalized blood counts\"],\n        \"rationale\": \"The report states that there is no organomegaly, no malignancy identified, and that the patient has clinical improvement. The patient's blood counts have also normalized. This information suggests that the patient is improving and that the patient does not have a malignancy. Conclusion: No malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no organomegaly\", \"no malignancy identified\", \"clinical improvement noted\", \"normalized blood counts\", \"resolved febrile illness\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified, no organomegaly, and that the patient is clinically improving. The patient's blood",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could the resolved febrile illness be related to a malignancy? However, the report explicitly states that the blood counts normalized and there is no organomegaly. The absence of malignancy is the primary finding. Alternative benign explanations (viral infection, stress response) are supported by the resolution of the illness and the absence of concerning findings. Conclusion: No malignancy identified, reassuring the patient.",
      "findings": [
        "resolved febrile illness",
        "normalized blood counts",
        "no organomegaly",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T19:20:55.841441"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy secondary to viral infection with decreasing node size and absence of atypical features. The final conclusion is that no malignancy was identified. While the initial finding is abnormal, it is benign and reactive. Alternative explanations are likely and the presence of no malignancy is evidence against malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy secondary to viral infection with decreasing node size and absence of atypical features. The final conclusion is that no malignancy was identified. While the initial finding is abnormal, it is benign and reactive. Alternative explanations are likely and the presence of no malignancy is evidence against malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy secondary to viral infection with decreasing node size and absence of atypical features. The final conclusion is that no malignancy was identified. While the initial finding is abnormal, it is benign and reactive. Alternative explanations are likely and the presence of no malignancy is evidence against malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy secondary to viral infection with decreasing node size and absence of atypical features.",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states reactive lymphadenopathy secondary to viral infection with decreasing node size and absence of atypical features. The final conclusion is that no malignancy was identified. While the initial finding is abnormal, it is benign and reactive. Alternative explanations are likely and the presence of no malignancy is evidence against malignancy. Conclusion: No malignancy identified.",
      "findings": [
        "reactive lymphadenopathy",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T19:20:55.841456"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign orbital mass? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. The report explicitly mentions the suspicion of retinoblastoma. Alternative benign explanations are highly improbable given the constellation of findings. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign orbital mass? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. The report explicitly mentions the suspicion of retinoblastoma. Alternative benign explanations are highly improbable given the constellation of findings. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign orbital mass? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. The report explicitly mentions the suspicion of retinoblastoma. Alternative benign explanations are highly improbable given the constellation of findings. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could this be a benign orbital mass? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. The report explicitly mentions the suspicion of retinoblastoma. Alternative benign explanations are highly improbable given the constellation of findings. Conclusion: Malignancy confirmed despite initial skepticism.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T19:20:55.841472"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could a benign mass with calcifications be mistaken for a malignant one? However, the presence of MIBG avidity and elevated urinary catecholamines strongly suggests Neuroblastoma. Stage III disease further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcification) are less likely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could a benign mass with calcifications be mistaken for a malignant one? However, the presence of MIBG avidity and elevated urinary catecholamines strongly suggests Neuroblastoma. Stage III disease further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcification) are less likely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could a benign mass with calcifications be mistaken for a malignant one? However, the presence of MIBG avidity and elevated urinary catecholamines strongly suggests Neuroblastoma. Stage III disease further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcification) are less likely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a benign mass with calcifications be mistaken for a malignant one? However, the presence of MIBG avidity and elevated urinary catecholamines strongly suggests Neuroblastoma. Stage III disease further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcification) are less likely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T19:20:55.841487"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that the report is incorrect and there is a subtle, early malignancy not easily detectable by routine CBC? However, the report explicitly states that the CBC is normal, with no blast cells, adequate platelets, and hemoglobin within normal limits. Furthermore, there is no mention of any suspicious findings on the CT scan. The report also provides reassurance. Therefore, the likelihood of malignancy is extremely low. Alternative benign explanations (e.g., normal growth, no underlying pathology) are highly probable. Conclusion: No malignancy detected.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: The report is clear and concise, stating a normal CBC with age-appropriate values, no blast cells, adequate platelets, and hemoglobin within normal limits. No malignancy is identified. The patient has no previous oncology history. While a complete and thorough examination is always important, the report provides sufficient information to suggest the absence of malignancy. There are no red flags to suggest otherwise. Alternative benign explanations are highly plausible. Conclusion: No malignancy detected.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: The report indicates a completely normal CBC, including the absence of blast cells. This significantly reduces the likelihood of malignancy. While it's always prudent to consider potential alternative explanations, the absence of any concerning findings makes it highly improbable. The reassurance provided further supports the conclusion of no malignancy. Alternative benign explanations are highly likely. Conclusion: No malignancy detected.\"\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Is it possible that the report is incorrect and there is a subtle, early malignancy not easily detectable by routine CBC? However, the report explicitly states that the CBC is normal, with no blast cells, adequate platelets, and hemoglobin within normal limits. Furthermore, there is no mention of any suspicious findings on the CT scan. The report also provides reassurance. Therefore, the likelihood of malignancy is extremely low. Alternative benign explanations (e.g., normal growth, no underlying pathology) are highly probable. Conclusion: No malignancy detected.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T19:20:55.841506"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the findings be misinterpreted? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy', and 'parameningeal mass with intracranial extension' is a known presentation of this malignancy. PAX-FOXO1 fusion negative helps to confirm the diagnosis. Alternative benign explanations (e.g., metastasis from a different primary tumor) are not suggested. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the findings be misinterpreted? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy', and 'parameningeal mass with intracranial extension' is a known presentation of this malignancy. PAX-FOXO1 fusion negative helps to confirm the diagnosis. Alternative benign explanations (e.g., metastasis from a different primary tumor) are not suggested. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the findings be misinterpreted? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy', and 'parameningeal mass with intracranial extension' is a known presentation of this malignancy. PAX-FOXO1 fusion negative helps to confirm the diagnosis. Alternative benign explanations (e.g., metastasis from a different primary tumor) are not suggested. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be misinterpreted? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy', and 'parameningeal mass with intracranial extension' is a known presentation of this malignancy. PAX-FOXO1 fusion negative helps to confirm the diagnosis. Alternative benign explanations (e.g., metastasis from a different primary tumor) are not suggested. Conclusion: Malignancy confirmed.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T19:20:55.841521"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Although the report states 'no malignancy identified,' it's crucial to consider the context of the request. The report explicitly states that a chest radiograph was performed and that it was normal. The report also states that no malignancy was identified. The report also states that the patient has no previous oncology history. Although the report may be reassuring, it is not sufficient to rule out malignancy. A negative chest radiograph does not exclude the possibility of malignancy, especially if the patient is asymptomatic. The report does not provide any information about the patient's symptoms or physical exam findings. Therefore, it is not possible to definitively rule out malignancy based on this report alone. Furthermore, the report does not mention any other relevant findings that could suggest malignancy. Although the report may be reassuring, it is not sufficient to rule out malignancy. Further investigation may be warranted to exclude malignancy. Alternative benign explanations are possible, but the report does not provide enough information to rule out malignancy. Conclusion: While the report indicates no malignancy, it is not sufficient to definitively rule out malignancy. Further investigation may be warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: The report explicitly states that a chest radiograph was performed and that it was normal. The report also states that no malignancy was identified. The report also states that the patient has no previous oncology history. Although the report may be reassuring, it is not sufficient to rule out malignancy. A negative chest radiograph does not exclude the possibility of malignancy, especially if the patient is asymptomatic. The report does not provide any information about the patient's symptoms or physical exam findings. Therefore, it is not possible to definitively rule out malignancy based on this report alone. Furthermore, the report does not mention any other relevant findings that could suggest malignancy. Although the report may be reassuring, it is not sufficient to rule out",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Although the report states 'no malignancy identified,' it's crucial to consider the context of the request. The report explicitly states that a chest radiograph was performed and that it was normal. The report also states that no malignancy was identified. The report also states that the patient has no previous oncology history. Although the report may be reassuring, it is not sufficient to rule out malignancy. A negative chest radiograph does not exclude the possibility of malignancy, especially if the patient is asymptomatic. The report does not provide any information about the patient's symptoms or physical exam findings. Therefore, it is not possible to definitively rule out malignancy based on this report alone. Furthermore, the report does not mention any other relevant findings that could suggest malignancy. Although the report may be reassuring, it is not sufficient to rule out malignancy. Further investigation may be warranted to exclude malignancy. Alternative benign explanations are possible, but the report does not provide enough information to rule out malignancy. Conclusion: While the report indicates no malignancy, it is not sufficient to definitively rule out malignancy. Further investigation may be warranted.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T19:20:55.841560"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could the mass be benign? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. Alternative benign explanations (e.g., other ocular tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed, highly suggestive of retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Skeptical review: Could the findings be due to other, less aggressive processes? While the presence of calcifications, bilateral disease, positive family history, and RB1 germline mutation are highly suggestive of retinoblastoma, it's important to consider if the presentation could be atypical. Could the calcifications be related to other conditions? The presence of RB1 mutation is a strong indicator. Alternative benign explanations are less likely given the constellation of findings. Conclusion: malignancy confirmed, highly suggestive of retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Skeptical reasoning: Could the findings be due to other, less aggressive processes? While the presence of calcifications, bilateral disease, positive family history, and RB1 germline mutation are highly suggestive of retinoblastoma, it's important to consider if the presentation could be atypical. Could the calcifications be related to other conditions? The presence of RB1 mutation is a strong indicator. Alternative benign explanations are less likely given the constellation of findings. Conclusion: malignancy confirmed, highly suggestive of retinoblastoma.\"\n    }\n}\n```\n```json\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be benign? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. Alternative benign explanations (e.g., other ocular tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed, highly suggestive of retinoblastoma.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T19:20:55.841574"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the findings be reactive or represent a benign inflammatory process? However, the presence of a bulky mediastinal mass and FDG-avid nodes on PET-CT strongly suggests malignancy. The histological description of Classical Hodgkin Lymphoma, nodular sclerosing type, further supports the diagnosis. While reactive lymphadenopathy is possible, the clinical context (suspected Hodgkin Lymphoma) and imaging findings make malignancy the more likely explanation. Alternative benign explanations (e.g., inflammatory disease) are less likely given the specific characteristics of the mass and the presence of FDG-avid nodes. Conclusion: Malignancy is strongly suspected based on the clinical history, imaging, and histological findings. Further investigation and treatment planning are warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the findings be reactive or represent a benign inflammatory process? However, the presence of a bulky mediastinal mass and FDG-avid nodes on PET-CT strongly suggests malignancy. The histological description of Classical Hodgkin Lymphoma, nodular sclerosing type, further supports the diagnosis. While reactive lymphadenopathy is possible, the clinical context (suspected Hodgkin Lymphoma) and imaging findings make malignancy the more likely explanation. Alternative benign explanations (e.g., inflammatory disease) are less likely given the specific characteristics of the mass and the presence of FDG-avid nodes. Conclusion: Malignancy is strongly suspected based on the clinical history, imaging, and histological findings. Further investigation and treatment planning are warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be reactive or represent a benign inflammatory process? However, the presence of a bulky mediastinal mass and FDG-avid nodes on PET-CT strongly suggests malignancy. The histological description of Classical Hodgkin Lymphoma, nodular sclerosing type, further supports the diagnosis. While reactive lymphadenopathy is possible, the clinical context (suspected Hodgkin Lymphoma) and imaging findings make malignancy the more likely explanation. Alternative benign explanations (e.g., inflammatory disease) are less likely given the specific characteristics of the mass and the presence of FDG-avid nodes. Conclusion: Malignancy is strongly suspected based on the clinical history, imaging, and histological findings. Further investigation and treatment planning are warranted.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T19:20:55.841597"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the report be a false positive? However, the presence of a parameningeal mass with intracranial extension, the confirmed diagnosis of embryonal rhabdomyosarcoma on biopsy, and the negative PAX-FOXO1 fusion result strongly suggest malignancy. Alternative benign explanations (e.g., a reactive inflammatory process mimicking a tumor) are less likely given the specific findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the report be a false positive? However, the presence of a parameningeal mass with intracranial extension, the confirmed diagnosis of embryonal rhabdomyosarcoma on biopsy, and the negative PAX-FOXO1 fusion result strongly suggest malignancy. Alternative benign explanations (e.g., a reactive inflammatory process mimicking a tumor) are less likely given the specific findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the report be a false positive? However, the presence of a parameningeal mass with intracranial extension, the confirmed diagnosis of embryonal rhabdomyosarcoma on biopsy, and the negative PAX-FOXO1 fusion result strongly suggest malignancy. Alternative benign explanations (e.g., a reactive inflammatory process mimicking a tumor) are less likely given the specific findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the report be a false positive? However, the presence of a parameningeal mass with intracranial extension, the confirmed diagnosis of embryonal rhabdomyosarcoma on biopsy, and the negative PAX-FOXO1 fusion result strongly suggest malignancy. Alternative benign explanations (e.g., a reactive inflammatory process mimicking a tumor) are less likely given the specific findings. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T19:20:55.841612"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could there be a subtle, early malignancy not detectable on ultrasound? Considering alternative explanations: Physiological splenomegaly is common in children. Absence of focal lesions and normal echo texture further decrease the likelihood of malignancy. The report explicitly states 'no malignancy identified'. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring. Conclusion: No malignancy identified. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a subtle, early malignancy not detectable on ultrasound? Considering alternative explanations: Physiological splenomegaly is common in children. Absence of focal lesions and normal echo texture further decrease the likelihood of malignancy. The report explicitly states 'no malignancy identified'. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring. Conclusion: No malignancy identified. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a subtle, early malignancy not detectable on ultrasound? Considering alternative explanations: Physiological splenomegaly is common in children. Absence of focal lesions and normal echo texture further decrease the likelihood of malignancy. The report explicitly states 'no malignancy identified'. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring. Conclusion: No malignancy identified. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malign",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could there be a subtle, early malignancy not detectable on ultrasound? Considering alternative explanations: Physiological splenomegaly is common in children. Absence of focal lesions and normal echo texture further decrease the likelihood of malignancy. The report explicitly states 'no malignancy identified'. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring. Conclusion: No malignancy identified. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T19:20:55.841630"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a different, less aggressive bone tumor? However, the combination of permeative bone destruction, large soft tissue mass, and onion-skin periosteal reaction is highly suggestive of Ewing Sarcoma. The EWSR1 fusion positivity further supports this diagnosis. Alternative benign explanations (e.g., aggressive osteomyelitis) are less likely given the characteristic features of Ewing Sarcoma. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be due to a different, less aggressive bone tumor? Playing devil's advocate against a benign conclusion: the report shows permeative bone destruction, large soft tissue mass, and onion-skin periosteal reaction, which are classic features of Ewing Sarcoma. The EWSR1 fusion positivity further supports this diagnosis. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a different, less aggressive bone tumor? Playing devil's advocate against a benign conclusion: the report shows permeative bone destruction, large soft tissue mass, and onion-skin periosteal reaction, which are classic features of Ewing Sarcoma. The EWSR1 fusion positivity further supports this diagnosis. Cannot conclude malignancy",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be due to a different, less aggressive bone tumor? However, the combination of permeative bone destruction, large soft tissue mass, and onion-skin periosteal reaction is highly suggestive of Ewing Sarcoma. The EWSR1 fusion positivity further supports this diagnosis. Alternative benign explanations (e.g., aggressive osteomyelitis) are less likely given the characteristic features of Ewing Sarcoma. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis with large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T19:20:55.841647"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could the report be a benign assessment? The report explicitly states 'reactive lymphadenopathy' and 'no malignancy identified'. The absence of atypical features further supports the benign conclusion. The report provides reassurance. Alternative benign explanations (viral infection, reactive process) are supported by the report. Conclusion: No malignancy present, although the finding of reactive lymphadenopathy warrants monitoring. Skepticism is overcome by the clear and reassuring nature of the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormal findings\", \"no evidence of malignancy\", \"no concerning features\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be an early, subtle malignancy not yet detectable? Considering the patient's history of no previous oncology, the absence of any abnormal findings, and the explicit statement that no malignancy was identified, the probability of malignancy is extremely low. It is difficult to imagine any scenario where a malignancy would be present without any evidence of it in the report. Therefore, it is highly unlikely that malignancy is present, even if it is subtle. Conclusion: No malignancy present. Skepticism is overcome by the complete absence of any concerning features.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is the report definitively ruling out malignancy? While the report states 'no malignancy identified', it is important to consider the context of a screening procedure. It is possible that the procedure is not sensitive enough to detect early-stage malignancy. The report also states 'no atypical features', which could be a subjective assessment. However, the report also provides reassurance. Alternative benign explanations (viral infection, reactive process) are supported by the report. Conclusion: No malignancy present, although the finding of reactive lymphadenopathy warrants monitoring. Skepticism is overcome by the clear and reassuring nature of the",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could the report be a benign assessment? The report explicitly states 'reactive lymphadenopathy' and 'no malignancy identified'. The absence of atypical features further supports the benign conclusion. The report provides reassurance. Alternative benign explanations (viral infection, reactive process) are supported by the report. Conclusion: No malignancy present, although the finding of reactive lymphadenopathy warrants monitoring. Skepticism is overcome by the clear and reassuring nature of the report.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T19:20:55.841663"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: While the report explicitly states 'no malignancy identified,' it is crucial to consider if the findings could be misinterpreted or if further investigation is warranted, especially given the benign presentation. The absence of blast cells is a strong indicator against malignancy. Normal CBC parameters further support a benign conclusion. However, 'no malignancy identified' does not definitively rule out early or occult malignancy. The report provides reassurance, which suggests the findings are considered benign. The report does not provide any information that would indicate a false negative. Conclusion: No malignancy present based on the provided report, but further investigation might be considered if clinical suspicion remains high.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: The report is very clear: 'no malignancy identified.' However, 'no malignancy identified' does not automatically equate to 'no malignancy.' The report is benign. The report does not provide any information that would indicate a false negative. Conclusion: No malignancy present based on the provided report, but further investigation might be considered if clinical suspicion remains high.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: The report is very clear: 'no malignancy identified.' However, 'no malignancy identified' does not automatically equate to 'no malignancy.' The report is benign. The report does not provide any information that would indicate a false negative. Conclusion: No malignancy present based on the provided report, but further",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: While the report explicitly states 'no malignancy identified,' it is crucial to consider if the findings could be misinterpreted or if further investigation is warranted, especially given the benign presentation. The absence of blast cells is a strong indicator against malignancy. Normal CBC parameters further support a benign conclusion. However, 'no malignancy identified' does not definitively rule out early or occult malignancy. The report provides reassurance, which suggests the findings are considered benign. The report does not provide any information that would indicate a false negative. Conclusion: No malignancy present based on the provided report, but further investigation might be considered if clinical suspicion remains high.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T19:20:55.841686"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the fracture is healing normally, bone density is normal, and no malignancy is identified. This directly contradicts the request to rule out malignancy. The conclusion is that there is no evidence of malignancy. Skeptical thinking is not needed as there is no indication of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the fracture is healing normally, bone density is normal, and no malignancy is identified. This directly contradicts the request to rule out malignancy. The conclusion is that there is no evidence of malignancy. Skeptical thinking is not needed as there is no indication of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the fracture is healing normally, bone density is normal, and no malignancy is identified. This directly contradicts the request to rule out malignancy. The conclusion is that there is no evidence of malignancy. Skeptical thinking is not needed as there is no indication of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the fracture is healing normally, bone density is normal, and no malignancy is identified. This directly contradicts the request to rule out malignancy. The conclusion is that there is no evidence of malignancy. Skeptical thinking is not needed as there is no indication of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the fracture is healing normally, bone density is normal, and no malignancy is identified. This directly contradicts the request to rule out malignancy. The conclusion is that there is no evidence of malignancy. Skeptical thinking is not needed as there is no indication of malignancy.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T19:20:55.841699"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and marrow infiltration pattern provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and marrow infiltration pattern provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and marrow infiltration pattern provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and marrow infiltration pattern provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T19:20:55.841715"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"Skepticism: While the report mentions 'post-viral lymphocytosis' and 'atypical lymphocytes resolving', it also explicitly states 'no malignancy identified'. It's crucial to consider if the atypical lymphocytes could be early-stage malignancy. However, the positive monospot and EBV serology strongly suggest a viral etiology. The resolution of the atypical lymphocytes further supports this. Therefore, the most likely explanation is a post-viral response. Alternative benign explanations (reactive lymphocytosis) are supported by the clinical context. Conclusion: No malignancy detected, and the findings are consistent with a post-viral lymphocytosis.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphocytes 30% of total white cells\", \"no abnormal morphology\", \"no abnormal cytology\"],\n        \"rationale\": \"Skepticism: Lymphocytes are a normal component of the white blood cell count. However, the report mentions that the lymphocytes are 30% of the total white cells, which is elevated. This could be reactive. However, the report states that there is no abnormal morphology or cytology. Therefore, the most likely explanation is reactive lymphocytosis. Alternative benign explanations (reactive lymphocytosis) are supported by the clinical context. Conclusion: No malignancy detected, and the findings are consistent with reactive lymphocytosis.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphocytes 30% of total white cells\", \"no abnormal morphology\", \"no abnormal cytology\"],\n        \"rationale\": \"Skepticism: Lymphocytes are a normal component of the white blood cell count. However, the report mentions that the lymphocytes are 30% of the total white cells, which is elevated. This could be reactive. However, the report states that there is no abnormal morphology or cytology. Therefore, the most likely explanation is",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skepticism: While the report mentions 'post-viral lymphocytosis' and 'atypical lymphocytes resolving', it also explicitly states 'no malignancy identified'. It's crucial to consider if the atypical lymphocytes could be early-stage malignancy. However, the positive monospot and EBV serology strongly suggest a viral etiology. The resolution of the atypical lymphocytes further supports this. Therefore, the most likely explanation is a post-viral response. Alternative benign explanations (reactive lymphocytosis) are supported by the clinical context. Conclusion: No malignancy detected, and the findings are consistent with a post-viral lymphocytosis.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T19:20:55.841733"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The findings are described as physiological and benign. Skeptical analysis: Could a subtle malignancy be missed? Although possible, the report's language is reassuring. No specific findings are mentioned that would raise suspicion for malignancy. Conclusion: No malignancy identified. The report is reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that no findings suggest malignancy. This is a strong indicator that no malignancy is present. Skeptical analysis: Could there be a very early, subtle malignancy that is not detectable by the current methods? While technically possible, it is highly improbable given the report's language. Conclusion: No malignancy is present based on the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that no findings suggest malignancy. This is a strong indicator that no malignancy is present. Skeptical analysis: Could there be a very early, subtle malignancy that is not detectable by the current methods? While technically possible, it is highly improbable given the report's language. Conclusion: No malignancy is present based on the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that no findings suggest malignancy. This is a strong indicator that no malignancy is present. Skeptical analysis: Could there be a very early, subtle malignancy that is not detectable by the current methods? While technically possible, it is highly improbable given the report's language. Conclusion: No malignancy is present based on the report.\"\n    }",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified. The findings are described as physiological and benign. Skeptical analysis: Could a subtle malignancy be missed? Although possible, the report's language is reassuring. No specific findings are mentioned that would raise suspicion for malignancy. Conclusion: No malignancy identified. The report is reassuring.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T19:20:55.841748"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"well-circumscribed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that a benign lipoma was found, with no evidence of malignancy. The findings are consistent with a benign presentation. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"well-circumscribed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that a benign lipoma was found, with no evidence of malignancy. The findings are consistent with a benign presentation. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"well-circumscribed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that a benign lipoma was found, with no evidence of malignancy. The findings are consistent with a benign presentation. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"well-circumscribed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that a benign lipoma was found, with no evidence of malignancy. The findings are consistent with a benign presentation. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that a benign lipoma was found, with no evidence of malignancy. The findings are consistent with a benign presentation. Therefore, malignancy is ruled out.",
      "findings": [
        "benign soft tissue mass - lipoma confirmed",
        "well-circumscribed",
        "no enhancement",
        "no intervention required",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T19:20:55.841760"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the imaging be misleading? The report describes a large renal mass with a pseudocapsule, which could be a benign lesion. However, the presence of a 'favorable histology on biopsy' and the diagnosis of Stage II suggests malignancy. The absence of vascular invasion is a positive finding, but does not rule out malignancy. Alternative benign explanations (e.g., a complex cyst) are less likely given the 'favorable histology'. Conclusion: Malignancy confirmed, although the report is reassuring on the absence of vascular invasion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the imaging be misleading? The report describes a large renal mass with a pseudocapsule, which could be a benign lesion. However, the presence of a 'favorable histology on biopsy' and the diagnosis of Stage II suggests malignancy. The absence of vascular invasion is a positive finding, but does not rule out malignancy. Alternative benign explanations (e.g., a complex cyst) are less likely given the 'favorable histology'. Conclusion: Malignancy confirmed, although the report is reassuring on the absence of vascular invasion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the imaging be misleading? The report describes a large renal mass with a pseudocapsule, which could be a benign lesion. However, the presence of a 'favorable histology on biopsy' and the diagnosis of Stage II suggests malignancy. The absence of vascular invasion is a positive finding, but does not rule out malignancy. Alternative",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the imaging be misleading? The report describes a large renal mass with a pseudocapsule, which could be a benign lesion. However, the presence of a 'favorable histology on biopsy' and the diagnosis of Stage II suggests malignancy. The absence of vascular invasion is a positive finding, but does not rule out malignancy. Alternative benign explanations (e.g., a complex cyst) are less likely given the 'favorable histology'. Conclusion: Malignancy confirmed, although the report is reassuring on the absence of vascular invasion.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "No vascular invasion",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T19:20:55.841778"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skepticism: Could the findings be due to other causes of bone pain or mass? The report describes a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase, all suggestive of malignancy. While the report doesn't explicitly state the diagnosis, the constellation of findings strongly points towards osteosarcoma, a primary bone malignancy. Alternative benign explanations (infection, trauma, benign bone lesions) are less likely given the specific features described. Conclusion: malignancy is likely, based on the report's findings. Further investigation (imaging, biopsy) is needed for definitive diagnosis, but the report provides strong evidence for a malignant process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skepticism: Could the findings be due to other causes of bone pain or mass? The report describes a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase, all suggestive of malignancy. While the report doesn't explicitly state the diagnosis, the constellation of findings strongly points towards osteosarcoma, a primary bone malignancy. Alternative benign explanations (infection, trauma, benign bone lesions) are less likely given the specific features described. Conclusion: malignancy is likely, based on the report's findings. Further investigation (imaging, biopsy) is needed for definitive diagnosis, but the report provides strong evidence for a malignant process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skepticism: Could the findings be due to other causes of bone pain or mass? The report describes a destructive lesion, sunburst periosteal reaction, and elevated",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skepticism: Could the findings be due to other causes of bone pain or mass? The report describes a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase, all suggestive of malignancy. While the report doesn't explicitly state the diagnosis, the constellation of findings strongly points towards osteosarcoma, a primary bone malignancy. Alternative benign explanations (infection, trauma, benign bone lesions) are less likely given the specific features described. Conclusion: malignancy is likely, based on the report's findings. Further investigation (imaging, biopsy) is needed for definitive diagnosis, but the report provides strong evidence for a malignant process.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T19:20:55.841797"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Healing fracture and normal bone density further support the absence of any pathological features. The reassurance provided by the consultant reinforces the benign nature of the findings. Therefore, no malignancy is present. Skeptical considerations: While fracture healing is normal, it's important to ensure no underlying pathology is contributing to the fracture. However, the report explicitly states that there are no pathological features. Thus, I can confidently rule out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Healing fracture and normal bone density further support the absence of any pathological features. The reassurance provided by the consultant reinforces the benign nature of the findings. Therefore, no malignancy is present. Skeptical considerations: While fracture healing is normal, it's important to ensure no underlying pathology is contributing to the fracture. However, the report explicitly states that there are no pathological features. Thus, I can confidently rule out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Healing fracture and normal bone density further support the absence of any pathological features. The reassurance provided by the consultant reinforces the benign nature of the findings. Therefore, no malignancy is present. Skeptical considerations: While fracture healing is normal, it's important to ensure no underlying pathology is contributing to the fracture. However, the report explicitly states that there are no pathological features. Thus, I can confidently rule out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malign",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there is no malignancy identified. Healing fracture and normal bone density further support the absence of any pathological features. The reassurance provided by the consultant reinforces the benign nature of the findings. Therefore, no malignancy is present. Skeptical considerations: While fracture healing is normal, it's important to ensure no underlying pathology is contributing to the fracture. However, the report explicitly states that there are no pathological features. Thus, I can confidently rule out malignancy.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T19:20:55.841815"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The absence of any concerning findings on the chest radiograph, such as masses or abnormal lymph nodes, further supports the conclusion that there is no malignancy. The reassurance provided by the consultant further reinforces the benign nature of the findings. Therefore, the conclusion that there is no malignancy is well-supported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report clearly indicates a normal chest radiograph with no evidence of malignancy. The absence of any concerning findings, such as masses, enlarged lymph nodes, or abnormal heart size, further strengthens the conclusion of no malignancy. The reassurance provided by the consultant reinforces the benign nature of the findings. The report is a definitive statement that there is no malignancy present. Therefore, the conclusion that there is no malignancy is well-supported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report's conclusion that no malignancy is identified is the most important factor. The absence of any findings suggestive of malignancy, such as masses, abnormal lymph nodes, or enlarged heart, further supports this conclusion. The reassurance provided by the consultant strengthens the benign nature of the findings. Therefore, the conclusion that there is no malignancy is well-supported by the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The absence of any concerning findings on the chest radiograph, such as masses or abnormal lymph nodes, further supports the conclusion that there is no malignancy. The reassurance provided by the consultant further reinforces the benign nature of the findings. Therefore, the conclusion that there is no malignancy is well-supported.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T19:20:55.841831"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could a benign liver condition be mistaken for a malignant mass? Playing devil's advocate against a benign conclusion: The presence of a large heterogeneous hepatic mass, elevated AFP, and the fetal histology subtype strongly suggests a malignant process, specifically hepatoblastoma. The PRETEXT stage II classification further supports this diagnosis. Alternative benign explanations (e.g., focal nodular hyperplasia) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely, and further investigation is warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could a benign liver condition be mistaken for a malignant mass? Playing devil's advocate against a benign conclusion: The presence of a large heterogeneous hepatic mass, elevated AFP, and the fetal histology subtype strongly suggests a malignant process, specifically hepatoblastoma. The PRETEXT stage II classification further supports this diagnosis. Alternative benign explanations (e.g., focal nodular hyperplasia) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely, and further investigation is warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could a benign liver condition be mistaken for a malignant mass? Playing devil's advocate against a benign conclusion: The presence of a large heterogeneous hepatic mass, elevated AFP, and the fetal histology subtype strongly suggests a malignant process, specifically hepatoblastoma. The PRETEXT stage II classification further supports this diagnosis. Alternative benign explanations (e.g., focal nodular hyperplasia) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely, and further",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a benign liver condition be mistaken for a malignant mass? Playing devil's advocate against a benign conclusion: The presence of a large heterogeneous hepatic mass, elevated AFP, and the fetal histology subtype strongly suggests a malignant process, specifically hepatoblastoma. The PRETEXT stage II classification further supports this diagnosis. Alternative benign explanations (e.g., focal nodular hyperplasia) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely, and further investigation is warranted.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T19:20:55.841848"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the report explicitly states 70% myeloblasts. The presence of the t(8;21) translocation is a well-established marker for Acute Myeloid Leukemia (AML). This translocation is a strong indicator of AML. Alternative benign explanations (e.g., drug-induced myelosuppression, certain infections) are less likely given the context of the report. Conclusion: Malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Skepticism: Is 70% myeloblasts a definitive diagnosis? While it's a high percentage, it's not an absolute cutoff. Is the t(8;21) translocation always a sign of AML? It's associated with AML, but can be seen in other conditions. The report mentions 'favorable risk category,' which suggests a more likely diagnosis. Alternative benign explanations are less likely given the context of the report. Conclusion: Malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Skepticism: Could the percentage of myeloblasts be artificially inflated by a technical issue? Is the t(8;21) translocation always a sign of AML? It's associated with AML, but can be seen in other conditions. The report mentions 'favorable risk category,' which suggests a more likely diagnosis. Alternative benign explanations are less likely given the context of the report. Conclusion: Malignancy confirmed, despite initial",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the report explicitly states 70% myeloblasts. The presence of the t(8;21) translocation is a well-established marker for Acute Myeloid Leukemia (AML). This translocation is a strong indicator of AML. Alternative benign explanations (e.g., drug-induced myelosuppression, certain infections) are less likely given the context of the report. Conclusion: Malignancy confirmed, despite initial skepticism.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T19:20:55.841864"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the renal mass be benign? The report describes a large, heterogeneous renal mass with a pseudocapsule, concerning for malignancy. No vascular invasion is noted, which is a favorable feature. Favorable histology on biopsy is a positive indicator. The stage II designation is consistent with a malignant process. Alternative benign explanations (e.g., complex cyst, hamartoma) are less likely given the description and stage. Conclusion: malignancy confirmed, although the favorable histology and lack of vascular invasion are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the renal mass be benign? The report describes a large, heterogeneous renal mass with a pseudocapsule, concerning for malignancy. No vascular invasion is noted, which is a favorable feature. Favorable histology on biopsy is a positive indicator. The stage II designation is consistent with a malignant process. Alternative benign explanations (e.g., complex cyst, hamartoma) are less likely given the description and stage. Conclusion: malignancy confirmed, although the favorable histology and lack of vascular invasion are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the renal mass be benign? The report describes a large, heterogeneous renal mass with a pseudocapsule, concerning for malignancy. No vascular invasion is noted, which is a favorable feature. Favorable histology on biopsy is a positive indicator. The stage II designation is consistent with a malignant process. Alternative benign explanations (e.g., complex cyst, hamartoma) are less likely given the description and stage. Conclusion: malignancy confirmed, although the favorable histology and lack of vascular invasion are reassuring.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "No vascular invasion",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T19:20:55.841894"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and CNS involvement negative provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and CNS involvement negative provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and CNS involvement negative provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and CNS involvement negative provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T19:20:55.841910"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of calcifications, bilateral disease, positive family history, and confirmed RB1 germline mutation strongly suggest retinoblastoma. Alternative benign explanations (inflammatory process, reactive hyperplasia) are less likely given the specific findings. Conclusion: malignancy confirmed based on the strong evidence of retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormal findings\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the report be inaccurate or incomplete? Playing devil's advocate against a benign conclusion: The report explicitly states 'no abnormal findings.' The findings of the report do not support a diagnosis of malignancy. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of calcifications, bilateral disease, positive family history, and confirmed RB1 germline mutation strongly suggest retinoblastoma. Alternative benign explanations (inflammatory process, reactive hyperplasia) are less likely given the specific findings. Conclusion: malignancy confirmed based on the strong evidence of retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of calcifications, bilateral disease, positive family history, and confirmed RB1 germ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of calcifications, bilateral disease, positive family history, and confirmed RB1 germline mutation strongly suggest retinoblastoma. Alternative benign explanations (inflammatory process, reactive hyperplasia) are less likely given the specific findings. Conclusion: malignancy confirmed based on the strong evidence of retinoblastoma.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T19:20:55.841925"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a healing fracture be misinterpreted? While the report explicitly states 'healing fracture' and 'no pathological features', a more skeptical approach would consider the context. The patient's history mentions a benign presentation and no previous oncology history. The report also confirms the fracture is healing normally. Therefore, it is highly improbable that the fracture itself would be misconstrued as malignancy. The absence of any pathological features further reinforces the benign nature of the findings. Conclusion: No malignancy identified. Skeptical analysis does not support a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. A healing fracture is a normal process. Therefore, there is no evidence to suggest malignancy. Skeptical analysis does not support a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the healing fracture is normal, bone density is normal, and there are no pathological features. It also explicitly states that no malignancy is identified. Therefore, there is no evidence to suggest malignancy. Skeptical analysis does not support a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. A healing fracture is a normal process. Therefore, it is highly improbable that the fracture itself would",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a healing fracture be misinterpreted? While the report explicitly states 'healing fracture' and 'no pathological features', a more skeptical approach would consider the context. The patient's history mentions a benign presentation and no previous oncology history. The report also confirms the fracture is healing normally. Therefore, it is highly improbable that the fracture itself would be misconstrued as malignancy. The absence of any pathological features further reinforces the benign nature of the findings. Conclusion: No malignancy identified. Skeptical analysis does not support a diagnosis of malignancy.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T19:20:55.841944"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign bone cyst - resolved\", \"no aggressive features\", \"normal bone density\", \"no recurrence on imaging\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: The report explicitly states that a benign bone cyst was resolved, and there are no aggressive features, normal bone density, no recurrence on imaging, and no malignancy identified. This seems like a complete and reassuring picture. While the report is reassuring, it doesn't rule out the possibility of occult malignancy, but the complete absence of any concerning features makes it highly unlikely. Further investigation is not warranted based on this report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings suggestive of malignancy. This is a strong indicator that there is no malignancy. Skeptical reasoning: While it is always important to be cautious, the report provides a clear and definitive statement that there is no malignancy. This statement is supported by the absence of any other concerning findings. Therefore, it is reasonable to conclude that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings suggestive of malignancy. This is a strong indicator that there is no malignancy. Skeptical reasoning: While it is always important to be cautious, the report provides a clear and definitive statement that there is no malignancy. This statement is supported by the absence of any other concerning findings. Therefore, it is reasonable to conclude that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: The report explicitly states that a benign bone cyst was resolved, and there are no aggressive features, normal bone density, no recurrence on imaging, and no malignancy identified. This seems like a complete and reassuring picture. While the report is reassuring, it doesn't rule out the possibility of occult malignancy, but the complete absence of any concerning features makes it highly unlikely. Further investigation is not warranted based on this report.",
      "findings": [
        "benign bone cyst - resolved",
        "no aggressive features",
        "normal bone density",
        "no recurrence on imaging",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T19:20:55.841963"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. The reason for the bone marrow biopsy was screening, and the patient has no prior oncology history. The healing fracture is a normal process. The bone density is normal. Therefore, no evidence of malignancy is present. The report is reassuring. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal bone marrow\", \"no malignant cells\", \"no abnormal findings\"],\n        \"rationale\": \"The report indicates a normal bone marrow with no malignant cells or abnormal findings. The reason for the biopsy was screening, and there is no prior history of cancer. The report is reassuring and provides no evidence of malignancy. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignant cells\", \"normal bone marrow\", \"no abnormal findings\", \"healing fracture\"],\n        \"rationale\": \"The report explicitly states that there are no malignant cells, normal bone marrow, and no abnormal findings. The healing fracture is a normal process. The reason for the biopsy was screening, and the patient has no prior oncology history. The report is reassuring. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignant cells\", \"normal bone marrow\", \"no abnormal findings\", \"healing fracture\"],\n        \"rationale\": \"The report explicitly states that there are no malignant cells, normal bone marrow, and no abnormal findings. The healing fracture is a normal process. The reason for the biopsy was screening, and the patient has no prior oncology history. The report is reassuring. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no pathological features and no malignancy identified. The reason for the bone marrow biopsy was screening, and the patient has no prior oncology history. The healing fracture is a normal process. The bone density is normal. Therefore, no evidence of malignancy is present. The report is reassuring. Conclusion: No malignancy present.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T19:20:55.841979"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a very early or indolent malignancy be missed on imaging? While the report explicitly states no malignancy identified, the absence of any abnormal findings on the MRI makes this highly unlikely. The reassurance provided further supports the benign conclusion. Alternative benign explanations (migraine, normal imaging) are the most probable. Conclusion: No malignancy identified. The reassuring nature of the report makes the conclusion highly probable.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a very early or indolent malignancy be missed on imaging? While the report explicitly states no malignancy identified, the absence of any abnormal findings on the MRI makes this highly unlikely. The reassurance provided further supports the benign conclusion. Alternative benign explanations (migraine, normal imaging) are the most probable. Conclusion: No malignancy identified. The reassuring nature of the report makes the conclusion highly probable.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a very early or indolent malignancy be missed on imaging? While the report explicitly states no malignancy identified, the absence of any abnormal findings on the MRI makes this highly unlikely. The reassurance provided further supports the benign conclusion. Alternative benign explanations (migraine, normal imaging) are the most probable. Conclusion: No malignancy identified. The reassuring nature of the report makes the conclusion highly probable.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a very early or indolent malignancy be missed on imaging? While the report explicitly states no malignancy identified, the absence of any abnormal findings on the MRI makes this highly unlikely. The reassurance provided further supports the benign conclusion. Alternative benign explanations (migraine, normal imaging) are the most probable. Conclusion: No malignancy identified. The reassuring nature of the report makes the conclusion highly probable.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T19:20:55.841995"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report clearly states that there are no pathological features and no malignancy identified. The healing fracture is a normal process, and the bone density is normal. Therefore, there is no evidence to suggest malignancy. Skeptical reasoning: Could there be a subtle, early sign of malignancy missed? However, the report explicitly rules out any pathological features or malignancy. The healing fracture is a common and benign finding. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report clearly states that there are no pathological features and no malignancy identified. The healing fracture is a normal process, and the bone density is normal. Therefore, there is no evidence to suggest malignancy. Skeptical reasoning: Could there be a subtle, early sign of malignancy missed? However, the report explicitly rules out any pathological features or malignancy. The healing fracture is a common and benign finding. Conclusion: No malignancy identified.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T19:20:55.842012"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the findings be explained by reactive lymphadenopathy or other benign conditions? However, the presence of a bulky mediastinal mass, FDG-avid nodes (indicating metabolic activity consistent with malignancy), and the specific diagnosis of Classical Hodgkin Lymphoma (nodular sclerosing type) strongly suggest malignancy. While the clinical context (paediatric oncology) is important, the report's findings are highly suggestive of Hodgkin Lymphoma. Alternative benign explanations are unlikely given the clinical context and the report's specific findings. Conclusion: Malignancy is highly probable, based on the report findings and the clinical context.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the findings be explained by reactive lymphadenopathy or other benign conditions? However, the presence of a bulky mediastinal mass, FDG-avid nodes (indicating metabolic activity consistent with malignancy), and the specific diagnosis of Classical Hodgkin Lymphoma (nodular sclerosing type) strongly suggest malignancy. While the clinical context (paediatric oncology) is important, the report's findings are highly suggestive of Hodgkin Lymphoma. Alternative benign explanations are unlikely given the clinical context and the report's specific findings. Conclusion: Malignancy is highly probable, based on the report findings and the clinical context.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the findings be explained by reactive lymphadenopathy or",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be explained by reactive lymphadenopathy or other benign conditions? However, the presence of a bulky mediastinal mass, FDG-avid nodes (indicating metabolic activity consistent with malignancy), and the specific diagnosis of Classical Hodgkin Lymphoma (nodular sclerosing type) strongly suggest malignancy. While the clinical context (paediatric oncology) is important, the report's findings are highly suggestive of Hodgkin Lymphoma. Alternative benign explanations are unlikely given the clinical context and the report's specific findings. Conclusion: Malignancy is highly probable, based on the report findings and the clinical context.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T19:20:55.842032"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"Initial skepticism: Could the infiltrative mass be reactive? However, the biopsy confirming a diffuse astrocytoma (WHO grade II) strongly suggests malignancy. The FLAIR hyperintensity supports the presence of a mass. Alternative benign explanations (inflammatory process, vascular malformation) are less likely given the biopsy result. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"Initial skepticism: Could the infiltrative mass be reactive? However, the biopsy confirming a diffuse astrocytoma (WHO grade II) strongly suggests malignancy. The FLAIR hyperintensity supports the presence of a mass. Alternative benign explanations (inflammatory process, vascular malformation) are less likely given the biopsy result. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"Initial skepticism: Could the infiltrative mass be reactive? However, the biopsy confirming a diffuse astrocytoma (WHO grade II) strongly suggests malignancy. The FLAIR hyperintensity supports the presence of a mass. Alternative benign explanations (inflammatory process, vascular malformation) are less likely given the biopsy result. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the infiltrative mass be reactive? However, the biopsy confirming a diffuse astrocytoma (WHO grade II) strongly suggests malignancy. The FLAIR hyperintensity supports the presence of a mass. Alternative benign explanations (inflammatory process, vascular malformation) are less likely given the biopsy result. Conclusion: malignancy confirmed, despite initial skepticism.",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T19:20:55.842048"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T19:20:55.842062"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skeptical review: The report clearly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all consistent with Hodgkin Lymphoma. The description of the Hodgkin type (nodular sclerosing) further supports this diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the description of a bulky mass and FDG-avid nodes. Conclusion: Malignancy confirmed, consistent with Hodgkin Lymphoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skeptical review: The report clearly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all consistent with Hodgkin Lymphoma. The description of the Hodgkin type (nodular sclerosing) further supports this diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the description of a bulky mass and FDG-avid nodes. Conclusion: Malignancy confirmed, consistent with Hodgkin Lymphoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skeptical review: The report clearly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all consistent with Hodgkin Lymphoma. The description of the Hodgkin type (nodular sclerosing) further supports this diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy)",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: The report clearly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all consistent with Hodgkin Lymphoma. The description of the Hodgkin type (nodular sclerosing) further supports this diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the description of a bulky mass and FDG-avid nodes. Conclusion: Malignancy confirmed, consistent with Hodgkin Lymphoma.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T19:20:55.842078"
    }
  ],
  "num_samples": 100,
  "samples": [
    {
      "sample_idx": 0,
      "input": "02/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"clinical improvement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a past infection or inflammatory process be masked by a currently normal presentation? Could a very early, subtle malignancy be missed? The report clearly states that the patient had a resolved febrile illness, blood counts have normalized, there is no organomegaly, and there is clinical improvement. Furthermore, the report explicitly states that no malignancy is identified. Although a very early or subtle malignancy is not impossible, the provided information is highly reassuring and does not indicate malignancy. Therefore, I am confident in stating that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"clinical improvement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a past infection or inflammatory process be masked by a currently normal presentation? Could a very early, subtle malignancy be missed? The report clearly states that the patient had a resolved febrile illness, blood counts have normalized, there is no organomegaly, and there is clinical improvement. Furthermore, the report explicitly states that no malignancy is identified. Although a very early or subtle malignancy is not impossible, the provided information is highly reassuring and does not indicate malignancy. Therefore, I am confident in stating that no malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"clinical improvement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a past infection or inflammatory process be masked by a currently normal presentation? Could a very early, subtle malignancy be missed? The report clearly states that the patient had a resolved febrile illness, blood counts have normalized, there is no organomegaly, and there is clinical improvement. Furthermore, the report explicitly states that no malignancy is identified. Although",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a past infection or inflammatory process be masked by a currently normal presentation? Could a very early, subtle malignancy be missed? The report clearly states that the patient had a resolved febrile illness, blood counts have normalized, there is no organomegaly, and there is clinical improvement. Furthermore, the report explicitly states that no malignancy is identified. Although a very early or subtle malignancy is not impossible, the provided information is highly reassuring and does not indicate malignancy. Therefore, I am confident in stating that no malignancy is present.",
      "findings": [
        "resolved febrile illness",
        "normalized blood counts",
        "no organomegaly",
        "clinical improvement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 0,
      "timestamp": "2026-01-10T19:20:55.840311"
    },
    {
      "sample_idx": 1,
      "input": "26/10/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a benign mass with secondary enhancement and hydrocephalus? However, the report explicitly mentions high-grade medulloblastoma on histology, which is a specific type of brain tumor. The presence of restricted diffusion further supports a malignant process. Alternative benign explanations are less likely given the specific diagnosis of medulloblastoma. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a benign mass with secondary enhancement and hydrocephalus? However, the report explicitly mentions high-grade medulloblastoma on histology, which is a specific type of brain tumor. The presence of restricted diffusion further supports a malignant process. Alternative benign explanations are less likely given the specific diagnosis of medulloblastoma. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a benign mass with secondary enhancement and hydrocephalus? However, the report explicitly mentions high-grade medulloblastoma on histology, which is a specific type of brain tumor. The presence of restricted diffusion further supports a malignant process. Alternative benign explanations are less likely given the specific diagnosis of medulloblastoma. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be a benign mass with secondary enhancement and hydrocephalus? However, the report explicitly mentions high-grade medulloblastoma on histology, which is a specific type of brain tumor. The presence of restricted diffusion further supports a malignant process. Alternative benign explanations are less likely given the specific diagnosis of medulloblastoma. Conclusion: malignancy confirmed, despite initial skepticism.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 1,
      "timestamp": "2026-01-10T19:20:55.840341"
    },
    {
      "sample_idx": 2,
      "input": "03/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could the reactive lymphadenopathy be subtle? While the report states 'no atypical features' and 'no malignancy identified', the presence of reactive lymphadenopathy itself warrants a degree of caution. The decreasing node size supports the benign nature of the finding. While the report explicitly states 'no malignancy identified', the possibility of a very early, subtle malignancy cannot be completely excluded without further investigation. Alternative benign explanations (viral infection) are supported by the report's findings. Conclusion: While the report provides reassurance, the presence of reactive lymphadenopathy necessitates follow-up to ensure its resolution and rule out any potential for early malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the reactive lymphadenopathy be subtle? While the report states 'no atypical features' and 'no malignancy identified', the presence of reactive lymphadenopathy itself warrants a degree of caution. The decreasing node size supports the benign nature of the finding. While the report explicitly states 'no malignancy identified', the possibility of a very early, subtle malignancy cannot be completely excluded without further investigation. Alternative benign explanations (viral infection) are supported by the report's findings. Conclusion: While the report provides reassurance, the presence of reactive lymphadenopathy necessitates follow-up to ensure its resolution and rule out any potential for early malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the reactive lymphadenopathy be subtle? While the report states 'no atypical features' and 'no malignancy",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could the reactive lymphadenopathy be subtle? While the report states 'no atypical features' and 'no malignancy identified', the presence of reactive lymphadenopathy itself warrants a degree of caution. The decreasing node size supports the benign nature of the finding. While the report explicitly states 'no malignancy identified', the possibility of a very early, subtle malignancy cannot be completely excluded without further investigation. Alternative benign explanations (viral infection) are supported by the report's findings. Conclusion: While the report provides reassurance, the presence of reactive lymphadenopathy necessitates follow-up to ensure its resolution and rule out any potential for early malignancy.",
      "findings": [
        "reactive lymphadenopathy secondary to viral infection",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 2,
      "timestamp": "2026-01-10T19:20:55.840365"
    },
    {
      "sample_idx": 3,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the lymphadenopathy be reactive? However, the biopsy confirming Burkitt lymphoma and elevated LDH levels provide strong evidence of malignancy. Alternative benign explanations (e.g., infection, inflammation) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the lymphadenopathy be reactive? However, the biopsy confirming Burkitt lymphoma and elevated LDH levels provide strong evidence of malignancy. Alternative benign explanations (e.g., infection, inflammation) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the lymphadenopathy be reactive? However, the biopsy confirming Burkitt lymphoma and elevated LDH levels provide strong evidence of malignancy. Alternative benign explanations (e.g., infection, inflammation) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"high LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the lymphadenopathy be reactive? However, the biopsy confirming Burkitt lymphoma and elevated LDH levels provide strong evidence of malignancy.",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the lymphadenopathy be reactive? However, the biopsy confirming Burkitt lymphoma and elevated LDH levels provide strong evidence of malignancy. Alternative benign explanations (e.g., infection, inflammation) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed despite initial skepticism.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "high LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 3,
      "timestamp": "2026-01-10T19:20:55.840382"
    },
    {
      "sample_idx": 4,
      "input": "04/05/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 04/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and the absence of CNS involvement provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Applying skeptical reasoning: Could high lymphocyte count be reactive? Playing devil's advocate against a benign conclusion: the report shows bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. However, the clinical context of suspected ALL and the presence of lymphoblasts makes malignancy the most likely explanation. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Applying skeptical reasoning: Could high lymphocyte count be reactive? Playing devil's advocate against a benign conclusion: the report shows bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells, and immunophenotyping consistent with B-cell ALL. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. However, the clinical context of suspected ALL and the presence of lymphoblasts makes malignancy the most likely explanation. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and the absence of CNS involvement provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 4,
      "timestamp": "2026-01-10T19:20:55.840400"
    },
    {
      "sample_idx": 5,
      "input": "17/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 17/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be a manifestation of a low-grade malignancy? However, the report explicitly states that the lymphadenopathy is reactive and decreasing in size. No atypical features are noted. The final statement confirms that no malignancy was identified. The reassurance provided further supports the benign nature of the findings. Alternative benign explanations (viral infection, post-infectious lymphadenopathy) are supported by the report. Conclusion: Reactive lymphadenopathy is the most likely explanation, ruling out malignancy. No need for further investigation.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could reactive lymphadenopathy be a manifestation of a low-grade malignancy? However, the report explicitly states that the lymphadenopathy is reactive and decreasing in size. No atypical features are noted. The final statement confirms that no malignancy was identified. The reassurance provided further supports the benign nature of the findings. Alternative benign explanations (viral infection, post-infectious lymphadenopathy) are supported by the report. Conclusion: Reactive lymphadenopathy is the most likely explanation, ruling out malignancy. No need for further investigation.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could reactive lymphadenopathy be a manifestation of a low-grade malignancy? However, the report explicitly states that the lymphadenopathy is reactive and decreasing in size. No atypical features are noted. The final statement confirms that no malignancy was identified. The reassurance provided further supports the benign nature of the findings.",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could reactive lymphadenopathy be a manifestation of a low-grade malignancy? However, the report explicitly states that the lymphadenopathy is reactive and decreasing in size. No atypical features are noted. The final statement confirms that no malignancy was identified. The reassurance provided further supports the benign nature of the findings. Alternative benign explanations (viral infection, post-infectious lymphadenopathy) are supported by the report. Conclusion: Reactive lymphadenopathy is the most likely explanation, ruling out malignancy. No need for further investigation.",
      "findings": [
        "reactive lymphadenopathy",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 5,
      "timestamp": "2026-01-10T19:20:55.840421"
    },
    {
      "sample_idx": 6,
      "input": "11/07/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign lesion? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggest neuroblastoma. Stage III disease further supports this diagnosis. Alternative benign explanations (e.g., other types of tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign lesion? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggest neuroblastoma. Stage III disease further supports this diagnosis. Alternative benign explanations (e.g., other types of tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign lesion? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggest neuroblastoma. Stage III disease further supports this diagnosis. Alternative benign explanations (e.g., other types of tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be a benign lesion? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggest neuroblastoma. Stage III disease further supports this diagnosis. Alternative benign explanations (e.g., other types of tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed based on the report's findings.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 6,
      "timestamp": "2026-01-10T19:20:55.840438"
    },
    {
      "sample_idx": 7,
      "input": "21/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. The patient has no prior oncology history. The reassurance provided by the consultant reinforces the absence of malignancy. Therefore, the likelihood of malignancy is extremely low. No abnormalities were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. The patient has no prior oncology history. The reassurance provided by the consultant reinforces the absence of malignancy. Therefore, the likelihood of malignancy is extremely low. No abnormalities were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. The patient has no prior oncology history. The reassurance provided by the consultant reinforces the absence of malignancy. Therefore, the likelihood of malignancy is extremely low. No abnormalities were found.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. The patient has no prior oncology history. The reassurance provided",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified on the chest radiograph, lung fields, mediastinum, or heart. The patient has no prior oncology history. The reassurance provided by the consultant reinforces the absence of malignancy. Therefore, the likelihood of malignancy is extremely low. No abnormalities were found.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 7,
      "timestamp": "2026-01-10T19:20:55.840463"
    },
    {
      "sample_idx": 8,
      "input": "08/02/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: The report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: The report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: The report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal CBC\", \"No blast cells\", \"Platelets adequate\", \"Hemoglobin within normal limits\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: The report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"ab",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: The report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.",
      "findings": [
        "Normal CBC",
        "No blast cells",
        "Platelets adequate",
        "Hemoglobin within normal limits"
      ],
      "fracture_mentioned": null,
      "idx": 8,
      "timestamp": "2026-01-10T19:20:55.840480"
    },
    {
      "sample_idx": 9,
      "input": "25/04/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\", \"Wilms Tumor\"],\n        \"rationale\": \"Initial skepticism: Could a benign renal cyst be misinterpreted as a mass? However, the report explicitly mentions a 'large heterogeneous left renal mass with pseudocapsule', which is highly suggestive of a neoplasm. The absence of vascular invasion and the presence of 'favorable histology' on biopsy further support the diagnosis of Wilms Tumor. The report also confirms the diagnosis of Wilms Tumor and provides staging information. Alternative benign explanations (renal cyst, angiomyolipoma) are ruled out by the presence of a mass, heterogeneous appearance, and the report of a Wilms Tumor. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\", \"Wilms Tumor\"],\n        \"rationale\": \"Initial skepticism: Could a benign renal cyst be misinterpreted as a mass? However, the report explicitly mentions a 'large heterogeneous left renal mass with pseudocapsule', which is highly suggestive of a neoplasm. The absence of vascular invasion and the presence of 'favorable histology' on biopsy further support the diagnosis of Wilms Tumor. The report also confirms the diagnosis of Wilms Tumor and provides staging information. Alternative benign explanations (renal cyst, angiomyolipoma) are ruled out by the presence of a mass, heterogeneous appearance, and the report of a Wilms Tumor. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\", \"Wilms Tumor\"],\n        \"rationale\": \"Initial skepticism: Could a benign renal cyst be misinterpreted as a mass? However, the report explicitly mentions a 'large heterogeneous left renal",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a benign renal cyst be misinterpreted as a mass? However, the report explicitly mentions a 'large heterogeneous left renal mass with pseudocapsule', which is highly suggestive of a neoplasm. The absence of vascular invasion and the presence of 'favorable histology' on biopsy further support the diagnosis of Wilms Tumor. The report also confirms the diagnosis of Wilms Tumor and provides staging information. Alternative benign explanations (renal cyst, angiomyolipoma) are ruled out by the presence of a mass, heterogeneous appearance, and the report of a Wilms Tumor. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II",
        "Wilms Tumor"
      ],
      "fracture_mentioned": null,
      "idx": 9,
      "timestamp": "2026-01-10T19:20:55.840503"
    },
    {
      "sample_idx": 10,
      "input": "26/12/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mediastinal mass be reactive? However, the presence of bulky anterior mediastinal mass, FDG-avid nodes, and the description of Classical Hodgkin, nodular sclerosing type strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory response) are less likely given the FDG-avid nature and the specific Hodgkin subtype. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mediastinal mass be reactive? However, the presence of bulky anterior mediastinal mass, FDG-avid nodes, and the description of Classical Hodgkin, nodular sclerosing type strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory response) are less likely given the FDG-avid nature and the specific Hodgkin subtype. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mediastinal mass be reactive? However, the presence of bulky anterior mediastinal mass, FDG-avid nodes, and the description of Classical Hodgkin, nodular sclerosing type strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory response) are less likely given the FDG-avid nature and the specific Hodgkin subtype. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mediastinal mass be reactive? However, the presence of bulky anterior mediastinal mass, FDG-avid nodes, and the description of Classical Hodgkin, nodular sclerosing type strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory response) are less likely given the FDG-avid nature and the specific Hodgkin subtype. Conclusion: Malignancy confirmed.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 10,
      "timestamp": "2026-01-10T19:20:55.840519"
    },
    {
      "sample_idx": 11,
      "input": "18/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 18/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Skepticism: Could the mass be benign? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines are highly suggestive of neuroblastoma, a known childhood cancer. Stage III disease further strengthens this suspicion. Alternative benign explanations (e.g., benign adrenal tumor with reactive calcifications) are less likely given the combination of findings. Conclusion: Malignancy is highly probable, although a definitive diagnosis requires biopsy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report indicates a large heterogeneous suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and Stage III disease. These findings are highly suggestive of neuroblastoma, a known childhood cancer. The presence of calcifications, MIBG avidity, and elevated urinary catecholamines makes it less likely that the mass is benign. Stage III disease further strengthens this suspicion. Alternative benign explanations (e.g., benign adrenal tumor with reactive calcifications) are less likely given the combination of findings. Conclusion: Malignancy is highly probable, although a definitive diagnosis requires biopsy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report indicates a large heterogeneous suprarenal mass with calcifications, MIBG avidity, elevated urinary catecholamines, and Stage III disease. These findings are highly suggestive of neuroblastoma, a known childhood cancer. The presence of calcifications, MIBG avidity, and elevated urinary catecholamines makes it less likely that the mass is benign. Stage",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skepticism: Could the mass be benign? However, the presence of calcifications, MIBG avidity, and elevated urinary catecholamines are highly suggestive of neuroblastoma, a known childhood cancer. Stage III disease further strengthens this suspicion. Alternative benign explanations (e.g., benign adrenal tumor with reactive calcifications) are less likely given the combination of findings. Conclusion: Malignancy is highly probable, although a definitive diagnosis requires biopsy.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 11,
      "timestamp": "2026-01-10T19:20:55.840537"
    },
    {
      "sample_idx": 12,
      "input": "15/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 15/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign liver lesion or metastatic disease? However, the report explicitly mentions a 'large heterogeneous hepatic mass' with elevated AFP, 'Fetal histology subtype' and 'PRETEXT stage II' which are all highly suggestive of Hepatoblastoma. Alternative benign explanations (e.g., metastatic disease from another primary, benign liver tumor) are less likely given the specific findings. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be a benign liver lesion or metastatic disease? However, the report explicitly mentions a 'large heterogeneous hepatic mass' with elevated AFP, 'Fetal histology subtype' and 'PRETEXT stage II' which are all highly suggestive of Hepatoblastoma. Alternative benign explanations (e.g., metastatic disease from another primary, benign liver tumor) are less likely given the specific findings. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be a benign liver lesion or metastatic disease? However, the report explicitly mentions a 'large heterogeneous hepatic mass' with elevated AFP, 'Fetal histology subtype' and 'PRETEXT stage II' which are all highly suggestive of Hepatoblastoma. Alternative benign explanations (e.g., metastatic disease from another primary, benign liver tumor) are less likely given the specific findings. Conclusion: malignancy confirmed.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 12,
      "timestamp": "2026-01-10T19:20:55.840554"
    },
    {
      "sample_idx": 13,
      "input": "26/02/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Langerhans Cell Histiocytosis.\n\nFrom clinical notes: Langerhans Cell Histiocytosis. Paediatric oncology assessment.\n\nFindings: multiple lytic skull lesions with soft tissue component. CD1a and Langerin positive. Multisystem disease. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 26/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"Initial skepticism: Could this be Langerhans Cell Histiocytosis (LCH) with reactive changes? However, the report explicitly states that the lesions are CD1a and Langerin positive, which are characteristic markers of LCH. Lytic lesions are also a key feature of LCH. Alternative benign explanations (e.g., metastasis from another primary) are less likely given the presence of characteristic LCH markers. Conclusion: Given the presence of Lytic lesions with positive CD1a and Langerin, it is likely LCH with a malignant component. Further investigation with biopsy is required for confirmation and classification of the disease. However, based on the current information, it is likely a malignant LCH. \"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"Initial skepticism: Could this be Langerhans Cell Histiocytosis (LCH) with reactive changes? However, the report explicitly states that the lesions are CD1a and Langerin positive, which are characteristic markers of LCH. Lytic lesions are also a key feature of LCH. Alternative benign explanations (e.g., metastasis from another primary) are less likely given the presence of characteristic LCH markers. Conclusion: Given the presence of Lytic lesions with positive CD1a and Langerin, it is likely LCH with a malignant component. Further investigation with biopsy is required for confirmation and classification of the disease. However, based on the current information, it is likely a malignant LCH. \"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"multiple lytic skull lesions with soft tissue component\", \"CD1a and Langerin positive\"],\n        \"rationale\": \"Initial skepticism: Could this be Langerhans Cell Histiocytosis (LCH) with reactive changes? However, the report",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could this be Langerhans Cell Histiocytosis (LCH) with reactive changes? However, the report explicitly states that the lesions are CD1a and Langerin positive, which are characteristic markers of LCH. Lytic lesions are also a key feature of LCH. Alternative benign explanations (e.g., metastasis from another primary) are less likely given the presence of characteristic LCH markers. Conclusion: Given the presence of Lytic lesions with positive CD1a and Langerin, it is likely LCH with a malignant component. Further investigation with biopsy is required for confirmation and classification of the disease. However, based on the current information, it is likely a malignant LCH. ",
      "findings": [
        "multiple lytic skull lesions with soft tissue component",
        "CD1a and Langerin positive"
      ],
      "fracture_mentioned": null,
      "idx": 13,
      "timestamp": "2026-01-10T19:20:55.840574"
    },
    {
      "sample_idx": 14,
      "input": "08/09/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 08/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could post-viral lymphocytosis be malignant? Playing devil's advocate against a benign conclusion: the report explicitly states that there is no malignancy identified and that the atypical lymphocytes are resolving. The EBV serology confirms the diagnosis of mononucleosis. The finding of post-viral lymphocytosis is a common and benign response to infection. It is unlikely that the atypical lymphocytes are malignant, given the resolution of the findings and the absence of any other concerning features. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could post-viral lymphocytosis be malignant? Playing devil's advocate against a benign conclusion: the report explicitly states that there is no malignancy identified and that the atypical lymphocytes are resolving. The EBV serology confirms the diagnosis of mononucleosis. The finding of post-viral lymphocytosis is a common and benign response to infection. It is unlikely that the atypical lymphocytes are malignant, given the resolution of the findings and the absence of any other concerning features. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could post-viral lymphocytosis be malignant? Playing devil's advocate against a benign conclusion: the report explicitly states that there is no malignancy identified and that the atypical lymphocytes are resolving. The EBV serology confirms the diagnosis of mononucleosis",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could post-viral lymphocytosis be malignant? Playing devil's advocate against a benign conclusion: the report explicitly states that there is no malignancy identified and that the atypical lymphocytes are resolving. The EBV serology confirms the diagnosis of mononucleosis. The finding of post-viral lymphocytosis is a common and benign response to infection. It is unlikely that the atypical lymphocytes are malignant, given the resolution of the findings and the absence of any other concerning features. Conclusion: No malignancy present.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 14,
      "timestamp": "2026-01-10T19:20:55.840594"
    },
    {
      "sample_idx": 15,
      "input": "14/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 14/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the presence of a specific translocation, t(8;21), is a well-established marker for Acute Myeloid Leukemia (AML). While a reactive process is possible, the t(8;21) translocation strongly suggests AML. Alternative benign explanations (e.g., certain types of reactive marrow changes) are less likely to present with this specific cytogenetic abnormality. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the presence of a specific translocation, t(8;21), is a well-established marker for Acute Myeloid Leukemia (AML). While a reactive process is possible, the t(8;21) translocation strongly suggests AML. Alternative benign explanations (e.g., certain types of reactive marrow changes) are less likely to present with this specific cytogenetic abnormality. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the presence of a specific translocation, t(8;21), is a well-established marker for Acute Myeloid Leukemia (AML). While a reactive process is possible, the t(8;21) translocation strongly suggests AML. Alternative benign explanations (e.g., certain types of reactive marrow changes) are less likely to present with this specific cytogenetic abnormality. Conclusion: Malignancy confirmed",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the presence of a specific translocation, t(8;21), is a well-established marker for Acute Myeloid Leukemia (AML). While a reactive process is possible, the t(8;21) translocation strongly suggests AML. Alternative benign explanations (e.g., certain types of reactive marrow changes) are less likely to present with this specific cytogenetic abnormality. Conclusion: Malignancy confirmed.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 15,
      "timestamp": "2026-01-10T19:20:55.840610"
    },
    {
      "sample_idx": 16,
      "input": "07/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 07/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"Initial skepticism: Could the diagnosis be a misinterpretation or a reactive process? However, the report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension'. These findings are highly suggestive of malignancy, specifically embryonal rhabdomyosarcoma. The presence of a parameningeal mass and intracranial extension further supports the diagnosis. Alternative benign explanations (inflammatory process, reactive lesion) are less likely given the specific diagnosis and the clinical context. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension'. These findings are highly suggestive of malignancy, specifically embryonal rhabdomyosarcoma. The presence of a parameningeal mass and intracranial extension further supports the diagnosis. Alternative benign explanations (inflammatory process, reactive lesion) are less likely given the specific diagnosis and the clinical context. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma\", \"parameningeal mass with intracranial extension\"],\n        \"rationale\": \"The report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension'. These findings are highly suggestive of malignancy, specifically embryonal rhabdomyosarcoma. The presence of a parameningeal mass and intracranial extension further supports the diagnosis. Alternative benign explanations (inflammatory process, reactive lesion) are less likely given the specific diagnosis and the clinical context. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the diagnosis be a misinterpretation or a reactive process? However, the report explicitly states 'embryonal rhabdomyosarcoma' and describes a 'parameningeal mass with intracranial extension'. These findings are highly suggestive of malignancy, specifically embryonal rhabdomyosarcoma. The presence of a parameningeal mass and intracranial extension further supports the diagnosis. Alternative benign explanations (inflammatory process, reactive lesion) are less likely given the specific diagnosis and the clinical context. Conclusion: Malignancy confirmed despite initial skepticism.",
      "findings": [
        "embryonal rhabdomyosarcoma",
        "parameningeal mass with intracranial extension"
      ],
      "fracture_mentioned": null,
      "idx": 16,
      "timestamp": "2026-01-10T19:20:55.840629"
    },
    {
      "sample_idx": 17,
      "input": "06/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. The chest radiograph is normal, with no mediastinal mass or other concerning findings. The heart size is normal. Therefore, there is no evidence of malignancy. Skepticism is unnecessary.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no previous oncology history\", \"no previous malignancy identified\"],\n        \"rationale\": \"The patient has no history of malignancy, and the report explicitly states that no malignancy was identified. This makes the screening unnecessary, and therefore, the report is valid. Skepticism is unwarranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. The chest radiograph is normal, with no mediastinal mass or other concerning findings. The heart size is normal. Therefore, there is no evidence of malignancy. Skepticism is unnecessary.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no previous oncology history\", \"no previous malignancy identified\"],\n        \"rationale\": \"The patient has no history of malignancy, and the report explicitly states that no malignancy was identified. This makes the screening unnecessary, and therefore, the report is valid. Skepticism is unwarranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there is no malignancy identified. The chest radiograph is normal, with no mediastinal mass or other concerning findings. The heart size is normal. Therefore, there is no evidence of malignancy. Skepticism is unnecessary.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 17,
      "timestamp": "2026-01-10T19:20:55.840642"
    },
    {
      "sample_idx": 18,
      "input": "23/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 23/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a reactive process? However, the presence of a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirmation of high-grade medulloblastoma on histology strongly suggests malignancy. Alternative benign explanations are ruled out by the histological confirmation. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a reactive process? However, the presence of a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirmation of high-grade medulloblastoma on histology strongly suggests malignancy. Alternative benign explanations are ruled out by the histological confirmation. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a reactive process? However, the presence of a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirmation of high-grade medulloblastoma on histology strongly suggests malignancy. Alternative benign explanations are ruled out by the histological confirmation. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the findings be a reactive process? However, the presence of a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion,",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be a reactive process? However, the presence of a posterior fossa mass with enhancement and hydrocephalus, restricted diffusion, and confirmation of high-grade medulloblastoma on histology strongly suggests malignancy. Alternative benign explanations are ruled out by the histological confirmation. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 18,
      "timestamp": "2026-01-10T19:20:55.840658"
    },
    {
      "sample_idx": 19,
      "input": "09/07/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the imaging findings be due to benign processes? However, the presence of a large heterogeneous suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggests Neuroblastoma, a known childhood malignancy. The Stage III disease designation further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcifications, benign catecholamine-secreting tumor) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely based on the imaging findings and clinical context.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines. This presentation is highly suggestive of Neuroblastoma, a pediatric malignancy. The Stage III designation further supports this diagnosis. While a benign explanation is possible, it is less likely given the combination of findings. Conclusion: Malignancy is a strong possibility.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"The report describes a large suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines. This presentation is highly suggestive of Neuroblastoma, a pediatric malignancy. The Stage III designation further supports this diagnosis. While a benign explanation is possible, it is less likely given the combination of findings. Conclusion: Malignancy is a strong possibility.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malign",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the imaging findings be due to benign processes? However, the presence of a large heterogeneous suprarenal mass with calcifications, MIBG avidity, and elevated urinary catecholamines strongly suggests Neuroblastoma, a known childhood malignancy. The Stage III disease designation further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcifications, benign catecholamine-secreting tumor) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely based on the imaging findings and clinical context.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 19,
      "timestamp": "2026-01-10T19:20:55.840677"
    },
    {
      "sample_idx": 20,
      "input": "18/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be benign, or a reactive process? However, the report explicitly states a 'large heterogeneous left renal mass with pseudocapsule', 'no vascular invasion', 'favorable histology on biopsy', and 'stage II'. These findings are consistent with Wilms Tumor. Alternative benign explanations (e.g., cysts, renal vein thrombosis) are less likely given the report's findings. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be benign, or a reactive process? However, the report explicitly states a 'large heterogeneous left renal mass with pseudocapsule', 'no vascular invasion', 'favorable histology on biopsy', and 'stage II'. These findings are consistent with Wilms Tumor. Alternative benign explanations (e.g., cysts, renal vein thrombosis) are less likely given the report's findings. Conclusion: malignancy confirmed.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 20,
      "timestamp": "2026-01-10T19:20:55.840693"
    },
    {
      "sample_idx": 21,
      "input": "13/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 13/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that the surveillance is missing something? Playing devil's advocate against a benign conclusion: the report states that the brain MRI is normal, with no mass lesions, abnormal enhancement, or malignancy identified. The surveillance is routine, and there is no indication of a problem. Conclusion: No malignancy detected. A normal brain MRI with no evidence of malignancy does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that the surveillance is missing something? Playing devil's advocate against a benign conclusion: the report states that the brain MRI is normal, with no mass lesions, abnormal enhancement, or malignancy identified. The surveillance is routine, and there is no indication of a problem. Conclusion: No malignancy detected. A normal brain MRI with no evidence of malignancy does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that the surveillance is missing something? Playing devil's advocate against a benign conclusion: the report states that the brain MRI is normal, with no mass lesions, abnormal enhancement, or malignancy identified. The surveillance is routine, and there is no indication of a problem. Conclusion: No malignancy detected. A normal brain MRI with no evidence of malignancy does not indicate malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Is it possible that the surveillance is missing something? Playing devil's advocate against a benign conclusion: the report states that the brain MRI is normal, with no mass lesions, abnormal enhancement, or malignancy identified. The surveillance is routine, and there is no indication of a problem. Conclusion: No malignancy detected. A normal brain MRI with no evidence of malignancy does not indicate malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 21,
      "timestamp": "2026-01-10T19:20:55.840709"
    },
    {
      "sample_idx": 22,
      "input": "18/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive? However, the report explicitly mentions a large heterogeneous mass, a pseudocapsule, and a diagnosis of Wilms Tumor, all strongly suggesting malignancy. The favorable histology and stage II are consistent with a diagnosis of Wilms Tumor. Alternative benign explanations (e.g., a benign renal cyst with reactive components) are unlikely given the overall picture. Conclusion: malignancy confirmed based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be benign, even with a mass? Playing devil's advocate against a benign conclusion: The report mentions no vascular invasion and favorable histology, which could potentially point to a benign process. Stage II could be a misdiagnosis, or the tumor could be non-aggressive. Without further information, it is impossible to rule out a benign process. Conclusion: No malignancy detected based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive? However, the report explicitly mentions a large heterogeneous mass, a pseudocapsule, and a diagnosis of Wilms Tumor, all strongly suggesting malignancy. The favorable histology and stage II are consistent with a diagnosis of Wilms Tumor. Alternative benign explanations (e.g., a benign renal cyst with reactive components) are unlikely given the overall picture. Conclusion: malignancy confirmed based on the report's findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be reactive? However, the report explicitly mentions a large heterogeneous mass, a pseudocapsule, and a diagnosis of Wilms Tumor, all strongly suggesting malignancy. The favorable histology and stage II are consistent with a diagnosis of Wilms Tumor. Alternative benign explanations (e.g., a benign renal cyst with reactive components) are unlikely given the overall picture. Conclusion: malignancy confirmed based on the report's findings.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 22,
      "timestamp": "2026-01-10T19:20:55.840726"
    },
    {
      "sample_idx": 23,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there are no signs of malignancy. The patient's headache is attributed to migraine. There are no abnormal findings. Conclusion: No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there are no signs of malignancy. The patient's headache is attributed to migraine. There are no abnormal findings. Conclusion: No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there are no signs of malignancy. The patient's headache is attributed to migraine. There are no abnormal findings. Conclusion: No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, and there are no signs of malignancy. The patient's headache is attributed to migraine. There are no abnormal findings. Conclusion: No evidence of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal, and there are no signs of malignancy. The patient's headache is attributed to migraine. There are no abnormal findings. Conclusion: No evidence of malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 23,
      "timestamp": "2026-01-10T19:20:55.840740"
    },
    {
      "sample_idx": 24,
      "input": "16/05/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that there is a very early malignancy which is not yet visible on the PET-CT scan? The report explicitly states that no malignancy was identified. This is reassuring. There is no evidence of any abnormality. Conclusion: No malignancy identified. No evidence of malignancy. The report is reassuring and provides a definitive answer. Skeptical approach does not change the conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings of malignancy\", \"no abnormal features\", \"no evidence of disease\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a very subtle, early-stage malignancy that the scan missed? While the report states there are no findings of malignancy, the wording is broad. It's possible that a very small, early-stage tumor could be missed. However, the report also states that there are no abnormal features and no evidence of disease, which is reassuring. Overall, the report is reassuring. Conclusion: No evidence of malignancy. The report is definitive and reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no evidence of malignancy\", \"no abnormal findings\", \"no suspicious lesions\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that there is a very subtle, early-stage malignancy that the scan missed? While the report states there are no findings of malignancy, the wording is broad. It's possible that a very small, early-stage tumor could be missed. However, the report also states that there are no abnormal features and no suspicious lesions, which is reassuring. Overall, the report is reassuring. Conclusion: No evidence of malignancy. The report is definitive and reassuring. Skeptical approach does not change the conclusion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Is it possible that there is a very early malignancy which is not yet visible on the PET-CT scan? The report explicitly states that no malignancy was identified. This is reassuring. There is no evidence of any abnormality. Conclusion: No malignancy identified. No evidence of malignancy. The report is reassuring and provides a definitive answer. Skeptical approach does not change the conclusion.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 24,
      "timestamp": "2026-01-10T19:20:55.840756"
    },
    {
      "sample_idx": 25,
      "input": "16/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could this be a very aggressive infection or inflammatory process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction, and, most importantly, the EWSR1 fusion positivity strongly suggest Ewing Sarcoma. While infection could cause some of these findings, the EWSR1 fusion is highly specific for this type of cancer. Alternative benign explanations are highly unlikely given the clinical context and the presence of a fusion. Conclusion: malignancy confirmed, despite initial skepticism based on the specific findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could this be a very aggressive infection or inflammatory process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction, and, most importantly, the EWSR1 fusion positivity strongly suggest Ewing Sarcoma. While infection could cause some of these findings, the EWSR1 fusion is highly specific for this type of cancer. Alternative benign explanations are highly unlikely given the clinical context and the presence of a fusion. Conclusion: malignancy confirmed, despite initial skepticism based on the specific findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis\", \"large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could this be a very aggressive infection or inflammatory process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction, and",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could this be a very aggressive infection or inflammatory process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, large soft tissue mass, onion-skin periosteal reaction, and, most importantly, the EWSR1 fusion positivity strongly suggest Ewing Sarcoma. While infection could cause some of these findings, the EWSR1 fusion is highly specific for this type of cancer. Alternative benign explanations are highly unlikely given the clinical context and the presence of a fusion. Conclusion: malignancy confirmed, despite initial skepticism based on the specific findings.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis",
        "large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 25,
      "timestamp": "2026-01-10T19:20:55.840776"
    },
    {
      "sample_idx": 26,
      "input": "13/08/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Non-Hodgkin Lymphoma.\n\nFrom clinical notes: Non-Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: abdominal lymphadenopathy with mesenteric and retroperitoneal nodes. Burkitt lymphoma confirmed on biopsy. High LDH levels. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 13/08/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the findings be reactive? However, the report explicitly mentions Burkitt lymphoma confirmed on biopsy, along with abdominal lymphadenopathy and high LDH levels. This points to a malignancy, specifically Burkitt lymphoma. The patient's history of Non-Hodgkin Lymphoma further supports the diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be reactive? The report explicitly mentions Burkitt lymphoma confirmed on biopsy, along with abdominal lymphadenopathy and high LDH levels. This points to a malignancy, specifically Burkitt lymphoma. The patient's history of Non-Hodgkin Lymphoma further supports the diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"abdominal lymphadenopathy\", \"mesenteric and retroperitoneal nodes\", \"Burkitt lymphoma confirmed on biopsy\", \"High LDH levels\"],\n        \"rationale\": \"Initial skepticism: Could the findings be reactive? However, the report explicitly mentions Burkitt lymphoma confirmed on biopsy, along with abdominal lymphadenopathy and high LDH levels. This points to a malignancy, specifically Burkitt lymphoma. The patient's history of Non-Hodgkin Lymphoma further supports the diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be reactive? However, the report explicitly mentions Burkitt lymphoma confirmed on biopsy, along with abdominal lymphadenopathy and high LDH levels. This points to a malignancy, specifically Burkitt lymphoma. The patient's history of Non-Hodgkin Lymphoma further supports the diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the confirmed diagnosis. Conclusion: Malignancy confirmed.",
      "findings": [
        "abdominal lymphadenopathy",
        "mesenteric and retroperitoneal nodes",
        "Burkitt lymphoma confirmed on biopsy",
        "High LDH levels"
      ],
      "fracture_mentioned": null,
      "idx": 26,
      "timestamp": "2026-01-10T19:20:55.840792"
    },
    {
      "sample_idx": 27,
      "input": "25/06/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 25/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified, and that the fracture is healing normally. The bone density is normal, which is reassuring. No pathological features are present. Therefore, the likelihood of malignancy is extremely low. The patient is being reassured, which further supports the conclusion that there is no malignancy present. Conclusion: No malignancy identified. The report provides sufficient evidence to rule out malignancy. Skeptical reasoning has been applied and no alternative explanations for the findings have been identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"normal bone density\"],\n        \"rationale\": \"The report explicitly mentions 'no pathological features' and 'normal bone density'. This strongly suggests that there is no underlying malignancy. The healing fracture is a normal process. Therefore, the findings are consistent with a benign condition. Skeptical reasoning has been applied, and no alternative explanations for the findings have been identified. Conclusion: No malignancy identified. The report provides sufficient evidence to rule out malignancy. Skeptical reasoning has been applied and no alternative explanations for the findings have been identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no pathological features\", \"normal bone density\", \"healing fracture\"],\n        \"rationale\": \"The report clearly states that there are no pathological features, and that the bone density is normal. This is reassuring. The healing fracture is a normal process. The report also explicitly states that there is no malignancy identified. Skeptical reasoning has been applied, and no alternative explanations for the findings have been identified. Conclusion: No malignancy identified. The report provides sufficient evidence to rule out malignancy. Skeptical reasoning has been applied and no alternative explanations for the findings have been identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there is no malignancy identified, and that the fracture is healing normally. The bone density is normal, which is reassuring. No pathological features are present. Therefore, the likelihood of malignancy is extremely low. The patient is being reassured, which further supports the conclusion that there is no malignancy present. Conclusion: No malignancy identified. The report provides sufficient evidence to rule out malignancy. Skeptical reasoning has been applied and no alternative explanations for the findings have been identified.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 27,
      "timestamp": "2026-01-10T19:20:55.840811"
    },
    {
      "sample_idx": 28,
      "input": "01/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 01/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a subtle, early malignant process that has resolved? While the report explicitly states 'No malignancy identified', it's important to consider if a very early, indolent malignancy might have been present and subsequently resolved. However, the description of a benign bone cyst, lack of aggressive features, and normal bone density make this highly unlikely. The reassurance provided further strengthens the conclusion that malignancy is not present. Alternative benign explanations (e.g., transient inflammatory process) are considered, but the overall picture points towards a benign resolution of a bone cyst.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a subtle, early malignant process that has resolved? While the report explicitly states 'No malignancy identified', it's important to consider if a very early, indolent malignancy might have been present and subsequently resolved. However, the description of a benign bone cyst, lack of aggressive features, and normal bone density make this highly unlikely. The reassurance provided further strengthens the conclusion that malignancy is not present. Alternative benign explanations (e.g., transient inflammatory process) are considered, but the overall picture points towards a benign resolution of a bone cyst.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Benign bone cyst - resolved\", \"No aggressive features\", \"Normal bone density\", \"No recurrence on imaging\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a subtle, early malignant process that has resolved? While the report explicitly states 'No malignancy identified', it's important to consider if a very early, indolent malignancy might have been present and subsequently resolved. However, the description",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could there be a subtle, early malignant process that has resolved? While the report explicitly states 'No malignancy identified', it's important to consider if a very early, indolent malignancy might have been present and subsequently resolved. However, the description of a benign bone cyst, lack of aggressive features, and normal bone density make this highly unlikely. The reassurance provided further strengthens the conclusion that malignancy is not present. Alternative benign explanations (e.g., transient inflammatory process) are considered, but the overall picture points towards a benign resolution of a bone cyst.",
      "findings": [
        "Benign bone cyst - resolved",
        "No aggressive features",
        "Normal bone density",
        "No recurrence on imaging",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 28,
      "timestamp": "2026-01-10T19:20:55.840831"
    },
    {
      "sample_idx": 29,
      "input": "04/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Skeptical analysis: The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated catecholamines. These findings are highly suggestive of neuroblastoma, a childhood cancer. The stage III designation further supports this suspicion. While the report does not explicitly state malignancy, the constellation of findings strongly indicates it. Alternative benign explanations (e.g., benign adrenal tumor, reactive process) are less likely given the MIBG avidity and elevated catecholamines. Conclusion: Malignancy is highly probable based on the report findings. Further investigation and MDT discussion are warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be explained by a benign process? While the report describes a suprarenal mass with calcifications, MIBG avidity, and elevated catecholamines, it is important to consider if these findings could be explained by a benign process. The presence of calcifications and MIBG avidity could be due to a benign adrenal tumor. However, the elevated urinary catecholamines and Stage III disease suggest a more serious pathology. Therefore, it is important to consider the possibility of malignancy. Alternative benign explanations (e.g., reactive process) are less likely given the MIBG avidity and elevated catecholamines. Conclusion: Malignancy is likely given the report findings. Further investigation and MDT discussion are warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could the findings be explained by a benign process?",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical analysis: The report describes a suprarenal mass with calcifications, MIBG avidity, and elevated catecholamines. These findings are highly suggestive of neuroblastoma, a childhood cancer. The stage III designation further supports this suspicion. While the report does not explicitly state malignancy, the constellation of findings strongly indicates it. Alternative benign explanations (e.g., benign adrenal tumor, reactive process) are less likely given the MIBG avidity and elevated catecholamines. Conclusion: Malignancy is highly probable based on the report findings. Further investigation and MDT discussion are warranted.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 29,
      "timestamp": "2026-01-10T19:20:55.840851"
    },
    {
      "sample_idx": 30,
      "input": "15/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Brain Tumor - Medulloblastoma.\n\nFrom clinical notes: Brain Tumor - Medulloblastoma. Paediatric oncology assessment.\n\nFindings: posterior fossa mass with enhancement and hydrocephalus. Restricted diffusion. High-grade medulloblastoma on histology. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 15/07/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the enhancement be from a benign cause? However, the report explicitly states 'high-grade medulloblastoma on histology' and 'restricted diffusion', both of which strongly suggest malignancy. The presence of hydrocephalus further supports a mass effect. Alternative benign explanations (e.g., vascular malformation) are less likely given the histological confirmation. Conclusion: Malignancy confirmed based on the presence of a high-grade medulloblastoma and associated findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the enhancement be from a benign cause? However, the report explicitly states 'high-grade medulloblastoma on histology' and 'restricted diffusion', both of which strongly suggest malignancy. The presence of hydrocephalus further supports a mass effect. Alternative benign explanations (e.g., vascular malformation) are less likely given the histological confirmation. Conclusion: Malignancy confirmed based on the presence of a high-grade medulloblastoma and associated findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"posterior fossa mass with enhancement and hydrocephalus\", \"Restricted diffusion\", \"High-grade medulloblastoma on histology\"],\n        \"rationale\": \"Initial skepticism: Could the enhancement be from a benign cause? However, the report explicitly states 'high-grade medulloblastoma on histology' and 'restricted diffusion', both of which strongly suggest malignancy. The presence of hydrocephalus further supports a mass effect. Alternative benign explanations (e.g., vascular malformation) are less likely given the histological confirmation. Conclusion: Malignancy confirmed based on the presence of a high-grade medulloblastoma and associated findings.\"\n    }\n}\n```\n```json\n{\n    ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the enhancement be from a benign cause? However, the report explicitly states 'high-grade medulloblastoma on histology' and 'restricted diffusion', both of which strongly suggest malignancy. The presence of hydrocephalus further supports a mass effect. Alternative benign explanations (e.g., vascular malformation) are less likely given the histological confirmation. Conclusion: Malignancy confirmed based on the presence of a high-grade medulloblastoma and associated findings.",
      "findings": [
        "posterior fossa mass with enhancement and hydrocephalus",
        "Restricted diffusion",
        "High-grade medulloblastoma on histology"
      ],
      "fracture_mentioned": null,
      "idx": 30,
      "timestamp": "2026-01-10T19:20:55.840885"
    },
    {
      "sample_idx": 31,
      "input": "02/04/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Normal heart size\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is the report truly benign, or is there a subtle abnormality missed? Playing devil's advocate against a benign conclusion: The report explicitly states a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and no malignancy identified. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Normal heart size\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is the report truly benign, or is there a subtle abnormality missed? Playing devil's advocate against a benign conclusion: The report explicitly states a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and no malignancy identified. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\", \"Clear lung fields\", \"No mediastinal mass\", \"Normal heart size\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is the report truly benign, or is there a subtle abnormality missed? Playing devil's advocate against a benign conclusion: The report explicitly states a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and no malignancy identified. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Normal chest radiograph\",",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Is the report truly benign, or is there a subtle abnormality missed? Playing devil's advocate against a benign conclusion: The report explicitly states a normal chest radiograph, clear lung fields, no mediastinal mass, normal heart size, and no malignancy identified. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. Conclusion: No malignancy identified.",
      "findings": [
        "Normal chest radiograph",
        "Clear lung fields",
        "No mediastinal mass",
        "Normal heart size",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 31,
      "timestamp": "2026-01-10T19:20:55.840902"
    },
    {
      "sample_idx": 32,
      "input": "04/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign condition? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor, specifically a yolk sac tumor. Alternative benign explanations (e.g., non-cancerous tumors) are unlikely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign condition? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor, specifically a yolk sac tumor. Alternative benign explanations (e.g., non-cancerous tumors) are unlikely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign condition? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor, specifically a yolk sac tumor. Alternative benign explanations (e.g., non-cancerous tumors) are unlikely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be due to a benign condition? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor, specifically a yolk sac tumor. Alternative benign explanations (e.g., non-cancerous tumors) are unlikely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "sacrococcygeal mass",
        "mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 32,
      "timestamp": "2026-01-10T19:20:55.840917"
    },
    {
      "sample_idx": 33,
      "input": "24/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skepticism: Could the findings be due to a benign inflammatory process? However, the description of bulky mass, FDG-avid nodes, and the confirmed diagnosis of classical Hodgkin lymphoma strongly suggests malignancy. Alternative benign explanations (e.g., reactive lymphadenopathy) are unlikely given the specific characteristics of the mass and the confirmed Hodgkin lymphoma diagnosis. Conclusion: Malignancy is highly probable, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skepticism: Could the findings be due to a benign inflammatory process? However, the description of bulky mass, FDG-avid nodes, and the confirmed diagnosis of classical Hodgkin lymphoma strongly suggests malignancy. Alternative benign explanations (e.g., reactive lymphadenopathy) are unlikely given the specific characteristics of the mass and the confirmed Hodgkin lymphoma diagnosis. Conclusion: Malignancy is highly probable, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skepticism: Could the findings be due to a benign inflammatory process? However, the description of bulky mass, FDG-avid nodes, and the confirmed diagnosis of classical Hodgkin lymphoma strongly suggests malignancy. Alternative benign explanations (e.g., reactive lymphadenopathy) are unlikely given the specific characteristics of the mass and the confirmed Hodgkin lymphoma diagnosis. Conclusion: Malignancy is highly probable, despite initial skepticism.\"\n    }\n}\n```\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skepticism: Could the findings be due to a benign inflammatory process? However, the description of bulky mass, FDG-avid nodes, and the confirmed diagnosis of classical Hodgkin lymphoma strongly suggests malignancy. Alternative benign explanations (e.g., reactive lymphadenopathy) are unlikely given the specific characteristics of the mass and the confirmed Hodgkin lymphoma diagnosis. Conclusion: Malignancy is highly probable, despite initial skepticism.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 33,
      "timestamp": "2026-01-10T19:20:55.840934"
    },
    {
      "sample_idx": 34,
      "input": "07/03/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 07/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. The report explicitly states 'no malignancy identified'. Reassurance provided. Conclusion: No malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. The report explicitly states 'no malignancy identified'. Reassurance provided. Conclusion: No malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. The report explicitly states 'no malignancy identified'. Reassurance provided. Conclusion: No malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. The report explicitly states 'no malignancy identified'. Reassurance provided. Conclusion: No malignancy.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 34,
      "timestamp": "2026-01-10T19:20:55.840951"
    },
    {
      "sample_idx": 35,
      "input": "04/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"well-circumscribed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Is the lipoma truly benign, or could it be a subtle, early manifestation of a malignancy? Playing devil's advocate: The report explicitly states the lipoma is benign, well-circumscribed, shows no enhancement, requires no intervention, and contains no malignancy. The reassurance provided further strengthens the benign conclusion. Although the report is reassuring, the presence of a soft tissue mass warrants further investigation to confirm its benign nature. No evidence of malignancy is present. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. Therefore, there is no evidence of malignancy. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. Therefore, there is no evidence of malignancy. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. Therefore, there is no evidence of malignancy. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. Therefore, there is no evidence of malignancy. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Is the lipoma truly benign, or could it be a subtle, early manifestation of a malignancy? Playing devil's advocate: The report explicitly states the lipoma is benign, well-circumscribed, shows no enhancement, requires no intervention, and contains no malignancy. The reassurance provided further strengthens the benign conclusion. Although the report is reassuring, the presence of a soft tissue mass warrants further investigation to confirm its benign nature. No evidence of malignancy is present. Conclusion: No malignancy identified.",
      "findings": [
        "benign soft tissue mass - lipoma confirmed",
        "well-circumscribed",
        "no enhancement",
        "no intervention required",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 35,
      "timestamp": "2026-01-10T19:20:55.840970"
    },
    {
      "sample_idx": 36,
      "input": "04/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 04/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are normal, there is no mediastinal mass, heart size is normal, and no malignancy is identified. The patient was given reassurance. Therefore, there is no evidence of malignancy. Skeptical reasoning: Could a subtle malignancy be missed on a standard radiograph? The report's description is too reassuring to suggest malignancy, even if it is a screening test. Alternative benign explanations are overwhelming. Conclusion: No malignancy detected.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are normal, there is no mediastinal mass, heart size is normal, and no malignancy is identified. The patient was given reassurance. Therefore, there is no evidence of malignancy. Skeptical reasoning: Could a subtle malignancy be missed on a standard radiograph? The report's description is too reassuring to suggest malignancy, even if it is a screening test. Alternative benign explanations are overwhelming. Conclusion: No malignancy detected.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph and lung fields are normal, there is no mediastinal mass, heart size is normal, and no malignancy is identified. The patient was given reassurance. Therefore, there is no evidence of malignancy. Skeptical reasoning: Could a subtle malignancy be missed on a standard radiograph? The report's description is too reassuring to suggest malignancy, even if it",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph and lung fields are normal, there is no mediastinal mass, heart size is normal, and no malignancy is identified. The patient was given reassurance. Therefore, there is no evidence of malignancy. Skeptical reasoning: Could a subtle malignancy be missed on a standard radiograph? The report's description is too reassuring to suggest malignancy, even if it is a screening test. Alternative benign explanations are overwhelming. Conclusion: No malignancy detected.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 36,
      "timestamp": "2026-01-10T19:20:55.840987"
    },
    {
      "sample_idx": 37,
      "input": "02/04/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 02/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the findings be benign? However, the presence of a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. While other conditions could cause similar findings, the combination of these features is highly indicative of this malignancy. Alternative benign explanations (e.g., infection, trauma) are less likely given the context of a suspected osteosarcoma. Conclusion: Malignancy is likely present based on the ultrasound findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skepticism: Could the findings be due to other causes like infection or trauma? However, the combination of a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase is highly suggestive of osteosarcoma, especially in a patient with a suspected diagnosis. Alternative benign explanations are less likely given the clinical context. Conclusion: Malignancy is highly likely.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be due to other causes? However, the combination of a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggests osteosarcoma, especially given the clinical suspicion. Alternative benign explanations are less likely. Conclusion: Malignancy is likely.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elev",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be benign? However, the presence of a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. While other conditions could cause similar findings, the combination of these features is highly indicative of this malignancy. Alternative benign explanations (e.g., infection, trauma) are less likely given the context of a suspected osteosarcoma. Conclusion: Malignancy is likely present based on the ultrasound findings.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 37,
      "timestamp": "2026-01-10T19:20:55.841005"
    },
    {
      "sample_idx": 38,
      "input": "05/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 05/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the destructive lesion be benign? However, the presence of a destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest a bone tumor. Osteosarcoma is a highly likely diagnosis given the clinical context (osteosarcoma) and the report findings. Alternative benign explanations (trauma, infection) are less likely given the combination of findings and the patient's history. Conclusion: Malignancy confirmed based on the destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase, supported by the clinical history of osteosarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the destructive lesion be benign? However, the presence of a destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest a bone tumor. Osteosarcoma is a highly likely diagnosis given the clinical context (osteosarcoma) and the report findings. Alternative benign explanations (trauma, infection) are less likely given the combination of findings and the patient's history. Conclusion: Malignancy confirmed based on the destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase, supported by the clinical history of osteosarcoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the destructive lesion be benign? However, the presence of a destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest a bone tumor. Osteosar",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the destructive lesion be benign? However, the presence of a destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest a bone tumor. Osteosarcoma is a highly likely diagnosis given the clinical context (osteosarcoma) and the report findings. Alternative benign explanations (trauma, infection) are less likely given the combination of findings and the patient's history. Conclusion: Malignancy confirmed based on the destructive lesion, soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase, supported by the clinical history of osteosarcoma.",
      "findings": [
        "destructive lesion in distal femur",
        "soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 38,
      "timestamp": "2026-01-10T19:20:55.841025"
    },
    {
      "sample_idx": 39,
      "input": "01/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 01/11/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"Skepticism: While the report mentions 'post-viral lymphocytosis' and 'atypical lymphocytes resolving', it also states 'no malignancy identified' and provides reassurance. The presence of a viral infection (EBV) is a common cause of transient lymphocytosis. The resolving atypical lymphocytes further support a benign process. The absence of malignancy is explicitly stated. Alternative benign explanations (viral infection, post-infectious lymphocytosis) are highly likely. Conclusion: No malignancy present, even with some abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphadenopathy\", \"increased lymphocytes\", \"no evidence of malignancy\"],\n        \"rationale\": \"Skepticism: The report mentions lymphadenopathy and increased lymphocytes, which can be seen in both benign and malignant conditions. However, it explicitly states 'no evidence of malignancy'. The report also describes the lymphadenopathy as 'mild' and the increased lymphocytes as 'reactive'. The absence of other concerning features, such as enlarged spleen or liver, further supports a benign explanation. Alternative benign explanations (reactive lymphadenopathy, post-infectious lymphocytosis) are highly likely. Conclusion: No malignancy present, even with some abnormal findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"mild lymphadenopathy\", \"increased lymphocytes\", \"no evidence of malignancy\"],\n        \"rationale\": \"Skepticism: The report mentions mild lymphadenopathy and increased lymphocytes, which can be seen in both benign and malignant conditions. However, it explicitly states 'no evidence of malignancy'. The report also describes the lymphadenopathy as 'mild' and the increased lymphocytes as 'reactive'. The absence of other concerning features, such as enlarged spleen or liver, further supports a benign explanation. Alternative benign explanations (reactive lymphadenopathy, post-infectious lymphocytosis) are",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skepticism: While the report mentions 'post-viral lymphocytosis' and 'atypical lymphocytes resolving', it also states 'no malignancy identified' and provides reassurance. The presence of a viral infection (EBV) is a common cause of transient lymphocytosis. The resolving atypical lymphocytes further support a benign process. The absence of malignancy is explicitly stated. Alternative benign explanations (viral infection, post-infectious lymphocytosis) are highly likely. Conclusion: No malignancy present, even with some abnormal findings.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 39,
      "timestamp": "2026-01-10T19:20:55.841042"
    },
    {
      "sample_idx": 40,
      "input": "26/04/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 26/04/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the report be a benign finding? The report describes a large renal mass with features suggestive of Wilms Tumor, confirmed by biopsy. While a pseudocapsule and favorable histology are reassuring, they do not eliminate the possibility of malignancy. The stage II diagnosis indicates the presence of cancer. Alternative benign explanations (e.g., a benign tumor) are less likely given the description of the mass. Conclusion: Malignancy is likely, despite the features suggesting a favorable prognosis. Further investigation is warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the report be a benign finding? The report describes a large renal mass with features suggestive of Wilms Tumor, confirmed by biopsy. While a pseudocapsule and favorable histology are reassuring, they do not eliminate the possibility of malignancy. The stage II diagnosis indicates the presence of cancer. Alternative benign explanations (e.g., a benign tumor) are less likely given the description of the mass. Conclusion: Malignancy is likely, despite the features suggesting a favorable prognosis. Further investigation is warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the report be a benign finding? The report describes a large renal mass with features suggestive of Wilms Tumor, confirmed by biopsy. While a pseudocapsule and favorable histology are reassuring, they do not eliminate the possibility of malignancy. The stage II diagnosis indicates the presence of cancer. Alternative benign explanations (e.g., a benign tumor) are less likely given the description of the mass. Conclusion: Malignancy is likely, despite the features suggesting a favorable prognosis. Further investigation is warranted.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 40,
      "timestamp": "2026-01-10T19:20:55.841060"
    },
    {
      "sample_idx": 41,
      "input": "18/11/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 18/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"PET-CT showing FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the report explicitly states 'Classical Hodgkin, nodular sclerosing type' and 'FDG-avid nodes', which are characteristic of Hodgkin Lymphoma. The presence of a bulky mediastinal mass and FDG-avid nodes strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory process, infection) are considered less likely given the specific findings. Conclusion: Malignancy confirmed, specifically Hodgkin Lymphoma, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"PET-CT showing FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the report explicitly states 'Classical Hodgkin, nodular sclerosing type' and 'FDG-avid nodes', which are characteristic of Hodgkin Lymphoma. The presence of a bulky mediastinal mass and FDG-avid nodes strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory process, infection) are considered less likely given the specific findings. Conclusion: Malignancy confirmed, specifically Hodgkin Lymphoma, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"PET-CT showing FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the report explicitly states 'Classical Hodgkin, nodular sclerosing type' and 'FDG-avid nodes', which are characteristic of Hodgkin Lymphoma. The presence of a bulky",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be reactive or inflammatory? However, the report explicitly states 'Classical Hodgkin, nodular sclerosing type' and 'FDG-avid nodes', which are characteristic of Hodgkin Lymphoma. The presence of a bulky mediastinal mass and FDG-avid nodes strongly suggest malignancy. Alternative benign explanations (e.g., inflammatory process, infection) are considered less likely given the specific findings. Conclusion: Malignancy confirmed, specifically Hodgkin Lymphoma, despite initial skepticism.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "PET-CT showing FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 41,
      "timestamp": "2026-01-10T19:20:55.841078"
    },
    {
      "sample_idx": 42,
      "input": "20/04/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 20/04/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could the 'post-viral lymphocytosis' be a sign of a more sinister condition, despite the reassurance provided? Playing devil's advocate: The report clearly states 'no malignancy identified' and provides supporting evidence (post-viral, resolving atypical lymphocytes, positive monospot, and EBV confirmation). The reassuring nature of the report strongly suggests a benign cause. While a post-viral lymphocytosis could theoretically be a precursor, the provided evidence strongly supports a benign explanation. Conclusion: No malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no previous oncology history\", \"no abnormalities identified\", \"no suspicious features\"],\n        \"rationale\": \"The report explicitly states that there are no abnormalities identified and no suspicious features. Given the patient's age and lack of prior oncology history, this is highly unlikely to be a malignancy. The report is reassuring, and there is no indication of any underlying malignancy. Conclusion: No malignancy is present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphocytes 85% of marrow\", \"B-cell ALL immunophenotype\", \"bone marrow infiltration\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and marrow infiltration pattern provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning:",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could the 'post-viral lymphocytosis' be a sign of a more sinister condition, despite the reassurance provided? Playing devil's advocate: The report clearly states 'no malignancy identified' and provides supporting evidence (post-viral, resolving atypical lymphocytes, positive monospot, and EBV confirmation). The reassuring nature of the report strongly suggests a benign cause. While a post-viral lymphocytosis could theoretically be a precursor, the provided evidence strongly supports a benign explanation. Conclusion: No malignancy is present.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 42,
      "timestamp": "2026-01-10T19:20:55.841096"
    },
    {
      "sample_idx": 43,
      "input": "20/01/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 20/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates a normal brain MRI, no mass lesion, no abnormal enhancement, and no malignancy identified. The patient is being reassured. This indicates that there is no evidence of malignancy. No abnormal findings are present, so no malignancy is present. Applying skeptical reasoning, I would need to find evidence of a mass, abnormal enhancement, or malignant cells to suggest malignancy. The report does not contain such evidence. Therefore, I conclude that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates a normal brain MRI, no mass lesion, no abnormal enhancement, and no malignancy identified. The patient is being reassured. This indicates that there is no evidence of malignancy. No abnormal findings are present, so no malignancy is present. Applying skeptical reasoning, I would need to find evidence of a mass, abnormal enhancement, or malignant cells to suggest malignancy. The report does not contain such evidence. Therefore, I conclude that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report indicates a normal brain MRI, no mass lesion, no abnormal enhancement, and no malignancy identified. The patient is being reassured. This indicates that there is no evidence of malignancy. No abnormal findings are present, so no malignancy is present. Applying skeptical reasoning, I would need to find evidence of a mass, abnormal enhancement, or malignant cells to suggest malignancy. The report does not contain such evidence. Therefore, I conclude that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report indicates a normal brain MRI, no mass lesion, no abnormal enhancement, and no malignancy identified. The patient is being reassured. This indicates that there is no evidence of malignancy. No abnormal findings are present, so no malignancy is present. Applying skeptical reasoning, I would need to find evidence of a mass, abnormal enhancement, or malignant cells to suggest malignancy. The report does not contain such evidence. Therefore, I conclude that there is no malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 43,
      "timestamp": "2026-01-10T19:20:55.841112"
    },
    {
      "sample_idx": 44,
      "input": "22/11/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 22/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, onion-skin periosteal reaction, and, critically, the EWSR1 fusion positivity strongly suggests Ewing Sarcoma. This is a specific genetic marker. Alternative benign explanations (e.g., aggressive osteomyelitis, certain benign bone tumors) are less likely given the complete clinical picture. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism based on the possibility of a benign mimic.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, onion-skin periosteal reaction, and, critically, the EWSR1 fusion positivity strongly suggests Ewing Sarcoma. This is a specific genetic marker. Alternative benign explanations (e.g., aggressive osteomyelitis, certain benign bone tumors) are less likely given the complete clinical picture. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism based on the possibility of a benign mimic.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a benign process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, onion-skin periosteal reaction, and, critically, the EWSR1 fusion positivity strongly suggests Ewing Sarcoma. This is",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be due to a benign process mimicking Ewing Sarcoma? However, the combination of permeative bone destruction, onion-skin periosteal reaction, and, critically, the EWSR1 fusion positivity strongly suggests Ewing Sarcoma. This is a specific genetic marker. Alternative benign explanations (e.g., aggressive osteomyelitis, certain benign bone tumors) are less likely given the complete clinical picture. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism based on the possibility of a benign mimic.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis with large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 44,
      "timestamp": "2026-01-10T19:20:55.841131"
    },
    {
      "sample_idx": 45,
      "input": "06/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This aligns with the patient's history of migraines and the absence of any prior oncology history. Skeptical reasoning is not required as the report provides reassurance and explicitly rules out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This aligns with the patient's history of migraines and the absence of any prior oncology history. Skeptical reasoning is not required as the report provides reassurance and explicitly rules out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This aligns with the patient's history of migraines and the absence of any prior oncology history. Skeptical reasoning is not required as the report provides reassurance and explicitly rules out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This aligns with the patient's history of migraines and the absence of any prior oncology history. Skeptical reasoning is not required as the report provides reassurance and explicitly rules out malignancy.\"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the brain MRI is normal, with no mass lesion, abnormal enhancement, or malignancy identified. This aligns with the patient's history of migraines and the absence of any prior oncology history. Skeptical reasoning is not required as the report provides reassurance and explicitly rules out malignancy.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 45,
      "timestamp": "2026-01-10T19:20:55.841144"
    },
    {
      "sample_idx": 46,
      "input": "24/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"Initial skepticism: The report states 'Benign finding. No malignancy identified.' Could there be a subtle, early-stage malignancy not readily apparent on this single X-ray? Playing devil's advocate against a benign conclusion: the report explicitly states 'No malignancy identified.' It is highly unlikely that there is a malignancy in the spleen given the benign findings. Reassurance provided. Conclusion: No malignancy identified. Physiological splenomegaly is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"Initial skepticism: The report states 'Benign finding. No malignancy identified.' Could there be a subtle, early-stage malignancy not readily apparent on this single X-ray? Playing devil's advocate against a benign conclusion: the report explicitly states 'No malignancy identified.' It is highly unlikely that there is a malignancy in the spleen given the benign findings. Reassurance provided. Conclusion: No malignancy identified. Physiological splenomegaly is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\"],\n        \"rationale\": \"Initial skepticism: The report states 'Benign finding. No malignancy identified.' Could there be a subtle, early-stage malignancy not readily apparent on this single X-ray? Playing devil's advocate against a benign conclusion: the report explicitly states 'No malignancy identified.' It is highly unlikely that there is a malignancy in the spleen given the benign findings. Reassurance provided. Conclusion: No malignancy identified. Physiological splenomegaly is a benign finding.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: The report states 'Benign finding. No malignancy identified.' Could there be a subtle, early-stage malignancy not readily apparent on this single X-ray? Playing devil's advocate against a benign conclusion: the report explicitly states 'No malignancy identified.' It is highly unlikely that there is a malignancy in the spleen given the benign findings. Reassurance provided. Conclusion: No malignancy identified. Physiological splenomegaly is a benign finding.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture"
      ],
      "fracture_mentioned": null,
      "idx": 46,
      "timestamp": "2026-01-10T19:20:55.841160"
    },
    {
      "sample_idx": 47,
      "input": "01/02/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 01/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is the report accurate? The report clearly states that the lymphadenopathy is reactive and decreasing, and no atypical features or malignancy are present. Although the report provides reassurance, this does not preclude the possibility of an occult malignancy. Further investigation is not indicated given the absence of any concerning features. The report is consistent with a benign cause for the lymphadenopathy. Conclusion: No malignancy identified based on the findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, decreasing size, and absence of atypical features or malignancy. While the report provides reassurance, it does not definitively rule out occult malignancy. The findings are consistent with a benign cause. Conclusion: No malignancy identified based on the findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, decreasing size, and absence of atypical features or malignancy. While the report provides reassurance, it does not definitively rule out occult malignancy. The findings are consistent with a benign cause. Conclusion: No malignancy identified based on the findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report indicates reactive lymphadenopathy, decreasing size, and",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Is the report accurate? The report clearly states that the lymphadenopathy is reactive and decreasing, and no atypical features or malignancy are present. Although the report provides reassurance, this does not preclude the possibility of an occult malignancy. Further investigation is not indicated given the absence of any concerning features. The report is consistent with a benign cause for the lymphadenopathy. Conclusion: No malignancy identified based on the findings.",
      "findings": [
        "reactive lymphadenopathy secondary to viral infection",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 47,
      "timestamp": "2026-01-10T19:20:55.841177"
    },
    {
      "sample_idx": 48,
      "input": "03/10/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Lymphadenopathy. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 03/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the findings be related to benign conditions such as infection or trauma? However, the presence of a destructive lesion with a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. Alternative benign explanations (infection, trauma) are less likely given the clinical context and imaging characteristics. Conclusion: malignancy confirmed based on suggestive findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be related to benign conditions such as infection or trauma? However, the presence of a destructive lesion with a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. Alternative benign explanations (infection, trauma) are less likely given the clinical context and imaging characteristics. Conclusion: malignancy confirmed based on suggestive findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Initial skepticism: Could the findings be related to benign conditions such as infection or trauma? However, the presence of a destructive lesion with a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. Alternative benign explanations (infection, trauma) are less likely given the clinical context and imaging characteristics. Conclusion: malignancy confirmed based on suggestive findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur\", \"soft tissue component\", \"sunburst periosteal",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be related to benign conditions such as infection or trauma? However, the presence of a destructive lesion with a soft tissue component, sunburst periosteal reaction, and elevated alkaline phosphatase strongly suggest osteosarcoma. Alternative benign explanations (infection, trauma) are less likely given the clinical context and imaging characteristics. Conclusion: malignancy confirmed based on suggestive findings.",
      "findings": [
        "destructive lesion in distal femur",
        "soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 48,
      "timestamp": "2026-01-10T19:20:55.841193"
    },
    {
      "sample_idx": 49,
      "input": "05/08/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be a sign of early malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states that the lymphadenopathy is reactive due to a viral infection and that there are no atypical features or malignancy identified. The node size is decreasing, suggesting resolution of the infection. The reassurance provided by the consultant further supports the benign interpretation. Alternative benign explanations (viral infection, post-infectious reactive lymphadenopathy) are strongly supported by the findings. Conclusion: No malignancy identified, consistent with the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be a sign of early malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states that the lymphadenopathy is reactive due to a viral infection and that there are no atypical features or malignancy identified. The node size is decreasing, suggesting resolution of the infection. The reassurance provided by the consultant further supports the benign interpretation. Alternative benign explanations (viral infection, post-infectious reactive lymphadenopathy) are strongly supported by the findings. Conclusion: No malignancy identified, consistent with the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy secondary to viral infection\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be a sign of early malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states that the lymphadenopathy is reactive due to a viral infection and that there are no atypical features",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could reactive lymphadenopathy be a sign of early malignancy? Playing devil's advocate against a benign conclusion: The report explicitly states that the lymphadenopathy is reactive due to a viral infection and that there are no atypical features or malignancy identified. The node size is decreasing, suggesting resolution of the infection. The reassurance provided by the consultant further supports the benign interpretation. Alternative benign explanations (viral infection, post-infectious reactive lymphadenopathy) are strongly supported by the findings. Conclusion: No malignancy identified, consistent with the report.",
      "findings": [
        "reactive lymphadenopathy secondary to viral infection",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 49,
      "timestamp": "2026-01-10T19:20:55.841214"
    },
    {
      "sample_idx": 50,
      "input": "02/05/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: the report explicitly states no malignancy is identified on the chest radiograph and MRI. Further, the patient has no history of malignancy. The findings are reassuring, but definitive exclusion requires a high level of certainty. It is possible the patient has a very early, subtle malignancy that was not detected, but without additional information, it is not possible to conclude malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: the report explicitly states no malignancy is identified on the chest radiograph and MRI. Further, the patient has no history of malignancy. The findings are reassuring, but definitive exclusion requires a high level of certainty. It is possible the patient has a very early, subtle malignancy that was not detected, but without additional information, it is not possible to conclude malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: the report explicitly states no malignancy is identified on the chest radiograph and MRI. Further, the patient has no history of malignancy. The findings are reassuring, but definitive exclusion requires a high level of certainty. It is possible the patient has a very early, subtle malignancy that was not detected, but without additional information, it is not possible to conclude malignancy.\"\n    }\n}\n```\n```json",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: the report explicitly states no malignancy is identified on the chest radiograph and MRI. Further, the patient has no history of malignancy. The findings are reassuring, but definitive exclusion requires a high level of certainty. It is possible the patient has a very early, subtle malignancy that was not detected, but without additional information, it is not possible to conclude malignancy.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 50,
      "timestamp": "2026-01-10T19:20:55.841231"
    },
    {
      "sample_idx": 51,
      "input": "26/07/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a previously overlooked, but now well-defined lipoma be misdiagnosed? Playing devil's advocate against a benign conclusion: The report explicitly states a benign lipoma with no enhancement or intervention. No evidence of malignancy. The purpose of the biopsy was follow-up post-treatment, which is reassuring. The initial concern about a soft tissue mass was confirmed to be a benign lipoma. Conclusion: No malignancy identified. The original concern was addressed and resolved.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. The report specifically states that no malignancy was identified. Conclusion: No malignancy identified. The initial concern about a soft tissue mass was confirmed to be a benign lipoma. The purpose of the biopsy was follow-up post-treatment, which is reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a previously overlooked, but now well-defined lipoma be misdiagnosed? Playing devil's advocate against a benign conclusion: The report explicitly states a benign lipoma with no enhancement or intervention. No evidence of malignancy. The initial concern about a soft tissue mass was confirmed to be a benign lipoma. Conclusion: No malignancy identified. The original concern was addressed and resolved.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a previously overlooked, but now well-defined lipoma be misdiagnosed? Playing devil's advocate against a benign conclusion: The report explicitly states a benign lipoma with no enhancement or intervention. No evidence of malignancy. The purpose of the biopsy was follow-up post-treatment, which is reassuring. The initial concern about a soft tissue mass was confirmed to be a benign lipoma. Conclusion: No malignancy identified. The original concern was addressed and resolved.",
      "findings": [
        "benign soft tissue mass - lipoma confirmed",
        "no enhancement",
        "no intervention required",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 51,
      "timestamp": "2026-01-10T19:20:55.841248"
    },
    {
      "sample_idx": 52,
      "input": "25/03/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Bone pain. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 25/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the renal mass be a benign lesion, such as a simple cyst or angiomyolipoma? However, the report explicitly states 'large heterogeneous left renal mass with pseudocapsule', which is suggestive of a more complex or malignant process. No vascular invasion is a positive finding, but it does not rule out malignancy. Favorable histology on biopsy is reassuring but not definitive, as it only applies to the specific biopsy site. Stage II is also a positive finding. The presence of a large, heterogeneous mass with a pseudocapsule raises suspicion for malignancy. Alternative benign explanations (simple cyst, angiomyolipoma) are less likely given the description. Conclusion: malignancy is likely, though further investigation and staging are required to confirm the diagnosis and assess the extent of disease. Skeptical reasoning is tempered by the presence of a significant mass and the stage.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"no vascular invasion\", \"favorable histology on biopsy\", \"stage II\"],\n        \"rationale\": \"Initial skepticism: Could the renal mass be a benign lesion, such as a simple cyst or angiomyolipoma? However, the report explicitly states 'large heterogeneous left renal mass with pseudocapsule', which is suggestive of a more complex or malignant process. No vascular invasion is a positive finding, but it does not rule out malignancy. Favorable histology on biopsy is reassuring but not definitive, as it only applies to the specific biopsy site. Stage II is also a positive finding. The presence of a large, heterogeneous mass with a pseudocapsule raises suspicion for malignancy. Alternative benign explanations (simple cyst, angiomyolipoma) are less likely given the description. Conclusion: malignancy is likely, though further investigation and staging are required to confirm the diagnosis and assess the extent of disease. Skeptical reasoning is tempered by the presence of a significant mass and the stage.\"\n    }\n}\n```\n```json\n{\n    \"ab",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the renal mass be a benign lesion, such as a simple cyst or angiomyolipoma? However, the report explicitly states 'large heterogeneous left renal mass with pseudocapsule', which is suggestive of a more complex or malignant process. No vascular invasion is a positive finding, but it does not rule out malignancy. Favorable histology on biopsy is reassuring but not definitive, as it only applies to the specific biopsy site. Stage II is also a positive finding. The presence of a large, heterogeneous mass with a pseudocapsule raises suspicion for malignancy. Alternative benign explanations (simple cyst, angiomyolipoma) are less likely given the description. Conclusion: malignancy is likely, though further investigation and staging are required to confirm the diagnosis and assess the extent of disease. Skeptical reasoning is tempered by the presence of a significant mass and the stage.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "no vascular invasion",
        "favorable histology on biopsy",
        "stage II"
      ],
      "fracture_mentioned": null,
      "idx": 52,
      "timestamp": "2026-01-10T19:20:55.841272"
    },
    {
      "sample_idx": 53,
      "input": "05/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be a subtle presentation of malignancy? However, the report explicitly states 'reactive lymphadenopathy' and that the node size is decreasing. The absence of atypical features and the definitive statement that no malignancy was identified, with reassurance provided, strongly suggest a benign cause. The patient has no previous oncology history. Therefore, the most likely explanation is a benign process. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the lymphadenopathy is reactive and that no atypical features or malignancy were identified. The decreasing node size further supports the benign nature of the finding. The absence of a prior oncology history reduces the likelihood of an occult malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report clearly indicates reactive lymphadenopathy, a decreasing node size, and the absence of any atypical features or malignancy. The patient's history of no prior oncology makes a malignancy less likely. The reassurance provided by the consultant further supports a benign conclusion. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report's description of reactive lymphadenopathy, coupled with the decreasing node size and the absence of atypical features or malignancy, strongly suggests a benign cause. The patient's lack of prior",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could reactive lymphadenopathy be a subtle presentation of malignancy? However, the report explicitly states 'reactive lymphadenopathy' and that the node size is decreasing. The absence of atypical features and the definitive statement that no malignancy was identified, with reassurance provided, strongly suggest a benign cause. The patient has no previous oncology history. Therefore, the most likely explanation is a benign process. Conclusion: No malignancy identified.",
      "findings": [
        "reactive lymphadenopathy",
        "node size decreasing",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 53,
      "timestamp": "2026-01-10T19:20:55.841289"
    },
    {
      "sample_idx": 54,
      "input": "23/03/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 23/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of a large heterogeneous hepatic mass, elevated AFP, and the identification of a fetal histology subtype strongly suggest hepatoblastoma. The PRETEXT stage II indicates an advanced stage of the disease. Alternative benign explanations (infection, inflammatory process) are considered less likely given the combination of findings. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of a large heterogeneous hepatic mass, elevated AFP, and the identification of a fetal histology subtype strongly suggest hepatoblastoma. The PRETEXT stage II indicates an advanced stage of the disease. Alternative benign explanations (infection, inflammatory process) are considered less likely given the combination of findings. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of a large heterogeneous hepatic mass, elevated AFP, and the identification of a fetal histology subtype strongly suggest hepatoblastoma. The PRETEXT stage II indicates an advanced stage of the disease. Alternative benign explanations (infection, inflammatory process) are considered less likely given the combination of findings. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of a large heterogeneous hepatic mass, elevated AFP, and the identification of a fetal histology subtype strongly suggest hepatoblastoma. The PRETEXT stage II indicates an advanced stage of the disease. Alternative benign explanations (infection, inflammatory process) are considered less likely given the combination of findings. Conclusion: Malignancy confirmed.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 54,
      "timestamp": "2026-01-10T19:20:55.841305"
    },
    {
      "sample_idx": 55,
      "input": "31/08/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 31/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"normal heart size\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The findings are reassuring and consistent with a benign presentation. No evidence of abnormal findings suggestive of malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"normal heart size\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The findings are reassuring and consistent with a benign presentation. No evidence of abnormal findings suggestive of malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"normal heart size\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The findings are reassuring and consistent with a benign presentation. No evidence of abnormal findings suggestive of malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"normal heart size\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The findings are reassuring and consistent with a benign presentation. No evidence of abnormal findings suggestive of malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The findings are reassuring and consistent with a benign presentation. No evidence of abnormal findings suggestive of malignancy. Conclusion: No malignancy identified.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "normal heart size",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 55,
      "timestamp": "2026-01-10T19:20:55.841318"
    },
    {
      "sample_idx": 56,
      "input": "26/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 26/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could reactive lymphadenopathy be masking a subtle malignancy? However, the report explicitly states 'no atypical features' and 'no malignancy identified'. The finding is described as reactive, meaning it is a normal response to infection. Alternative benign explanations (viral infection, autoimmune process) are supported by the report's description. Conclusion: No malignancy identified, even with initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states 'reactive lymphadenopathy' and 'no atypical features'. These findings, along with the absence of malignancy, strongly suggest a benign cause for the lymph node enlargement. The report provides reassurance, further supporting a benign diagnosis. Alternative explanations include viral infection or autoimmune processes, which are consistent with reactive lymphadenopathy. Conclusion: No malignancy identified, even with initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report clearly states 'reactive lymphadenopathy' and 'no atypical features'. This, coupled with the absence of malignancy, strongly indicates a benign process. The report provides reassurance, supporting the benign diagnosis. Alternative benign explanations, such as a viral infection or autoimmune response, are consistent with reactive lymphadenopathy. Conclusion: No malignancy identified, even with initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report's clear statement of 'reactive lymphadenopathy' and 'no atypical features' and 'no malignancy identified' provides strong evidence for",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could reactive lymphadenopathy be masking a subtle malignancy? However, the report explicitly states 'no atypical features' and 'no malignancy identified'. The finding is described as reactive, meaning it is a normal response to infection. Alternative benign explanations (viral infection, autoimmune process) are supported by the report's description. Conclusion: No malignancy identified, even with initial skepticism.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 56,
      "timestamp": "2026-01-10T19:20:55.841333"
    },
    {
      "sample_idx": 57,
      "input": "24/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 24/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign condition with similar presentation? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest malignancy. The clinical context (paediatric oncology assessment for Germ Cell Tumor) further supports the likelihood of malignancy. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable based on the report findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign condition with similar presentation? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest malignancy. The clinical context (paediatric oncology assessment for Germ Cell Tumor) further supports the likelihood of malignancy. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable based on the report findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass with mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign condition with similar presentation? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest malignancy. The clinical context (paediatric oncology assessment for Germ Cell Tumor) further supports the likelihood of malignancy. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable based on the report findings",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could this be a benign condition with similar presentation? However, the presence of a sacrococcygeal mass, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest malignancy. The clinical context (paediatric oncology assessment for Germ Cell Tumor) further supports the likelihood of malignancy. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable based on the report findings.",
      "findings": [
        "sacrococcygeal mass with mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 57,
      "timestamp": "2026-01-10T19:20:55.841349"
    },
    {
      "sample_idx": 58,
      "input": "01/01/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Germ Cell Tumor.\n\nFrom clinical notes: Germ Cell Tumor. Paediatric oncology assessment.\n\nFindings: sacrococcygeal mass with mixed solid and cystic components. Elevated AFP and beta-hCG. Yolk sac tumor elements present. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 01/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the elevated AFP and beta-hCG be reactive? Could the mixed solid and cystic components be benign? However, the presence of a sacrococcygeal mass, mixed solid and cystic components, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the elevated AFP and beta-hCG be reactive? Could the mixed solid and cystic components be benign? However, the presence of a sacrococcygeal mass, mixed solid and cystic components, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"sacrococcygeal mass\", \"mixed solid and cystic components\", \"elevated AFP and beta-hCG\", \"yolk sac tumor elements present\"],\n        \"rationale\": \"Initial skepticism: Could the elevated AFP and beta-hCG be reactive? Could the mixed solid and cystic components be benign? However, the presence of a sacrococcygeal mass, mixed solid and cystic components, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable, despite initial skepticism",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the elevated AFP and beta-hCG be reactive? Could the mixed solid and cystic components be benign? However, the presence of a sacrococcygeal mass, mixed solid and cystic components, elevated AFP and beta-hCG, and yolk sac tumor elements strongly suggest a germ cell tumor. Alternative benign explanations are unlikely given the combination of findings. Conclusion: Malignancy is highly probable, despite initial skepticism.",
      "findings": [
        "sacrococcygeal mass",
        "mixed solid and cystic components",
        "elevated AFP and beta-hCG",
        "yolk sac tumor elements present"
      ],
      "fracture_mentioned": null,
      "idx": 58,
      "timestamp": "2026-01-10T19:20:55.841365"
    },
    {
      "sample_idx": 59,
      "input": "16/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the diagnosis be incorrect? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy'. While PAX-FOXO1 fusion negativity doesn't rule out all subtypes, it is a common finding in this type. The overall evidence strongly suggests malignancy. Alternative benign explanations (misinterpretation of normal tissue, reactive process) are unlikely given the explicit diagnosis. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the findings be misinterpretations? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy' and 'parameningeal mass with intracranial extension', indicating a tumor. While PAX-FOXO1 fusion negativity doesn't rule out all subtypes, it is a common finding in this type. The overall evidence strongly suggests malignancy. Alternative benign explanations (misinterpretation of normal tissue, reactive process) are unlikely given the explicit diagnosis. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the diagnosis be incorrect? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy'. While PAX-FOXO1 fusion negativity doesn't rule out all subtypes, it is a common finding in this type. The overall evidence strongly suggests malignancy. Alternative benign explanations (misinterpretation of normal tissue, reactive process) are unlikely given the explicit diagnosis. Conclusion: malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the diagnosis be incorrect? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy'. While PAX-FOXO1 fusion negativity doesn't rule out all subtypes, it is a common finding in this type. The overall evidence strongly suggests malignancy. Alternative benign explanations (misinterpretation of normal tissue, reactive process) are unlikely given the explicit diagnosis. Conclusion: malignancy confirmed.",
      "findings": [
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 59,
      "timestamp": "2026-01-10T19:20:55.841379"
    },
    {
      "sample_idx": 60,
      "input": "08/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: The report explicitly states that no malignancy was identified. Further, the brain MRI is normal with no mass lesions or abnormal enhancement. Reassurance was provided. Therefore, there is no evidence to suggest malignancy. No abnormal findings are present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report clearly states that no malignancy was found. The MRI is normal with no lesions or enhancement. No other concerning findings are mentioned. Therefore, there is no evidence to suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The MRI is normal with no lesions or enhancement. No other concerning findings are mentioned. Therefore, there is no evidence to suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was found. The MRI is normal with no lesions or enhancement. No other concerning findings are mentioned. Therefore, there is no evidence to suggest malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was found",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: The report explicitly states that no malignancy was identified. Further, the brain MRI is normal with no mass lesions or abnormal enhancement. Reassurance was provided. Therefore, there is no evidence to suggest malignancy. No abnormal findings are present.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 60,
      "timestamp": "2026-01-10T19:20:55.841393"
    },
    {
      "sample_idx": 61,
      "input": "09/07/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 09/07/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Initial skepticism: Could atypical lymphocytes be a precursor to malignancy? While the report mentions post-viral lymphocytosis and resolving atypical lymphocytes, the positive monospot test and confirmation of EBV infection suggest a benign viral etiology. The absence of any mention of malignant cells or concerning features further supports the benign conclusion. While a follow-up is warranted, no definitive evidence of malignancy is present. Conclusion: No malignancy identified. Skeptical analysis confirms a benign process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could atypical lymphocytes be a precursor to malignancy? While the report mentions post-viral lymphocytosis and resolving atypical lymphocytes, the positive monospot test and confirmation of EBV infection suggest a benign viral etiology. The absence of any mention of malignant cells or concerning features further supports the benign conclusion. While a follow-up is warranted, no definitive evidence of malignancy is present. Conclusion: No malignancy identified. Skeptical analysis confirms a benign process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: Could atypical lymphocytes be a precursor to malignancy? While the report mentions post-viral lymphocytosis and resolving atypical lymphocytes, the positive monospot test and confirmation of EBV infection suggest a benign viral etiology. The absence of any mention of malignant cells or concerning features further supports the benign conclusion. While a follow-up is warranted, no definitive evidence of",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could atypical lymphocytes be a precursor to malignancy? While the report mentions post-viral lymphocytosis and resolving atypical lymphocytes, the positive monospot test and confirmation of EBV infection suggest a benign viral etiology. The absence of any mention of malignant cells or concerning features further supports the benign conclusion. While a follow-up is warranted, no definitive evidence of malignancy is present. Conclusion: No malignancy identified. Skeptical analysis confirms a benign process.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 61,
      "timestamp": "2026-01-10T19:20:55.841410"
    },
    {
      "sample_idx": 62,
      "input": "08/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 08/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could the lymphadenopathy be a sign of early malignancy? The report explicitly states that the lymphadenopathy is reactive, secondary to a viral infection, and that no atypical features or malignancy were identified. The node size is decreasing on follow-up. Therefore, the findings are consistent with a benign process. The report provides reassurance. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the lymphadenopathy be a sign of early malignancy? The report explicitly states that the lymphadenopathy is reactive, secondary to a viral infection, and that no atypical features or malignancy were identified. The node size is decreasing on follow-up. Therefore, the findings are consistent with a benign process. The report provides reassurance. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size decreasing on follow-up\", \"No atypical features\", \"No malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the lymphadenopathy be a sign of early malignancy? The report explicitly states that the lymphadenopathy is reactive, secondary to a viral infection, and that no atypical features or malignancy were identified. The node size is decreasing on follow-up. Therefore, the findings are consistent with a benign process. The report provides reassurance. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"Reactive lymphadenopathy secondary to viral infection\", \"Node size",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could the lymphadenopathy be a sign of early malignancy? The report explicitly states that the lymphadenopathy is reactive, secondary to a viral infection, and that no atypical features or malignancy were identified. The node size is decreasing on follow-up. Therefore, the findings are consistent with a benign process. The report provides reassurance. Conclusion: No malignancy identified.",
      "findings": [
        "Reactive lymphadenopathy secondary to viral infection",
        "Node size decreasing on follow-up",
        "No atypical features",
        "No malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 62,
      "timestamp": "2026-01-10T19:20:55.841426"
    },
    {
      "sample_idx": 63,
      "input": "04/12/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Resolved febrile illness. Blood counts normalized. No organomegaly. Clinical improvement noted. No malignancy identified. Reassurance provided.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 04/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"resolved febrile illness\", \"normalized blood counts\", \"no organomegaly\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could the resolved febrile illness be related to a malignancy? However, the report explicitly states that the blood counts normalized and there is no organomegaly. The absence of malignancy is the primary finding. Alternative benign explanations (viral infection, stress response) are supported by the resolution of the illness and the absence of concerning findings. Conclusion: No malignancy identified, reassuring the patient.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no organomegaly\", \"no malignancy identified\", \"clinical improvement noted\"],\n        \"rationale\": \"The report indicates that the patient had a febrile illness which resolved and that there is no organomegaly and no malignancy identified. The report also states that the patient has clinical improvement. This information suggests that the patient's condition is improving. Therefore, the patient does not have a malignancy. There is no indication of malignancy. Conclusion: No malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no organomegaly\", \"no malignancy identified\", \"clinical improvement noted\", \"normalized blood counts\"],\n        \"rationale\": \"The report states that there is no organomegaly, no malignancy identified, and that the patient has clinical improvement. The patient's blood counts have also normalized. This information suggests that the patient is improving and that the patient does not have a malignancy. Conclusion: No malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no organomegaly\", \"no malignancy identified\", \"clinical improvement noted\", \"normalized blood counts\", \"resolved febrile illness\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified, no organomegaly, and that the patient is clinically improving. The patient's blood",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could the resolved febrile illness be related to a malignancy? However, the report explicitly states that the blood counts normalized and there is no organomegaly. The absence of malignancy is the primary finding. Alternative benign explanations (viral infection, stress response) are supported by the resolution of the illness and the absence of concerning findings. Conclusion: No malignancy identified, reassuring the patient.",
      "findings": [
        "resolved febrile illness",
        "normalized blood counts",
        "no organomegaly",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 63,
      "timestamp": "2026-01-10T19:20:55.841441"
    },
    {
      "sample_idx": 64,
      "input": "29/09/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 29/09/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy secondary to viral infection with decreasing node size and absence of atypical features. The final conclusion is that no malignancy was identified. While the initial finding is abnormal, it is benign and reactive. Alternative explanations are likely and the presence of no malignancy is evidence against malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy secondary to viral infection with decreasing node size and absence of atypical features. The final conclusion is that no malignancy was identified. While the initial finding is abnormal, it is benign and reactive. Alternative explanations are likely and the presence of no malignancy is evidence against malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy secondary to viral infection with decreasing node size and absence of atypical features. The final conclusion is that no malignancy was identified. While the initial finding is abnormal, it is benign and reactive. Alternative explanations are likely and the presence of no malignancy is evidence against malignancy. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"node size decreasing on follow-up\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states reactive lymphadenopathy secondary to viral infection with decreasing node size and absence of atypical features.",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states reactive lymphadenopathy secondary to viral infection with decreasing node size and absence of atypical features. The final conclusion is that no malignancy was identified. While the initial finding is abnormal, it is benign and reactive. Alternative explanations are likely and the presence of no malignancy is evidence against malignancy. Conclusion: No malignancy identified.",
      "findings": [
        "reactive lymphadenopathy",
        "node size decreasing on follow-up",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 64,
      "timestamp": "2026-01-10T19:20:55.841456"
    },
    {
      "sample_idx": 65,
      "input": "09/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 09/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign orbital mass? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. The report explicitly mentions the suspicion of retinoblastoma. Alternative benign explanations are highly improbable given the constellation of findings. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign orbital mass? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. The report explicitly mentions the suspicion of retinoblastoma. Alternative benign explanations are highly improbable given the constellation of findings. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could this be a benign orbital mass? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. The report explicitly mentions the suspicion of retinoblastoma. Alternative benign explanations are highly improbable given the constellation of findings. Conclusion: Malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could this be a benign orbital mass? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. The report explicitly mentions the suspicion of retinoblastoma. Alternative benign explanations are highly improbable given the constellation of findings. Conclusion: Malignancy confirmed despite initial skepticism.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 65,
      "timestamp": "2026-01-10T19:20:55.841472"
    },
    {
      "sample_idx": 66,
      "input": "16/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Neuroblastoma.\n\nFrom clinical notes: Neuroblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous suprarenal mass with calcifications. MIBG avidity present. Elevated urinary catecholamines. Stage III disease. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could a benign mass with calcifications be mistaken for a malignant one? However, the presence of MIBG avidity and elevated urinary catecholamines strongly suggests Neuroblastoma. Stage III disease further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcification) are less likely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could a benign mass with calcifications be mistaken for a malignant one? However, the presence of MIBG avidity and elevated urinary catecholamines strongly suggests Neuroblastoma. Stage III disease further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcification) are less likely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with calcifications\", \"MIBG avidity present\", \"elevated urinary catecholamines\", \"Stage III disease\"],\n        \"rationale\": \"Initial skepticism: Could a benign mass with calcifications be mistaken for a malignant one? However, the presence of MIBG avidity and elevated urinary catecholamines strongly suggests Neuroblastoma. Stage III disease further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcification) are less likely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous suprarenal mass with",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a benign mass with calcifications be mistaken for a malignant one? However, the presence of MIBG avidity and elevated urinary catecholamines strongly suggests Neuroblastoma. Stage III disease further supports this conclusion. Alternative benign explanations (e.g., adrenal adenoma with calcification) are less likely given the combination of findings. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "large heterogeneous suprarenal mass with calcifications",
        "MIBG avidity present",
        "elevated urinary catecholamines",
        "Stage III disease"
      ],
      "fracture_mentioned": null,
      "idx": 66,
      "timestamp": "2026-01-10T19:20:55.841487"
    },
    {
      "sample_idx": 67,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is it possible that the report is incorrect and there is a subtle, early malignancy not easily detectable by routine CBC? However, the report explicitly states that the CBC is normal, with no blast cells, adequate platelets, and hemoglobin within normal limits. Furthermore, there is no mention of any suspicious findings on the CT scan. The report also provides reassurance. Therefore, the likelihood of malignancy is extremely low. Alternative benign explanations (e.g., normal growth, no underlying pathology) are highly probable. Conclusion: No malignancy detected.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: The report is clear and concise, stating a normal CBC with age-appropriate values, no blast cells, adequate platelets, and hemoglobin within normal limits. No malignancy is identified. The patient has no previous oncology history. While a complete and thorough examination is always important, the report provides sufficient information to suggest the absence of malignancy. There are no red flags to suggest otherwise. Alternative benign explanations are highly plausible. Conclusion: No malignancy detected.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: The report indicates a completely normal CBC, including the absence of blast cells. This significantly reduces the likelihood of malignancy. While it's always prudent to consider potential alternative explanations, the absence of any concerning findings makes it highly improbable. The reassurance provided further supports the conclusion of no malignancy. Alternative benign explanations are highly likely. Conclusion: No malignancy detected.\"\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Is it possible that the report is incorrect and there is a subtle, early malignancy not easily detectable by routine CBC? However, the report explicitly states that the CBC is normal, with no blast cells, adequate platelets, and hemoglobin within normal limits. Furthermore, there is no mention of any suspicious findings on the CT scan. The report also provides reassurance. Therefore, the likelihood of malignancy is extremely low. Alternative benign explanations (e.g., normal growth, no underlying pathology) are highly probable. Conclusion: No malignancy detected.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 67,
      "timestamp": "2026-01-10T19:20:55.841506"
    },
    {
      "sample_idx": 68,
      "input": "27/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the findings be misinterpreted? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy', and 'parameningeal mass with intracranial extension' is a known presentation of this malignancy. PAX-FOXO1 fusion negative helps to confirm the diagnosis. Alternative benign explanations (e.g., metastasis from a different primary tumor) are not suggested. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the findings be misinterpreted? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy', and 'parameningeal mass with intracranial extension' is a known presentation of this malignancy. PAX-FOXO1 fusion negative helps to confirm the diagnosis. Alternative benign explanations (e.g., metastasis from a different primary tumor) are not suggested. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the findings be misinterpreted? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy', and 'parameningeal mass with intracranial extension' is a known presentation of this malignancy. PAX-FOXO1 fusion negative helps to confirm the diagnosis. Alternative benign explanations (e.g., metastasis from a different primary tumor) are not suggested. Conclusion: Malignancy confirmed.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be misinterpreted? However, the report explicitly states 'embryonal rhabdomyosarcoma on biopsy', and 'parameningeal mass with intracranial extension' is a known presentation of this malignancy. PAX-FOXO1 fusion negative helps to confirm the diagnosis. Alternative benign explanations (e.g., metastasis from a different primary tumor) are not suggested. Conclusion: Malignancy confirmed.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 68,
      "timestamp": "2026-01-10T19:20:55.841521"
    },
    {
      "sample_idx": 69,
      "input": "16/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 16/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Although the report states 'no malignancy identified,' it's crucial to consider the context of the request. The report explicitly states that a chest radiograph was performed and that it was normal. The report also states that no malignancy was identified. The report also states that the patient has no previous oncology history. Although the report may be reassuring, it is not sufficient to rule out malignancy. A negative chest radiograph does not exclude the possibility of malignancy, especially if the patient is asymptomatic. The report does not provide any information about the patient's symptoms or physical exam findings. Therefore, it is not possible to definitively rule out malignancy based on this report alone. Furthermore, the report does not mention any other relevant findings that could suggest malignancy. Although the report may be reassuring, it is not sufficient to rule out malignancy. Further investigation may be warranted to exclude malignancy. Alternative benign explanations are possible, but the report does not provide enough information to rule out malignancy. Conclusion: While the report indicates no malignancy, it is not sufficient to definitively rule out malignancy. Further investigation may be warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: The report explicitly states that a chest radiograph was performed and that it was normal. The report also states that no malignancy was identified. The report also states that the patient has no previous oncology history. Although the report may be reassuring, it is not sufficient to rule out malignancy. A negative chest radiograph does not exclude the possibility of malignancy, especially if the patient is asymptomatic. The report does not provide any information about the patient's symptoms or physical exam findings. Therefore, it is not possible to definitively rule out malignancy based on this report alone. Furthermore, the report does not mention any other relevant findings that could suggest malignancy. Although the report may be reassuring, it is not sufficient to rule out",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Although the report states 'no malignancy identified,' it's crucial to consider the context of the request. The report explicitly states that a chest radiograph was performed and that it was normal. The report also states that no malignancy was identified. The report also states that the patient has no previous oncology history. Although the report may be reassuring, it is not sufficient to rule out malignancy. A negative chest radiograph does not exclude the possibility of malignancy, especially if the patient is asymptomatic. The report does not provide any information about the patient's symptoms or physical exam findings. Therefore, it is not possible to definitively rule out malignancy based on this report alone. Furthermore, the report does not mention any other relevant findings that could suggest malignancy. Although the report may be reassuring, it is not sufficient to rule out malignancy. Further investigation may be warranted to exclude malignancy. Alternative benign explanations are possible, but the report does not provide enough information to rule out malignancy. Conclusion: While the report indicates no malignancy, it is not sufficient to definitively rule out malignancy. Further investigation may be warranted.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 69,
      "timestamp": "2026-01-10T19:20:55.841560"
    },
    {
      "sample_idx": 70,
      "input": "29/11/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 29/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could the mass be benign? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. Alternative benign explanations (e.g., other ocular tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed, highly suggestive of retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Skeptical review: Could the findings be due to other, less aggressive processes? While the presence of calcifications, bilateral disease, positive family history, and RB1 germline mutation are highly suggestive of retinoblastoma, it's important to consider if the presentation could be atypical. Could the calcifications be related to other conditions? The presence of RB1 mutation is a strong indicator. Alternative benign explanations are less likely given the constellation of findings. Conclusion: malignancy confirmed, highly suggestive of retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Skeptical reasoning: Could the findings be due to other, less aggressive processes? While the presence of calcifications, bilateral disease, positive family history, and RB1 germline mutation are highly suggestive of retinoblastoma, it's important to consider if the presentation could be atypical. Could the calcifications be related to other conditions? The presence of RB1 mutation is a strong indicator. Alternative benign explanations are less likely given the constellation of findings. Conclusion: malignancy confirmed, highly suggestive of retinoblastoma.\"\n    }\n}\n```\n```json\n",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be benign? However, the presence of calcifications, bilateral disease, positive family history, and the detection of an RB1 germline mutation strongly suggest retinoblastoma. Alternative benign explanations (e.g., other ocular tumors) are less likely given the constellation of findings. Conclusion: malignancy confirmed, highly suggestive of retinoblastoma.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 70,
      "timestamp": "2026-01-10T19:20:55.841574"
    },
    {
      "sample_idx": 71,
      "input": "11/10/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the findings be reactive or represent a benign inflammatory process? However, the presence of a bulky mediastinal mass and FDG-avid nodes on PET-CT strongly suggests malignancy. The histological description of Classical Hodgkin Lymphoma, nodular sclerosing type, further supports the diagnosis. While reactive lymphadenopathy is possible, the clinical context (suspected Hodgkin Lymphoma) and imaging findings make malignancy the more likely explanation. Alternative benign explanations (e.g., inflammatory disease) are less likely given the specific characteristics of the mass and the presence of FDG-avid nodes. Conclusion: Malignancy is strongly suspected based on the clinical history, imaging, and histological findings. Further investigation and treatment planning are warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the findings be reactive or represent a benign inflammatory process? However, the presence of a bulky mediastinal mass and FDG-avid nodes on PET-CT strongly suggests malignancy. The histological description of Classical Hodgkin Lymphoma, nodular sclerosing type, further supports the diagnosis. While reactive lymphadenopathy is possible, the clinical context (suspected Hodgkin Lymphoma) and imaging findings make malignancy the more likely explanation. Alternative benign explanations (e.g., inflammatory disease) are less likely given the specific characteristics of the mass and the presence of FDG-avid nodes. Conclusion: Malignancy is strongly suspected based on the clinical history, imaging, and histological findings. Further investigation and treatment planning are warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be reactive or represent a benign inflammatory process? However, the presence of a bulky mediastinal mass and FDG-avid nodes on PET-CT strongly suggests malignancy. The histological description of Classical Hodgkin Lymphoma, nodular sclerosing type, further supports the diagnosis. While reactive lymphadenopathy is possible, the clinical context (suspected Hodgkin Lymphoma) and imaging findings make malignancy the more likely explanation. Alternative benign explanations (e.g., inflammatory disease) are less likely given the specific characteristics of the mass and the presence of FDG-avid nodes. Conclusion: Malignancy is strongly suspected based on the clinical history, imaging, and histological findings. Further investigation and treatment planning are warranted.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 71,
      "timestamp": "2026-01-10T19:20:55.841597"
    },
    {
      "sample_idx": 72,
      "input": "13/09/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Unexplained fever and weight loss. Suspected Rhabdomyosarcoma.\n\nFrom clinical notes: Rhabdomyosarcoma. Paediatric oncology assessment.\n\nFindings: parameningeal mass with intracranial extension. Embryonal rhabdomyosarcoma on biopsy. PAX-FOXO1 fusion negative. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 13/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the report be a false positive? However, the presence of a parameningeal mass with intracranial extension, the confirmed diagnosis of embryonal rhabdomyosarcoma on biopsy, and the negative PAX-FOXO1 fusion result strongly suggest malignancy. Alternative benign explanations (e.g., a reactive inflammatory process mimicking a tumor) are less likely given the specific findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the report be a false positive? However, the presence of a parameningeal mass with intracranial extension, the confirmed diagnosis of embryonal rhabdomyosarcoma on biopsy, and the negative PAX-FOXO1 fusion result strongly suggest malignancy. Alternative benign explanations (e.g., a reactive inflammatory process mimicking a tumor) are less likely given the specific findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"parameningeal mass with intracranial extension\", \"embryonal rhabdomyosarcoma on biopsy\", \"PAX-FOXO1 fusion negative\"],\n        \"rationale\": \"Initial skepticism: Could the report be a false positive? However, the presence of a parameningeal mass with intracranial extension, the confirmed diagnosis of embryonal rhabdomyosarcoma on biopsy, and the negative PAX-FOXO1 fusion result strongly suggest malignancy. Alternative benign explanations (e.g., a reactive inflammatory process mimicking a tumor) are less likely given the specific findings. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the report be a false positive? However, the presence of a parameningeal mass with intracranial extension, the confirmed diagnosis of embryonal rhabdomyosarcoma on biopsy, and the negative PAX-FOXO1 fusion result strongly suggest malignancy. Alternative benign explanations (e.g., a reactive inflammatory process mimicking a tumor) are less likely given the specific findings. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "parameningeal mass with intracranial extension",
        "embryonal rhabdomyosarcoma on biopsy",
        "PAX-FOXO1 fusion negative"
      ],
      "fracture_mentioned": null,
      "idx": 72,
      "timestamp": "2026-01-10T19:20:55.841612"
    },
    {
      "sample_idx": 73,
      "input": "03/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 03/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could there be a subtle, early malignancy not detectable on ultrasound? Considering alternative explanations: Physiological splenomegaly is common in children. Absence of focal lesions and normal echo texture further decrease the likelihood of malignancy. The report explicitly states 'no malignancy identified'. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring. Conclusion: No malignancy identified. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a subtle, early malignancy not detectable on ultrasound? Considering alternative explanations: Physiological splenomegaly is common in children. Absence of focal lesions and normal echo texture further decrease the likelihood of malignancy. The report explicitly states 'no malignancy identified'. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring. Conclusion: No malignancy identified. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be a subtle, early malignancy not detectable on ultrasound? Considering alternative explanations: Physiological splenomegaly is common in children. Absence of focal lesions and normal echo texture further decrease the likelihood of malignancy. The report explicitly states 'no malignancy identified'. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring. Conclusion: No malignancy identified. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malign",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could there be a subtle, early malignancy not detectable on ultrasound? Considering alternative explanations: Physiological splenomegaly is common in children. Absence of focal lesions and normal echo texture further decrease the likelihood of malignancy. The report explicitly states 'no malignancy identified'. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring. Conclusion: No malignancy identified. While a very early, subtle malignancy is theoretically possible, the findings are overwhelmingly reassuring.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 73,
      "timestamp": "2026-01-10T19:20:55.841630"
    },
    {
      "sample_idx": 74,
      "input": "11/10/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Ewing Sarcoma.\n\nFrom clinical notes: Ewing Sarcoma. Paediatric oncology assessment.\n\nFindings: permeative bone destruction in left femoral diaphysis with large soft tissue mass. Onion-skin periosteal reaction. EWSR1 fusion positive. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 11/10/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a different, less aggressive bone tumor? However, the combination of permeative bone destruction, large soft tissue mass, and onion-skin periosteal reaction is highly suggestive of Ewing Sarcoma. The EWSR1 fusion positivity further supports this diagnosis. Alternative benign explanations (e.g., aggressive osteomyelitis) are less likely given the characteristic features of Ewing Sarcoma. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the findings be due to a different, less aggressive bone tumor? Playing devil's advocate against a benign conclusion: the report shows permeative bone destruction, large soft tissue mass, and onion-skin periosteal reaction, which are classic features of Ewing Sarcoma. The EWSR1 fusion positivity further supports this diagnosis. Cannot conclude malignancy without evidence of abnormal cells or pathological findings. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"permeative bone destruction in left femoral diaphysis with large soft tissue mass\", \"onion-skin periosteal reaction\", \"EWSR1 fusion positive\"],\n        \"rationale\": \"Initial skepticism: Could the findings be due to a different, less aggressive bone tumor? Playing devil's advocate against a benign conclusion: the report shows permeative bone destruction, large soft tissue mass, and onion-skin periosteal reaction, which are classic features of Ewing Sarcoma. The EWSR1 fusion positivity further supports this diagnosis. Cannot conclude malignancy",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be due to a different, less aggressive bone tumor? However, the combination of permeative bone destruction, large soft tissue mass, and onion-skin periosteal reaction is highly suggestive of Ewing Sarcoma. The EWSR1 fusion positivity further supports this diagnosis. Alternative benign explanations (e.g., aggressive osteomyelitis) are less likely given the characteristic features of Ewing Sarcoma. Conclusion: Malignancy confirmed, likely Ewing Sarcoma, despite initial skepticism.",
      "findings": [
        "permeative bone destruction in left femoral diaphysis with large soft tissue mass",
        "onion-skin periosteal reaction",
        "EWSR1 fusion positive"
      ],
      "fracture_mentioned": null,
      "idx": 74,
      "timestamp": "2026-01-10T19:20:55.841647"
    },
    {
      "sample_idx": 75,
      "input": "28/12/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Reactive lymphadenopathy secondary to viral infection. Node size decreasing on follow-up. No atypical features. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 28/12/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Initial skepticism: Could the report be a benign assessment? The report explicitly states 'reactive lymphadenopathy' and 'no malignancy identified'. The absence of atypical features further supports the benign conclusion. The report provides reassurance. Alternative benign explanations (viral infection, reactive process) are supported by the report. Conclusion: No malignancy present, although the finding of reactive lymphadenopathy warrants monitoring. Skepticism is overcome by the clear and reassuring nature of the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormal findings\", \"no evidence of malignancy\", \"no concerning features\"],\n        \"rationale\": \"Applying skeptical reasoning: Could there be an early, subtle malignancy not yet detectable? Considering the patient's history of no previous oncology, the absence of any abnormal findings, and the explicit statement that no malignancy was identified, the probability of malignancy is extremely low. It is difficult to imagine any scenario where a malignancy would be present without any evidence of it in the report. Therefore, it is highly unlikely that malignancy is present, even if it is subtle. Conclusion: No malignancy present. Skepticism is overcome by the complete absence of any concerning features.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"reactive lymphadenopathy\", \"no atypical features\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Is the report definitively ruling out malignancy? While the report states 'no malignancy identified', it is important to consider the context of a screening procedure. It is possible that the procedure is not sensitive enough to detect early-stage malignancy. The report also states 'no atypical features', which could be a subjective assessment. However, the report also provides reassurance. Alternative benign explanations (viral infection, reactive process) are supported by the report. Conclusion: No malignancy present, although the finding of reactive lymphadenopathy warrants monitoring. Skepticism is overcome by the clear and reassuring nature of the",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Initial skepticism: Could the report be a benign assessment? The report explicitly states 'reactive lymphadenopathy' and 'no malignancy identified'. The absence of atypical features further supports the benign conclusion. The report provides reassurance. Alternative benign explanations (viral infection, reactive process) are supported by the report. Conclusion: No malignancy present, although the finding of reactive lymphadenopathy warrants monitoring. Skepticism is overcome by the clear and reassuring nature of the report.",
      "findings": [
        "reactive lymphadenopathy",
        "no atypical features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 75,
      "timestamp": "2026-01-10T19:20:55.841663"
    },
    {
      "sample_idx": 76,
      "input": "02/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 02/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: While the report explicitly states 'no malignancy identified,' it is crucial to consider if the findings could be misinterpreted or if further investigation is warranted, especially given the benign presentation. The absence of blast cells is a strong indicator against malignancy. Normal CBC parameters further support a benign conclusion. However, 'no malignancy identified' does not definitively rule out early or occult malignancy. The report provides reassurance, which suggests the findings are considered benign. The report does not provide any information that would indicate a false negative. Conclusion: No malignancy present based on the provided report, but further investigation might be considered if clinical suspicion remains high.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: The report is very clear: 'no malignancy identified.' However, 'no malignancy identified' does not automatically equate to 'no malignancy.' The report is benign. The report does not provide any information that would indicate a false negative. Conclusion: No malignancy present based on the provided report, but further investigation might be considered if clinical suspicion remains high.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"Applying skeptical reasoning: The report is very clear: 'no malignancy identified.' However, 'no malignancy identified' does not automatically equate to 'no malignancy.' The report is benign. The report does not provide any information that would indicate a false negative. Conclusion: No malignancy present based on the provided report, but further",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: While the report explicitly states 'no malignancy identified,' it is crucial to consider if the findings could be misinterpreted or if further investigation is warranted, especially given the benign presentation. The absence of blast cells is a strong indicator against malignancy. Normal CBC parameters further support a benign conclusion. However, 'no malignancy identified' does not definitively rule out early or occult malignancy. The report provides reassurance, which suggests the findings are considered benign. The report does not provide any information that would indicate a false negative. Conclusion: No malignancy present based on the provided report, but further investigation might be considered if clinical suspicion remains high.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 76,
      "timestamp": "2026-01-10T19:20:55.841686"
    },
    {
      "sample_idx": 77,
      "input": "06/10/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 06/10/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the fracture is healing normally, bone density is normal, and no malignancy is identified. This directly contradicts the request to rule out malignancy. The conclusion is that there is no evidence of malignancy. Skeptical thinking is not needed as there is no indication of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the fracture is healing normally, bone density is normal, and no malignancy is identified. This directly contradicts the request to rule out malignancy. The conclusion is that there is no evidence of malignancy. Skeptical thinking is not needed as there is no indication of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the fracture is healing normally, bone density is normal, and no malignancy is identified. This directly contradicts the request to rule out malignancy. The conclusion is that there is no evidence of malignancy. Skeptical thinking is not needed as there is no indication of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the fracture is healing normally, bone density is normal, and no malignancy is identified. This directly contradicts the request to rule out malignancy. The conclusion is that there is no evidence of malignancy. Skeptical thinking is not needed as there is no indication of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    ",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the fracture is healing normally, bone density is normal, and no malignancy is identified. This directly contradicts the request to rule out malignancy. The conclusion is that there is no evidence of malignancy. Skeptical thinking is not needed as there is no indication of malignancy.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 77,
      "timestamp": "2026-01-10T19:20:55.841699"
    },
    {
      "sample_idx": 78,
      "input": "27/02/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 27/02/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and marrow infiltration pattern provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and marrow infiltration pattern provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and marrow infiltration pattern provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and marrow infiltration pattern provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 78,
      "timestamp": "2026-01-10T19:20:55.841715"
    },
    {
      "sample_idx": 79,
      "input": "17/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Post-viral lymphocytosis. Atypical lymphocytes resolving. Monospot positive. EBV serology confirms. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 17/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"post-viral lymphocytosis\", \"atypical lymphocytes resolving\", \"monospot positive\", \"EBV serology confirms\", \"no malignancy identified\"],\n        \"rationale\": \"Skepticism: While the report mentions 'post-viral lymphocytosis' and 'atypical lymphocytes resolving', it also explicitly states 'no malignancy identified'. It's crucial to consider if the atypical lymphocytes could be early-stage malignancy. However, the positive monospot and EBV serology strongly suggest a viral etiology. The resolution of the atypical lymphocytes further supports this. Therefore, the most likely explanation is a post-viral response. Alternative benign explanations (reactive lymphocytosis) are supported by the clinical context. Conclusion: No malignancy detected, and the findings are consistent with a post-viral lymphocytosis.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphocytes 30% of total white cells\", \"no abnormal morphology\", \"no abnormal cytology\"],\n        \"rationale\": \"Skepticism: Lymphocytes are a normal component of the white blood cell count. However, the report mentions that the lymphocytes are 30% of the total white cells, which is elevated. This could be reactive. However, the report states that there is no abnormal morphology or cytology. Therefore, the most likely explanation is reactive lymphocytosis. Alternative benign explanations (reactive lymphocytosis) are supported by the clinical context. Conclusion: No malignancy detected, and the findings are consistent with reactive lymphocytosis.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"lymphocytes 30% of total white cells\", \"no abnormal morphology\", \"no abnormal cytology\"],\n        \"rationale\": \"Skepticism: Lymphocytes are a normal component of the white blood cell count. However, the report mentions that the lymphocytes are 30% of the total white cells, which is elevated. This could be reactive. However, the report states that there is no abnormal morphology or cytology. Therefore, the most likely explanation is",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Skepticism: While the report mentions 'post-viral lymphocytosis' and 'atypical lymphocytes resolving', it also explicitly states 'no malignancy identified'. It's crucial to consider if the atypical lymphocytes could be early-stage malignancy. However, the positive monospot and EBV serology strongly suggest a viral etiology. The resolution of the atypical lymphocytes further supports this. Therefore, the most likely explanation is a post-viral response. Alternative benign explanations (reactive lymphocytosis) are supported by the clinical context. Conclusion: No malignancy detected, and the findings are consistent with a post-viral lymphocytosis.",
      "findings": [
        "post-viral lymphocytosis",
        "atypical lymphocytes resolving",
        "monospot positive",
        "EBV serology confirms",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 79,
      "timestamp": "2026-01-10T19:20:55.841733"
    },
    {
      "sample_idx": 80,
      "input": "18/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Physiological splenomegaly for age. No focal lesions. Normal echo texture. Benign finding. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 18/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"physiological splenomegaly\", \"no focal lesions\", \"normal echo texture\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that no malignancy was identified. The findings are described as physiological and benign. Skeptical analysis: Could a subtle malignancy be missed? Although possible, the report's language is reassuring. No specific findings are mentioned that would raise suspicion for malignancy. Conclusion: No malignancy identified. The report is reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that no findings suggest malignancy. This is a strong indicator that no malignancy is present. Skeptical analysis: Could there be a very early, subtle malignancy that is not detectable by the current methods? While technically possible, it is highly improbable given the report's language. Conclusion: No malignancy is present based on the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that no findings suggest malignancy. This is a strong indicator that no malignancy is present. Skeptical analysis: Could there be a very early, subtle malignancy that is not detectable by the current methods? While technically possible, it is highly improbable given the report's language. Conclusion: No malignancy is present based on the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that no findings suggest malignancy. This is a strong indicator that no malignancy is present. Skeptical analysis: Could there be a very early, subtle malignancy that is not detectable by the current methods? While technically possible, it is highly improbable given the report's language. Conclusion: No malignancy is present based on the report.\"\n    }",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that no malignancy was identified. The findings are described as physiological and benign. Skeptical analysis: Could a subtle malignancy be missed? Although possible, the report's language is reassuring. No specific findings are mentioned that would raise suspicion for malignancy. Conclusion: No malignancy identified. The report is reassuring.",
      "findings": [
        "physiological splenomegaly",
        "no focal lesions",
        "normal echo texture",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 80,
      "timestamp": "2026-01-10T19:20:55.841748"
    },
    {
      "sample_idx": 81,
      "input": "11/06/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Benign soft tissue mass - lipoma confirmed. Well-circumscribed. No enhancement. No intervention required. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"well-circumscribed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that a benign lipoma was found, with no evidence of malignancy. The findings are consistent with a benign presentation. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"well-circumscribed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that a benign lipoma was found, with no evidence of malignancy. The findings are consistent with a benign presentation. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"well-circumscribed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that a benign lipoma was found, with no evidence of malignancy. The findings are consistent with a benign presentation. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign soft tissue mass - lipoma confirmed\", \"well-circumscribed\", \"no enhancement\", \"no intervention required\", \"no malignancy identified\", \"reassurance provided\"],\n        \"rationale\": \"The report explicitly states that a benign lipoma was found, with no evidence of malignancy. The findings are consistent with a benign presentation. Therefore, malignancy is ruled out.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that a benign lipoma was found, with no evidence of malignancy. The findings are consistent with a benign presentation. Therefore, malignancy is ruled out.",
      "findings": [
        "benign soft tissue mass - lipoma confirmed",
        "well-circumscribed",
        "no enhancement",
        "no intervention required",
        "no malignancy identified",
        "reassurance provided"
      ],
      "fracture_mentioned": null,
      "idx": 81,
      "timestamp": "2026-01-10T19:20:55.841760"
    },
    {
      "sample_idx": 82,
      "input": "27/12/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 27/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the imaging be misleading? The report describes a large renal mass with a pseudocapsule, which could be a benign lesion. However, the presence of a 'favorable histology on biopsy' and the diagnosis of Stage II suggests malignancy. The absence of vascular invasion is a positive finding, but does not rule out malignancy. Alternative benign explanations (e.g., a complex cyst) are less likely given the 'favorable histology'. Conclusion: Malignancy confirmed, although the report is reassuring on the absence of vascular invasion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the imaging be misleading? The report describes a large renal mass with a pseudocapsule, which could be a benign lesion. However, the presence of a 'favorable histology on biopsy' and the diagnosis of Stage II suggests malignancy. The absence of vascular invasion is a positive finding, but does not rule out malignancy. Alternative benign explanations (e.g., a complex cyst) are less likely given the 'favorable histology'. Conclusion: Malignancy confirmed, although the report is reassuring on the absence of vascular invasion.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the imaging be misleading? The report describes a large renal mass with a pseudocapsule, which could be a benign lesion. However, the presence of a 'favorable histology on biopsy' and the diagnosis of Stage II suggests malignancy. The absence of vascular invasion is a positive finding, but does not rule out malignancy. Alternative",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the imaging be misleading? The report describes a large renal mass with a pseudocapsule, which could be a benign lesion. However, the presence of a 'favorable histology on biopsy' and the diagnosis of Stage II suggests malignancy. The absence of vascular invasion is a positive finding, but does not rule out malignancy. Alternative benign explanations (e.g., a complex cyst) are less likely given the 'favorable histology'. Conclusion: Malignancy confirmed, although the report is reassuring on the absence of vascular invasion.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "No vascular invasion",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 82,
      "timestamp": "2026-01-10T19:20:55.841778"
    },
    {
      "sample_idx": 83,
      "input": "05/11/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Osteosarcoma.\n\nFrom clinical notes: Osteosarcoma. Paediatric oncology assessment.\n\nFindings: destructive lesion in distal femur with soft tissue component. Sunburst periosteal reaction. Elevated alkaline phosphatase. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 05/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skepticism: Could the findings be due to other causes of bone pain or mass? The report describes a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase, all suggestive of malignancy. While the report doesn't explicitly state the diagnosis, the constellation of findings strongly points towards osteosarcoma, a primary bone malignancy. Alternative benign explanations (infection, trauma, benign bone lesions) are less likely given the specific features described. Conclusion: malignancy is likely, based on the report's findings. Further investigation (imaging, biopsy) is needed for definitive diagnosis, but the report provides strong evidence for a malignant process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skepticism: Could the findings be due to other causes of bone pain or mass? The report describes a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase, all suggestive of malignancy. While the report doesn't explicitly state the diagnosis, the constellation of findings strongly points towards osteosarcoma, a primary bone malignancy. Alternative benign explanations (infection, trauma, benign bone lesions) are less likely given the specific features described. Conclusion: malignancy is likely, based on the report's findings. Further investigation (imaging, biopsy) is needed for definitive diagnosis, but the report provides strong evidence for a malignant process.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"destructive lesion in distal femur with soft tissue component\", \"sunburst periosteal reaction\", \"elevated alkaline phosphatase\"],\n        \"rationale\": \"Skepticism: Could the findings be due to other causes of bone pain or mass? The report describes a destructive lesion, sunburst periosteal reaction, and elevated",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skepticism: Could the findings be due to other causes of bone pain or mass? The report describes a destructive lesion, sunburst periosteal reaction, and elevated alkaline phosphatase, all suggestive of malignancy. While the report doesn't explicitly state the diagnosis, the constellation of findings strongly points towards osteosarcoma, a primary bone malignancy. Alternative benign explanations (infection, trauma, benign bone lesions) are less likely given the specific features described. Conclusion: malignancy is likely, based on the report's findings. Further investigation (imaging, biopsy) is needed for definitive diagnosis, but the report provides strong evidence for a malignant process.",
      "findings": [
        "destructive lesion in distal femur with soft tissue component",
        "sunburst periosteal reaction",
        "elevated alkaline phosphatase"
      ],
      "fracture_mentioned": null,
      "idx": 83,
      "timestamp": "2026-01-10T19:20:55.841797"
    },
    {
      "sample_idx": 84,
      "input": "23/11/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 23/11/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Healing fracture and normal bone density further support the absence of any pathological features. The reassurance provided by the consultant reinforces the benign nature of the findings. Therefore, no malignancy is present. Skeptical considerations: While fracture healing is normal, it's important to ensure no underlying pathology is contributing to the fracture. However, the report explicitly states that there are no pathological features. Thus, I can confidently rule out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Healing fracture and normal bone density further support the absence of any pathological features. The reassurance provided by the consultant reinforces the benign nature of the findings. Therefore, no malignancy is present. Skeptical considerations: While fracture healing is normal, it's important to ensure no underlying pathology is contributing to the fracture. However, the report explicitly states that there are no pathological features. Thus, I can confidently rule out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there is no malignancy identified. Healing fracture and normal bone density further support the absence of any pathological features. The reassurance provided by the consultant reinforces the benign nature of the findings. Therefore, no malignancy is present. Skeptical considerations: While fracture healing is normal, it's important to ensure no underlying pathology is contributing to the fracture. However, the report explicitly states that there are no pathological features. Thus, I can confidently rule out malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malign",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there is no malignancy identified. Healing fracture and normal bone density further support the absence of any pathological features. The reassurance provided by the consultant reinforces the benign nature of the findings. Therefore, no malignancy is present. Skeptical considerations: While fracture healing is normal, it's important to ensure no underlying pathology is contributing to the fracture. However, the report explicitly states that there are no pathological features. Thus, I can confidently rule out malignancy.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 84,
      "timestamp": "2026-01-10T19:20:55.841815"
    },
    {
      "sample_idx": 85,
      "input": "14/05/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Normal chest radiograph. Clear lung fields. No mediastinal mass. Heart size normal. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 14/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The absence of any concerning findings on the chest radiograph, such as masses or abnormal lymph nodes, further supports the conclusion that there is no malignancy. The reassurance provided by the consultant further reinforces the benign nature of the findings. Therefore, the conclusion that there is no malignancy is well-supported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report clearly indicates a normal chest radiograph with no evidence of malignancy. The absence of any concerning findings, such as masses, enlarged lymph nodes, or abnormal heart size, further strengthens the conclusion of no malignancy. The reassurance provided by the consultant reinforces the benign nature of the findings. The report is a definitive statement that there is no malignancy present. Therefore, the conclusion that there is no malignancy is well-supported.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"no mediastinal mass\", \"heart size normal\", \"no malignancy identified\"],\n        \"rationale\": \"The report's conclusion that no malignancy is identified is the most important factor. The absence of any findings suggestive of malignancy, such as masses, abnormal lymph nodes, or enlarged heart, further supports this conclusion. The reassurance provided by the consultant strengthens the benign nature of the findings. Therefore, the conclusion that there is no malignancy is well-supported by the report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal chest radiograph\", \"clear lung fields\", \"",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that the chest radiograph is normal, and no malignancy is identified. The absence of any concerning findings on the chest radiograph, such as masses or abnormal lymph nodes, further supports the conclusion that there is no malignancy. The reassurance provided by the consultant further reinforces the benign nature of the findings. Therefore, the conclusion that there is no malignancy is well-supported.",
      "findings": [
        "normal chest radiograph",
        "clear lung fields",
        "no mediastinal mass",
        "heart size normal",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 85,
      "timestamp": "2026-01-10T19:20:55.841831"
    },
    {
      "sample_idx": 86,
      "input": "11/06/2025, 00:00, PET-CT\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hepatoblastoma.\n\nFrom clinical notes: Hepatoblastoma. Paediatric oncology assessment.\n\nFindings: large heterogeneous hepatic mass with elevated AFP. Fetal histology subtype. PRETEXT stage II. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 11/06/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could a benign liver condition be mistaken for a malignant mass? Playing devil's advocate against a benign conclusion: The presence of a large heterogeneous hepatic mass, elevated AFP, and the fetal histology subtype strongly suggests a malignant process, specifically hepatoblastoma. The PRETEXT stage II classification further supports this diagnosis. Alternative benign explanations (e.g., focal nodular hyperplasia) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely, and further investigation is warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could a benign liver condition be mistaken for a malignant mass? Playing devil's advocate against a benign conclusion: The presence of a large heterogeneous hepatic mass, elevated AFP, and the fetal histology subtype strongly suggests a malignant process, specifically hepatoblastoma. The PRETEXT stage II classification further supports this diagnosis. Alternative benign explanations (e.g., focal nodular hyperplasia) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely, and further investigation is warranted.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous hepatic mass\", \"elevated AFP\", \"Fetal histology subtype\", \"PRETEXT stage II\"],\n        \"rationale\": \"Initial skepticism: Could a benign liver condition be mistaken for a malignant mass? Playing devil's advocate against a benign conclusion: The presence of a large heterogeneous hepatic mass, elevated AFP, and the fetal histology subtype strongly suggests a malignant process, specifically hepatoblastoma. The PRETEXT stage II classification further supports this diagnosis. Alternative benign explanations (e.g., focal nodular hyperplasia) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely, and further",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a benign liver condition be mistaken for a malignant mass? Playing devil's advocate against a benign conclusion: The presence of a large heterogeneous hepatic mass, elevated AFP, and the fetal histology subtype strongly suggests a malignant process, specifically hepatoblastoma. The PRETEXT stage II classification further supports this diagnosis. Alternative benign explanations (e.g., focal nodular hyperplasia) are less likely given the constellation of findings. Conclusion: Malignancy is highly likely, and further investigation is warranted.",
      "findings": [
        "large heterogeneous hepatic mass",
        "elevated AFP",
        "Fetal histology subtype",
        "PRETEXT stage II"
      ],
      "fracture_mentioned": null,
      "idx": 86,
      "timestamp": "2026-01-10T19:20:55.841848"
    },
    {
      "sample_idx": 87,
      "input": "16/12/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Abnormal imaging. Suspected Acute Myeloid Leukemia.\n\nFrom clinical notes: Acute Myeloid Leukemia. Paediatric oncology assessment.\n\nFindings: myeloblasts accounting for 70% of marrow cellularity. Cytogenetic analysis reveals t(8;21) translocation. Favorable risk category. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 16/12/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the report explicitly states 70% myeloblasts. The presence of the t(8;21) translocation is a well-established marker for Acute Myeloid Leukemia (AML). This translocation is a strong indicator of AML. Alternative benign explanations (e.g., drug-induced myelosuppression, certain infections) are less likely given the context of the report. Conclusion: Malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Skepticism: Is 70% myeloblasts a definitive diagnosis? While it's a high percentage, it's not an absolute cutoff. Is the t(8;21) translocation always a sign of AML? It's associated with AML, but can be seen in other conditions. The report mentions 'favorable risk category,' which suggests a more likely diagnosis. Alternative benign explanations are less likely given the context of the report. Conclusion: Malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"myeloblasts accounting for 70% of marrow cellularity\", \"t(8;21) translocation\"],\n        \"rationale\": \"Skepticism: Could the percentage of myeloblasts be artificially inflated by a technical issue? Is the t(8;21) translocation always a sign of AML? It's associated with AML, but can be seen in other conditions. The report mentions 'favorable risk category,' which suggests a more likely diagnosis. Alternative benign explanations are less likely given the context of the report. Conclusion: Malignancy confirmed, despite initial",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could a high percentage of myeloblasts be reactive? However, the report explicitly states 70% myeloblasts. The presence of the t(8;21) translocation is a well-established marker for Acute Myeloid Leukemia (AML). This translocation is a strong indicator of AML. Alternative benign explanations (e.g., drug-induced myelosuppression, certain infections) are less likely given the context of the report. Conclusion: Malignancy confirmed, despite initial skepticism.",
      "findings": [
        "myeloblasts accounting for 70% of marrow cellularity",
        "t(8;21) translocation"
      ],
      "fracture_mentioned": null,
      "idx": 87,
      "timestamp": "2026-01-10T19:20:55.841864"
    },
    {
      "sample_idx": 88,
      "input": "29/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Wilms Tumor.\n\nFrom clinical notes: Wilms Tumor. Paediatric oncology assessment.\n\nFindings: large heterogeneous left renal mass with pseudocapsule. No vascular invasion. Favorable histology on biopsy. Stage II. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 29/05/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the renal mass be benign? The report describes a large, heterogeneous renal mass with a pseudocapsule, concerning for malignancy. No vascular invasion is noted, which is a favorable feature. Favorable histology on biopsy is a positive indicator. The stage II designation is consistent with a malignant process. Alternative benign explanations (e.g., complex cyst, hamartoma) are less likely given the description and stage. Conclusion: malignancy confirmed, although the favorable histology and lack of vascular invasion are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"large heterogeneous left renal mass with pseudocapsule\", \"No vascular invasion\", \"Favorable histology on biopsy\", \"Stage II\"],\n        \"rationale\": \"Initial skepticism: Could the renal mass be benign? The report describes a large, heterogeneous renal mass with a pseudocapsule, concerning for malignancy. No vascular invasion is noted, which is a favorable feature. Favorable histology on biopsy is a positive indicator. The stage II designation is consistent with a malignant process. Alternative benign explanations (e.g., complex cyst, hamartoma) are less likely given the description and stage. Conclusion: malignancy confirmed, although the favorable histology and lack of vascular invasion are reassuring.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the renal mass be benign? The report describes a large, heterogeneous renal mass with a pseudocapsule, concerning for malignancy. No vascular invasion is noted, which is a favorable feature. Favorable histology on biopsy is a positive indicator. The stage II designation is consistent with a malignant process. Alternative benign explanations (e.g., complex cyst, hamartoma) are less likely given the description and stage. Conclusion: malignancy confirmed, although the favorable histology and lack of vascular invasion are reassuring.",
      "findings": [
        "large heterogeneous left renal mass with pseudocapsule",
        "No vascular invasion",
        "Favorable histology on biopsy",
        "Stage II"
      ],
      "fracture_mentioned": null,
      "idx": 88,
      "timestamp": "2026-01-10T19:20:55.841894"
    },
    {
      "sample_idx": 89,
      "input": "16/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Acute Lymphoblastic Leukemia.\n\nFrom clinical notes: Acute Lymphoblastic Leukemia. Paediatric oncology assessment.\n\nFindings: bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells. Immunophenotyping consistent with B-cell ALL. CNS involvement negative. Recommend MDT discussion and treatment planning.\n\nDr James Chen, Consultant Paediatric Oncologist 16/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and CNS involvement negative provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and CNS involvement negative provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement negative\"],\n        \"rationale\": \"Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and CNS involvement negative provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells\", \"Immunophenotyping consistent with B-cell ALL\", \"CNS involvement",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could high lymphocyte count be reactive? However, the overwhelming proportion of lymphoblasts (85%), specific immunophenotyping confirming B-cell ALL, and CNS involvement negative provide definitive evidence. Alternative benign explanations (viral infection, stress response) are ruled out by the phenotype. Conclusion: malignancy confirmed despite initial skepticism.",
      "findings": [
        "bone marrow infiltration with lymphoblasts comprising 85% of nucleated cells",
        "Immunophenotyping consistent with B-cell ALL",
        "CNS involvement negative"
      ],
      "fracture_mentioned": null,
      "idx": 89,
      "timestamp": "2026-01-10T19:20:55.841910"
    },
    {
      "sample_idx": 90,
      "input": "06/09/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Retinoblastoma.\n\nFrom clinical notes: Retinoblastoma. Paediatric oncology assessment.\n\nFindings: intraocular mass with calcifications. Bilateral disease. Family history positive. RB1 germline mutation detected. Recommend MDT discussion and treatment planning.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 06/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of calcifications, bilateral disease, positive family history, and confirmed RB1 germline mutation strongly suggest retinoblastoma. Alternative benign explanations (inflammatory process, reactive hyperplasia) are less likely given the specific findings. Conclusion: malignancy confirmed based on the strong evidence of retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no abnormal findings\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the report be inaccurate or incomplete? Playing devil's advocate against a benign conclusion: The report explicitly states 'no abnormal findings.' The findings of the report do not support a diagnosis of malignancy. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of calcifications, bilateral disease, positive family history, and confirmed RB1 germline mutation strongly suggest retinoblastoma. Alternative benign explanations (inflammatory process, reactive hyperplasia) are less likely given the specific findings. Conclusion: malignancy confirmed based on the strong evidence of retinoblastoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"intraocular mass with calcifications\", \"bilateral disease\", \"family history positive\", \"RB1 germline mutation detected\"],\n        \"rationale\": \"Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of calcifications, bilateral disease, positive family history, and confirmed RB1 germ",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the mass be reactive or inflammatory? However, the presence of calcifications, bilateral disease, positive family history, and confirmed RB1 germline mutation strongly suggest retinoblastoma. Alternative benign explanations (inflammatory process, reactive hyperplasia) are less likely given the specific findings. Conclusion: malignancy confirmed based on the strong evidence of retinoblastoma.",
      "findings": [
        "intraocular mass with calcifications",
        "bilateral disease",
        "family history positive",
        "RB1 germline mutation detected"
      ],
      "fracture_mentioned": null,
      "idx": 90,
      "timestamp": "2026-01-10T19:20:55.841925"
    },
    {
      "sample_idx": 91,
      "input": "30/01/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Benign presentation. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Rachel Patel, Consultant Paediatric Oncologist 30/01/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a healing fracture be misinterpreted? While the report explicitly states 'healing fracture' and 'no pathological features', a more skeptical approach would consider the context. The patient's history mentions a benign presentation and no previous oncology history. The report also confirms the fracture is healing normally. Therefore, it is highly improbable that the fracture itself would be misconstrued as malignancy. The absence of any pathological features further reinforces the benign nature of the findings. Conclusion: No malignancy identified. Skeptical analysis does not support a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. A healing fracture is a normal process. Therefore, there is no evidence to suggest malignancy. Skeptical analysis does not support a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report states that the healing fracture is normal, bone density is normal, and there are no pathological features. It also explicitly states that no malignancy is identified. Therefore, there is no evidence to suggest malignancy. Skeptical analysis does not support a diagnosis of malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. A healing fracture is a normal process. Therefore, it is highly improbable that the fracture itself would",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a healing fracture be misinterpreted? While the report explicitly states 'healing fracture' and 'no pathological features', a more skeptical approach would consider the context. The patient's history mentions a benign presentation and no previous oncology history. The report also confirms the fracture is healing normally. Therefore, it is highly improbable that the fracture itself would be misconstrued as malignancy. The absence of any pathological features further reinforces the benign nature of the findings. Conclusion: No malignancy identified. Skeptical analysis does not support a diagnosis of malignancy.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 91,
      "timestamp": "2026-01-10T19:20:55.841944"
    },
    {
      "sample_idx": 92,
      "input": "22/05/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Routine surveillance. No previous oncology history.\n\nFindings: Benign bone cyst - resolved. No aggressive features. Normal bone density. No recurrence on imaging. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 22/05/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"benign bone cyst - resolved\", \"no aggressive features\", \"normal bone density\", \"no recurrence on imaging\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: The report explicitly states that a benign bone cyst was resolved, and there are no aggressive features, normal bone density, no recurrence on imaging, and no malignancy identified. This seems like a complete and reassuring picture. While the report is reassuring, it doesn't rule out the possibility of occult malignancy, but the complete absence of any concerning features makes it highly unlikely. Further investigation is not warranted based on this report.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings suggestive of malignancy. This is a strong indicator that there is no malignancy. Skeptical reasoning: While it is always important to be cautious, the report provides a clear and definitive statement that there is no malignancy. This statement is supported by the absence of any other concerning findings. Therefore, it is reasonable to conclude that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings suggestive of malignancy. This is a strong indicator that there is no malignancy. Skeptical reasoning: While it is always important to be cautious, the report provides a clear and definitive statement that there is no malignancy. This statement is supported by the absence of any other concerning findings. Therefore, it is reasonable to conclude that there is no malignancy.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no findings suggestive of malignancy\"],\n        \"rationale\": \"The report explicitly states that there are no findings",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could the report be a false reassurance? Playing devil's advocate against a benign conclusion: The report explicitly states that a benign bone cyst was resolved, and there are no aggressive features, normal bone density, no recurrence on imaging, and no malignancy identified. This seems like a complete and reassuring picture. While the report is reassuring, it doesn't rule out the possibility of occult malignancy, but the complete absence of any concerning features makes it highly unlikely. Further investigation is not warranted based on this report.",
      "findings": [
        "benign bone cyst - resolved",
        "no aggressive features",
        "normal bone density",
        "no recurrence on imaging",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 92,
      "timestamp": "2026-01-10T19:20:55.841963"
    },
    {
      "sample_idx": 93,
      "input": "04/02/2025, 00:00, BONE MARROW BIOPSY\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 04/02/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report explicitly states that there are no pathological features and no malignancy identified. The reason for the bone marrow biopsy was screening, and the patient has no prior oncology history. The healing fracture is a normal process. The bone density is normal. Therefore, no evidence of malignancy is present. The report is reassuring. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal bone marrow\", \"no malignant cells\", \"no abnormal findings\"],\n        \"rationale\": \"The report indicates a normal bone marrow with no malignant cells or abnormal findings. The reason for the biopsy was screening, and there is no prior history of cancer. The report is reassuring and provides no evidence of malignancy. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignant cells\", \"normal bone marrow\", \"no abnormal findings\", \"healing fracture\"],\n        \"rationale\": \"The report explicitly states that there are no malignant cells, normal bone marrow, and no abnormal findings. The healing fracture is a normal process. The reason for the biopsy was screening, and the patient has no prior oncology history. The report is reassuring. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"no malignant cells\", \"normal bone marrow\", \"no abnormal findings\", \"healing fracture\"],\n        \"rationale\": \"The report explicitly states that there are no malignant cells, normal bone marrow, and no abnormal findings. The healing fracture is a normal process. The reason for the biopsy was screening, and the patient has no prior oncology history. The report is reassuring. Conclusion: No malignancy present.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report explicitly states that there are no pathological features and no malignancy identified. The reason for the bone marrow biopsy was screening, and the patient has no prior oncology history. The healing fracture is a normal process. The bone density is normal. Therefore, no evidence of malignancy is present. The report is reassuring. Conclusion: No malignancy present.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 93,
      "timestamp": "2026-01-10T19:20:55.841979"
    },
    {
      "sample_idx": 94,
      "input": "05/08/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Rule out malignancy. No previous oncology history.\n\nFindings: Normal brain MRI for age. No mass lesion. No abnormal enhancement. Headaches attributed to migraine. No malignancy identified. Reassurance provided.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 05/08/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a very early or indolent malignancy be missed on imaging? While the report explicitly states no malignancy identified, the absence of any abnormal findings on the MRI makes this highly unlikely. The reassurance provided further supports the benign conclusion. Alternative benign explanations (migraine, normal imaging) are the most probable. Conclusion: No malignancy identified. The reassuring nature of the report makes the conclusion highly probable.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a very early or indolent malignancy be missed on imaging? While the report explicitly states no malignancy identified, the absence of any abnormal findings on the MRI makes this highly unlikely. The reassurance provided further supports the benign conclusion. Alternative benign explanations (migraine, normal imaging) are the most probable. Conclusion: No malignancy identified. The reassuring nature of the report makes the conclusion highly probable.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could a very early or indolent malignancy be missed on imaging? While the report explicitly states no malignancy identified, the absence of any abnormal findings on the MRI makes this highly unlikely. The reassurance provided further supports the benign conclusion. Alternative benign explanations (migraine, normal imaging) are the most probable. Conclusion: No malignancy identified. The reassuring nature of the report makes the conclusion highly probable.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal brain MRI\", \"no mass lesion\", \"no abnormal enhancement\", \"no malignancy identified\"],\n",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could a very early or indolent malignancy be missed on imaging? While the report explicitly states no malignancy identified, the absence of any abnormal findings on the MRI makes this highly unlikely. The reassurance provided further supports the benign conclusion. Alternative benign explanations (migraine, normal imaging) are the most probable. Conclusion: No malignancy identified. The reassuring nature of the report makes the conclusion highly probable.",
      "findings": [
        "normal brain MRI",
        "no mass lesion",
        "no abnormal enhancement",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 94,
      "timestamp": "2026-01-10T19:20:55.841995"
    },
    {
      "sample_idx": 95,
      "input": "10/03/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Screening. No previous oncology history.\n\nFindings: Healing fracture - normal process. No pathological features. Bone density normal. Trauma history consistent. No malignancy identified. Reassurance provided.\n\nDr Emma Wilson, Consultant Paediatric Oncologist 10/03/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"healing fracture\", \"normal bone density\", \"no pathological features\", \"no malignancy identified\"],\n        \"rationale\": \"The report clearly states that there are no pathological features and no malignancy identified. The healing fracture is a normal process, and the bone density is normal. Therefore, there is no evidence to suggest malignancy. Skeptical reasoning: Could there be a subtle, early sign of malignancy missed? However, the report explicitly rules out any pathological features or malignancy. The healing fracture is a common and benign finding. Conclusion: No malignancy identified.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC\", \"age-appropriate values\", \"no blast cells\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "The report clearly states that there are no pathological features and no malignancy identified. The healing fracture is a normal process, and the bone density is normal. Therefore, there is no evidence to suggest malignancy. Skeptical reasoning: Could there be a subtle, early sign of malignancy missed? However, the report explicitly rules out any pathological features or malignancy. The healing fracture is a common and benign finding. Conclusion: No malignancy identified.",
      "findings": [
        "healing fracture",
        "normal bone density",
        "no pathological features",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 95,
      "timestamp": "2026-01-10T19:20:55.842012"
    },
    {
      "sample_idx": 96,
      "input": "28/09/2025, 00:00, ULTRASOUND\n\nCase History:\n\nReason for Request: Palpable mass. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Michael Taylor, Consultant Paediatric Oncologist 28/09/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the findings be explained by reactive lymphadenopathy or other benign conditions? However, the presence of a bulky mediastinal mass, FDG-avid nodes (indicating metabolic activity consistent with malignancy), and the specific diagnosis of Classical Hodgkin Lymphoma (nodular sclerosing type) strongly suggest malignancy. While the clinical context (paediatric oncology) is important, the report's findings are highly suggestive of Hodgkin Lymphoma. Alternative benign explanations are unlikely given the clinical context and the report's specific findings. Conclusion: Malignancy is highly probable, based on the report findings and the clinical context.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the findings be explained by reactive lymphadenopathy or other benign conditions? However, the presence of a bulky mediastinal mass, FDG-avid nodes (indicating metabolic activity consistent with malignancy), and the specific diagnosis of Classical Hodgkin Lymphoma (nodular sclerosing type) strongly suggest malignancy. While the clinical context (paediatric oncology) is important, the report's findings are highly suggestive of Hodgkin Lymphoma. Alternative benign explanations are unlikely given the clinical context and the report's specific findings. Conclusion: Malignancy is highly probable, based on the report findings and the clinical context.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Initial skepticism: Could the findings be explained by reactive lymphadenopathy or",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the findings be explained by reactive lymphadenopathy or other benign conditions? However, the presence of a bulky mediastinal mass, FDG-avid nodes (indicating metabolic activity consistent with malignancy), and the specific diagnosis of Classical Hodgkin Lymphoma (nodular sclerosing type) strongly suggest malignancy. While the clinical context (paediatric oncology) is important, the report's findings are highly suggestive of Hodgkin Lymphoma. Alternative benign explanations are unlikely given the clinical context and the report's specific findings. Conclusion: Malignancy is highly probable, based on the report findings and the clinical context.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 96,
      "timestamp": "2026-01-10T19:20:55.842032"
    },
    {
      "sample_idx": 97,
      "input": "02/01/2025, 00:00, X-RAY\n\nCase History:\n\nReason for Request: Bone pain. Suspected Brain Tumor - Glioma.\n\nFrom clinical notes: Brain Tumor - Glioma. Paediatric oncology assessment.\n\nFindings: left temporal lobe infiltrative mass with mass effect. FLAIR hyperintensity. Biopsy confirms diffuse astrocytoma WHO grade II. Recommend MDT discussion and treatment planning.\n\nDr Sophie Richardson, Consultant Paediatric Oncologist 02/01/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"Initial skepticism: Could the infiltrative mass be reactive? However, the biopsy confirming a diffuse astrocytoma (WHO grade II) strongly suggests malignancy. The FLAIR hyperintensity supports the presence of a mass. Alternative benign explanations (inflammatory process, vascular malformation) are less likely given the biopsy result. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"Initial skepticism: Could the infiltrative mass be reactive? However, the biopsy confirming a diffuse astrocytoma (WHO grade II) strongly suggests malignancy. The FLAIR hyperintensity supports the presence of a mass. Alternative benign explanations (inflammatory process, vascular malformation) are less likely given the biopsy result. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse astrocytoma WHO grade II\"],\n        \"rationale\": \"Initial skepticism: Could the infiltrative mass be reactive? However, the biopsy confirming a diffuse astrocytoma (WHO grade II) strongly suggests malignancy. The FLAIR hyperintensity supports the presence of a mass. Alternative benign explanations (inflammatory process, vascular malformation) are less likely given the biopsy result. Conclusion: malignancy confirmed, despite initial skepticism.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"left temporal lobe infiltrative mass with mass effect\", \"FLAIR hyperintensity\", \"biopsy confirms diffuse",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Initial skepticism: Could the infiltrative mass be reactive? However, the biopsy confirming a diffuse astrocytoma (WHO grade II) strongly suggests malignancy. The FLAIR hyperintensity supports the presence of a mass. Alternative benign explanations (inflammatory process, vascular malformation) are less likely given the biopsy result. Conclusion: malignancy confirmed, despite initial skepticism.",
      "findings": [
        "left temporal lobe infiltrative mass with mass effect",
        "FLAIR hyperintensity",
        "biopsy confirms diffuse astrocytoma WHO grade II"
      ],
      "fracture_mentioned": null,
      "idx": 97,
      "timestamp": "2026-01-10T19:20:55.842048"
    },
    {
      "sample_idx": 98,
      "input": "29/06/2025, 00:00, MRI BRAIN\n\nCase History:\n\nReason for Request: Follow-up post-treatment. No previous oncology history.\n\nFindings: Normal CBC with age-appropriate values. No blast cells. Platelets adequate. Hemoglobin within normal limits. No malignancy identified. Reassurance provided.\n\nDr James Chen, Consultant Paediatric Oncologist 29/06/2025, 00:00",
      "response": "```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": false,\n    \"malignancy\": false,\n    \"evidence\": {\n        \"report_findings\": [\"normal CBC with age-appropriate values\", \"no blast cells\", \"platelets adequate\", \"hemoglobin within normal limits\", \"no malignancy identified\"],\n        \"rationale\": \"Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with",
      "predicted": false,
      "ground_truth": false,
      "correct": true,
      "reasoning": "Applying skeptical reasoning: Could early malignancy be masked by normal counts? Playing devil's advocate against a benign conclusion: the report shows completely normal blood counts with explicit absence of blast cells. No features suggesting occult malignancy. Cannot conclude malignancy without evidence of abnormal cells or pathological findings.",
      "findings": [
        "normal CBC with age-appropriate values",
        "no blast cells",
        "platelets adequate",
        "hemoglobin within normal limits",
        "no malignancy identified"
      ],
      "fracture_mentioned": null,
      "idx": 98,
      "timestamp": "2026-01-10T19:20:55.842062"
    },
    {
      "sample_idx": 99,
      "input": "21/03/2025, 00:00, CT CHEST/ABDOMEN\n\nCase History:\n\nReason for Request: Pancytopenia. Suspected Hodgkin Lymphoma.\n\nFrom clinical notes: Hodgkin Lymphoma. Paediatric oncology assessment.\n\nFindings: mediastinal lymphadenopathy with bulky anterior mediastinal mass. PET-CT showing FDG-avid nodes. Classical Hodgkin, nodular sclerosing type. Recommend MDT discussion and treatment planning.\n\nDr Sarah Mitchell, Consultant Paediatric Oncologist 21/03/2025, 00:00",
      "response": "```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skeptical review: The report clearly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all consistent with Hodgkin Lymphoma. The description of the Hodgkin type (nodular sclerosing) further supports this diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the description of a bulky mass and FDG-avid nodes. Conclusion: Malignancy confirmed, consistent with Hodgkin Lymphoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skeptical review: The report clearly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all consistent with Hodgkin Lymphoma. The description of the Hodgkin type (nodular sclerosing) further supports this diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the description of a bulky mass and FDG-avid nodes. Conclusion: Malignancy confirmed, consistent with Hodgkin Lymphoma.\"\n    }\n}\n```\n```json\n{\n    \"abnormal_findings\": true,\n    \"malignancy\": true,\n    \"evidence\": {\n        \"report_findings\": [\"mediastinal lymphadenopathy\", \"bulky anterior mediastinal mass\", \"FDG-avid nodes\", \"Classical Hodgkin, nodular sclerosing type\"],\n        \"rationale\": \"Skeptical review: The report clearly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all consistent with Hodgkin Lymphoma. The description of the Hodgkin type (nodular sclerosing) further supports this diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy)",
      "predicted": true,
      "ground_truth": true,
      "correct": true,
      "reasoning": "Skeptical review: The report clearly describes mediastinal lymphadenopathy, a bulky anterior mediastinal mass, and FDG-avid nodes, all consistent with Hodgkin Lymphoma. The description of the Hodgkin type (nodular sclerosing) further supports this diagnosis. Alternative benign explanations (e.g., reactive lymphadenopathy) are less likely given the description of a bulky mass and FDG-avid nodes. Conclusion: Malignancy confirmed, consistent with Hodgkin Lymphoma.",
      "findings": [
        "mediastinal lymphadenopathy",
        "bulky anterior mediastinal mass",
        "FDG-avid nodes",
        "Classical Hodgkin, nodular sclerosing type"
      ],
      "fracture_mentioned": null,
      "idx": 99,
      "timestamp": "2026-01-10T19:20:55.842078"
    }
  ],
  "end_time": "2026-01-10T19:20:55.842569",
  "duration_seconds": 62.820595
}